Other or ill-defined heart diseases

I9_OTHILLHEART

heart disease: A disease involving the heart and/or pericardium.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I51, I52* Hospital discharge: ICD-9 — 429 Hospital discharge: ICD-8 — 42899\|42999 Cause of death: ICD-10 — I51, I52* Cause of death: ICD-9 — 429 Cause of death: ICD-8 — 42899\|42999 2 out of 7 registries used, show all original rules.	2538
4. Check minimum number of events None	2538
5. Include endpoints None	2538
6. Filter based on genotype QC (FinnGen only)	2466

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_OTHILLHEART
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I5[1-2]
HD_ICD_9	429
HD_ICD_8	42899\|42999
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I5[1-2]
COD_ICD_9	429
COD_ICD_8	42899\|42999
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or ill-defined heart diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33677	12205	20779
Only index persons	17579	6000	11579
Unadjusted period prevalence (%)
Whole population	0.50	0.35	0.58
Only index persons	0.37	0.22	0.44
Median age at first event (years)
Whole population	58.86	65.01	55.08
Only index persons	51.92	58.39	48.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2466	920	1546
Unadjusted period prevalence (%)	0.57	0.33	0.71
Median age at first event (years)	56.35	56.44	56.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2536: Matched controls
25352

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

91.6

311.1

163

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

311.0

292

I51.4

ICD-10 Finland

Myocarditis, unspecified

7260.2

307.7

956

I50.9

ICD-10 Finland

Heart failure, unspecified

75.0

307.7

535

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.2

307.7

822

1259

I51.7

ICD-10 Finland

Cardiomegaly

+∞

307.7

590

201

Kela drug reimbursment

Chronic cardiac insufficiency

23.5

307.7

333

162

C01AA05

ATC

digoxin; systemic

17.8

307.7

282

177

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

369.9

307.7

323

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

7.5

307.7

864

1638

I50.0

ICD-10 Finland

Congestive heart failure

172.5

307.7

304

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

169.5

307.7

259

I48

ICD-10 Finland

Atrial fibrillation and flutter

102.4

307.7

585

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

88.5

307.7

181

207

Kela drug reimbursment

Chronic arrhythmias

184.0

307.7

403

B01AA03

ATC

warfarin; systemic

8.6

307.7

668

1010

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.1

307.7

877

2035

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

81.9

289.6

154

I50.1

ICD-10 Finland

Left ventricular failure

1029.8

287.1

276

C03CA01

ATC

furosemide; systemic

4.5

274.5

960

3035

C07AB07

ATC

bisoprolol; oral

4.1

273.5

1391

5747

C03DA01

ATC

spironolactone; oral

6.5

246.1

454

826

XF404

NOMESCO Finland

Ambulatory ECG

10.6

230.8

264

274

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

49.7

212.0

123

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

311.4

199.2

200

K78

ICPC

Atrial fibrillation/flutter

18.7

198.8

160

I51.9

ICD-10 Finland

Heart disease, unspecified

666.4

190.5

186

TFP20

NOMESCO Finland

Cardiodefibrillation

287.0

184.4

186

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

180.4

171

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.0

168.7

573

1708

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

160.1

152

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

1643.3

156.9

151

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.4

155.1

273

467

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

330.4

153.5

154

B01AF02

ATC

apixaban; oral

6.6

153.1

261

432

AN1

Coronary angiography

4.9

152.5

371

852

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

149.4

1322

6922

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

7.5

148.1

222

320

I35.0

ICD-10 Finland

Aortic (valve) stenosis

25.3

144.8

102

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

63.5

144.5

250, ,

Kela drug reimbursment

61.9

140.3

I49.3

ICD-10 Finland

Ventricular premature depolarization

9.4

137.4

168

189

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

132.4

126

I48.1

ICD-10 Finland

Persistent atrial fibrillation

67.3

131.3

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

649.5

126.5

124

I34.1

ICD-10 Finland

Mitral (valve) prolapse

68.8

122.6

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

120.9

836

3758

I50

ICD-10 Finland

Heart failure

26.8

120.5

C01BD01

ATC

amiodarone; systemic

158.7

115.3

121

GD1LA

NOMESCO Finland

43.6

113.9

42999

ICD-8 Finland

Ill-defined heart disease, Other and unspecified heart disease

+∞

108.1

103

I47.1

ICD-10 Finland

Supraventricular tachycardia

25.2

108.0

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

539.7

105.5

104

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

104.4

497

1801

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.6

103.2

267

638

I51.1

ICD-10 Finland

Rupture of chordae tendineae, not elsewhere classified

+∞

101.7

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5.2

100.1

219

455

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.8

98.9

613

2567

C09AA05

ATC

ramipril; oral

2.7

96.2

683

3062

XF402

NOMESCO Finland

ECG with work load test

4.1

94.1

283

757

I47.2

ICD-10 Finland

Ventricular tachycardia

201.5

94.0

I48.2

ICD-10 Finland

Chronic atrial fibrillation

480.0

93.9

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

130.0

93.7

100

R06.0

ICD-10 Finland

Dyspnoea

2.6

92.1

701

3242

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

91.2

ZXD05

NOMESCO Finland

Urgent procedure

2.4

85.5

823

4222

I44.2

ICD-10 Finland

Atrioventricular block, complete

856.1

85.1

FL1AC

NOMESCO Finland

Left cardioangiography

12.5

81.6

I49.5

ICD-10 Finland

Sick sinus syndrome

119.5

75.3

TFP34

NOMESCO Finland

Electrophysiological investigation

257.5

73.8

WX892

NOMESCO Finland

Monitored bed care

3.9

73.7

236

657

K77

ICPC

Heart failure

27.7

72.0

C07AA07

ATC

sotalol; systemic

8.0

70.8

125

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

6.8

69.9

111

169

Angiography of the heart and coronary arteries

4.3

67.2

182

448

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

63.8

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

8.7

63.3

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

7.4

63.3

130

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

28.4

62.2

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

601.8

60.0

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.9

59.9

136

290

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

59.6

WX872

NOMESCO Finland

Intensive care

4.5

57.5

145

337

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

92.3

57.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

56.8

707

3921

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.7

56.5

107

42899

ICD-8 Finland

Other myocardial insufficiency

+∞

53.3

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

53.3

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

53.3

TK800

NOMESCO Finland

Hemodialysis

6.7

53.3

133

A12BA01

ATC

potassium chloride; oral

4.6

52.6

127

285

I51.5

ICD-10 Finland

Myocardial degeneration

+∞

52.3

C09DX04

ATC

valsartan and sacubitril; oral

+∞

51.2

I25.2

ICD-10 Finland

Old myocardial infarction

3.5

51.1

187

567

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

51.0

576

3061

C01BC04

ATC

flecainide; systemic

112.4

51.0

C07AB02

ATC

metoprolol; systemic

2.3

50.8

463

2258

AP1

Catheterization of the left side of the heart

9.7

50.5

4298A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[ASTHENIA VASOREGULATORIA]

+∞

50.2

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

50.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

50.0

199

636

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

49.1

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

132.6

48.9

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

48.9

449

2193

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

48.4

407

1915

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

48.3

181

557

I51.0

ICD-10 Finland

Cardiac septal defect, acquired

+∞

48.1

XF640, ,

NOMESCO Finland

8.0

47.8

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

7.6

47.6

L04AA06

ATC

mycophenolic acid; systemic

6.0

46.6

142

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.1

46.1

200

673

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

46.0

K84

ICPC

Heart disease other

6.4

45.8

121

I20.09

ICD-10 Finland

Unstable angina

3.7

45.5

153

438

C01DA14

ATC

isosorbide mononitrate; oral

2.4

45.5

370

1712

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.8

45.1

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.9

45.0

140

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

45.0

140

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

159.5

44.9

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

99.9

44.9

I44.1

ICD-10 Finland

Atrioventricular block, second degree

122.2

44.9

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

9.8

44.8

TFJ02

NOMESCO Finland

Muscle biopsy of heart

445.2

44.4

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

43.9

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

43.9

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

12.5

43.6

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.6

43.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.7

43.3

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

434.8

43.3

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.4

43.2

167

5253

FHL

Cardiac lung machine

12.5

42.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

42.5

297

1282

127

Kela drug reimbursment

Transplant complication

6.5

42.3

108

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

41.9

428

2172

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

40.8

523

2888

4294A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Functional disturbances following cardiac surgery

+∞

40.7

AA1AD

NOMESCO Finland

CT of head and brain

1.9

39.3

663

4011

H02AB06

ATC

prednisolone; systemic

1.7

39.2

1101

7750

C08DA01

ATC

verapamil; systemic

4.4

38.5

229

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

37.7

338

1623

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

36.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

36.4

268

1182

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.1

35.7

101

256

M04AA01

ATC

allopurinol; systemic

2.3

35.4

305

1439

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.6

35.4

225

926

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

35.0

450

2474

R02

ICPC

Shortness of breath/dyspnoea

2.3

34.5

296

1393

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

341.6

34.0

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.9

33.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

33.7

113

323

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

50.7

33.5

AS4

Physiological pacemaker insertion DDD (R)

+∞

33.4

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

33.4

R07.3

ICD-10 Finland

Other chest pain

2.3

33.1

260

1178

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.9

33.0

156

TFP35

NOMESCO Finland

Electroanatomical mapping

118.2

32.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

32.6

146

499

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

37.9

32.5

L04AX01

ATC

azathioprine; systemic

3.2

32.3

130

417

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.3

32.1

205

ZX120

NOMESCO Finland

Intravenous

2.4

32.1

233

1019

Z2221

NOMESCO Finland

Medical doctor

1.8

31.3

603

3763

R4110

NOMESCO Finland

Physiotherapy

1.8

31.3

627

3959

R50.9

ICD-10 Finland

Fever, unspecified

2.0

31.2

383

2067

L04AD02

ATC

tacrolimus; systemic

6.6

31.1

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

5.4

31.1

118

B33.2

ICD-10 Finland

Viral carditis

70.8

30.9

Z94.0

ICD-10 Finland

Kidney transplant status

6.5

30.7

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

30.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

30.2

237

1073

K80

ICPC

Cardiac arrhythmia NOS

2.9

29.9

149

541

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

8.6

29.6

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.9

29.3

224

N18.8

ICD-10 Finland

Other chronic renal failure

4.9

29.3

136

ZXE00

NOMESCO Finland

One hour or less

1.7

28.9

834

5791

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.9

28.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.7

28.2

244

N05CF01

ATC

zopiclone; oral

1.7

28.2

743

5034

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

28.2

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

28.2

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

39.4

28.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

27.9

196

844

B01AB05

ATC

enoxaparin; parenteral

1.7

27.9

639

4170

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

284.5

27.8

B01AF03

ATC

edoxaban; oral

11.3

27.6

PD5AD

NOMESCO Finland

CT of aorta

5.0

27.5

120

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.7

27.3

245

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

27.1

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.9

27.1

128

451

A11CC03

ATC

alfacalcidol; systemic

4.5

26.9

150

I44.0

ICD-10 Finland

Atrioventricular block, first degree

10.8

26.9

N05BA01

ATC

diazepam; systemic, rectal

2.0

26.9

316

1674

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.4

26.8

100

A02BC02

ATC

pantoprazole; systemic

1.6

26.8

1513

12251

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.5

26.2

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

26.1

H02AB04

ATC

methylprednisolone; systemic

2.0

25.8

322

1740

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

25.8

225

1063

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

25.6

298

1572

L04AD01

ATC

ciclosporin; systemic

4.7

25.5

128

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.9

25.5

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

4.9

25.3

117

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

25.3

113

386

A12AA04

ATC

calcium carbonate; oral

5.5

25.3

4298X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[MORBUS CORDIS ALIA DEFINITA]

+∞

25.0

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

25.0

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

24.8

123

N18.0

ICD-10 Finland

End-stage renal disease

8.1

24.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

24.5

618

4114

B01AE07

ATC

dabigatran etexilate; oral

4.5

24.3

137

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

24.3

320

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.6

24.3

Z3231

NOMESCO Finland

Registered nurse

1.7

24.2

599

3969

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.6

24.1

J01MA12

ATC

levofloxacin; systemic

1.8

23.9

410

2452

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

242.1

23.7

R03AC02

ATC

salbutamol; inhalant

1.5

23.6

1174

9137

Z94.1

ICD-10 Finland

Heart transplant status

47.1

23.3

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

7.1

23.3

N02AX02

ATC

tramadol; systemic, rectal

1.5

23.3

954

7111

R00.2

ICD-10 Finland

Palpitations

2.5

23.1

152

634

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

23.0

141

569

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

22.9

1CX08, ,

NOMESCO Finland

65.6

22.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

22.6

678

4701

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

22.5

263

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

5.1

22.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

22.2

240

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.4

22.1

152

647

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

21.9

AQ1

Conventional electrophysiological examination

+∞

21.9

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

21.9

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

21.8

223

1120

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

25.3

21.7

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

221.8

21.6

I40.8

ICD-10 Finland

Other acute myocarditis

221.8

21.6

J01FF01

ATC

clindamycin; systemic

1.6

21.6

569

3815

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.4

425

2645

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.2

408

2516

N05BA04

ATC

oxazepam; oral

1.6

21.1

581

3935

WX730

NOMESCO Finland

Conventional respirator

5.3

21.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

21.1

233

1204

H02AB07

ATC

prednisone; oral

1.9

21.1

302

1705

I40.0

ICD-10 Finland

Infective myocarditis

+∞

20.9

AP4

Myocardial biopsy

+∞

20.9

I49.1

ICD-10 Finland

Atrial premature depolarization

5.0

20.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

20.6

473

3058

R55

ICD-10 Finland

Syncope and collapse

2.0

20.5

237

1243

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

20.5

239

1258

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.9

20.5

348

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

4.2

20.3

127

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

20.2

779

5690

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.5

20.2

200

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.1

20.2

136

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

19.9

230

1206

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

19.9

128

529

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

19.8

107

405

N19

ICD-10 Finland

Unspecified kidney failure

3.1

19.7

269

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

8.2

19.6

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.2

19.4

K83

ICPC

Heart valve disease NOS

46.4

19.2

3AC01, ,

NOMESCO Finland

5.9

19.2

E66.8

ICD-10 Finland

Other obesity

2.6

19.1

115

460

Z2446

NOMESCO Finland

Social worker

2.2

19.0

157

724

Electrophysiological Special Examination

+∞

18.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.8

376

2340

E66.0

ICD-10 Finland

Obesity due to excess calories

6.6

18.7

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.3

18.7

142

632

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

18.6

144

646

SPAT1097

SPAT

Recording of ECG

1.9

18.3

268

1520

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

18.3

149

684

I45.9

ICD-10 Finland

Conduction disorder, unspecified

44.3

18.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

18.2

K99

ICPC

Cardiovascular disease other

4.0

18.2

129

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.1

520

3544

I20.00

ICD-10 Finland

Unstable angina

3.4

17.8

192

5314

FHL

Bypass surgery for four or more vessels

7.3

17.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.8

209

1103

4299X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Heart disease, unspecified

+∞

17.7

I30.0

ICD-10 Finland

Acute nonspecific idiopathic pericarditis

+∞

17.7

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

17.7

I51.6

ICD-10 Finland

Cardiovascular disease, unspecified

+∞

17.7

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.1

17.7

254

B01AC04

ATC

clopidogrel; oral

1.7

17.7

321

1942

R03BB04

ATC

tiotropium bromide; inhalant

2.0

17.7

216

1155

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.8

17.4

J46

ICD-10 Finland

Status asthmaticus

3.4

17.4

185

A46

ICD-10 Finland

Erysipelas

1.8

17.4

306

1834

WX882

NOMESCO Finland

High dependency care

3.3

17.2

201

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

17.2

412

2683

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

17.2

154

735

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

17.1

296

1765

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.1

16.8

235

C07AG02

ATC

carvedilol; oral

2.4

16.8

116

496

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

16.7

4293A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Cardiomegaly

+∞

16.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

16.7

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

16.7

C08DB01

ATC

diltiazem; oral

2.5

16.7

109

454

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

16.7

107

442

Catheterization and pressure measurement of the left side of the heart

4.5

16.6

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

16.4

16.5

I48.3

ICD-10 Finland

Typical atrial flutter

171.0

16.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

16.4

685

5047

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

16.3

334

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

16.2

179

923

C09AA02

ATC

enalapril; systemic

1.6

16.2

397

2596

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

16.2

400

K29

ICPC

Cardiovascular sympt/complt other

2.7

16.1

336

R04.0

ICD-10 Finland

Epistaxis

2.1

16.1

150

727

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.2

15.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

15.7

289

J01FA06

ATC

roxithromycin; oral

1.4

15.6

810

6211

L04AA01

ATC

[U] ciclosporin

4.8

15.6

I42

ICD-10 Finland

Cardiomyopathy

+∞

15.6

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

15.6

XF409

NOMESCO Finland

Other special ECG

26.4

15.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

15.6

134

629

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

160.9

15.5

J01MA14

ATC

moxifloxacin; systemic

1.9

15.4

194

1048

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

15.4

237

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

15.4

155

WX722

NOMESCO Finland

PEEP

2.5

15.3

386

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

15.3

108

466

137

Kela drug reimbursment

Uraemia requiring dialysis

5.5

15.2

5315

FHL

Bypass surgery using a mammary artery

5.5

15.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

15.2

711

5344

A11

ICPC

Chest pain NOS

2.0

15.1

177

933

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.0

513

3618

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.5

14.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

14.9

398

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.8

731

5544

M10.9

ICD-10 Finland

Gout, unspecified

2.1

14.8

136

656

C10AA01

ATC

simvastatin; oral

1.4

14.6

824

6399

N05CD07

ATC

temazepam; oral

1.7

14.6

262

1576

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

14.6

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

14.6

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

14.6

A10BK01

ATC

dapagliflozin; oral

2.0

14.6

150

755

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.8

14.5

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

150.8

14.5

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

14.5

197

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

14.5

128

608

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.5

14.4

142

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

14.3

202

1132

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

14.2

287

J01AA02

ATC

doxycycline; systemic

1.4

14.2

1695

14922

Z3226

NOMESCO Finland

Physiotherapist

1.6

14.1

361

2380

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

14.1

164

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.7

14.0

205

Kela drug reimbursment

Chronic hypertension

1.5

13.9

545

3945

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

13.9

423

R03BA01

ATC

beclometasone; inhalant

1.7

13.9

275

1701

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

13.8

223

1302

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

13.7

116

541

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

13.6

176

958

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

13.6

122

583

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

13.5

I31.8

ICD-10 Finland

Other specified diseases of pericardium

+∞

13.5

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

13.5

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

13.5

AS2

Ventricular pacemaker insertion VVI (R)

+∞

13.5

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

13.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

13.5

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

13.5

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

13.5

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

13.5

WX002

NOMESCO Finland

Sedation and analgesia

1.6

13.4

367

2457

J96.1

ICD-10 Finland

Chronic respiratory failure

3.3

13.4

154

N05AA02

ATC

levomepromazine; systemic

2.3

13.4

105

475

B01AC06

ATC

acetylsalicylic acid; oral

2.6

13.3

291

UJF32

NOMESCO Finland

Coloscopy

1.5

13.3

507

3649

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

13.2

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

13.2

112

WX213

NOMESCO Finland

Lower leg blockade

5.9

13.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

13.0

216

1271

R07.2

ICD-10 Finland

Precordial pain

3.3

13.0

152

B01AF01

ATC

rivaroxaban; oral

1.8

12.8

185

1044

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

12.8

149

784

K07

ICPC

Swollen ankles/oedema

2.4

12.8

370

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

12.7

404

2797

J01CA04

ATC

amoxicillin; systemic

1.4

12.7

1807

16205

K01

ICPC

Heart pain

4.4

12.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

12.6

354

2384

WX890

NOMESCO Finland

Intesive care monitoring

6.0

12.6

342

Kela drug reimbursment

Dronedarone

+∞

12.5

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

12.5

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

+∞

12.5

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

12.5

I40

ICD-10 Finland

Acute myocarditis

130.6

12.4

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

12.4

126

631

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

12.3

366

2494

C08CA05

ATC

nifedipine; systemic

2.0

12.3

126

633

S97

ICPC

Chronic ulcer skin

2.1

12.3

118

579

FM1AD

NOMESCO Finland

CT of heart

37.7

12.2

AP2

Catheterization of the right side of the heart

37.7

12.2

N06AB04

ATC

citalopram; systemic

1.5

12.2

421

2964

G47.3

ICD-10 Finland

Sleep apnoea

1.5

12.1

463

3327

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

11.1

12.0

A98

ICPC

Health maint/preventive medicine

0.7

12.0

1961

21039

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

11.8

1018

8410

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

11.7

120

604

Coronary artery bypass surgery

3.2

11.7

147

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.6

11.6

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

23.0

11.6

C07AA05

ATC

propranolol; systemic

1.5

11.5

365

2520

R07.1

ICD-10 Finland

Chest pain on breathing

3.4

11.5

123

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

11.5

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

11.5

7AX01, ,

NOMESCO Finland

+∞

11.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

11.5

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

11.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

11.4

549

4114

A02BC03

ATC

lansoprazole; oral

1.4

11.4

560

4214

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.4

173

992

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

11.4

468

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

11.4

193

1143

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.3

11.4

129

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

11.3

430

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.6

11.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.3

11.2

130

N06AX11

ATC

mirtazapine; oral

1.4

11.2

688

5376

Q21.10

ICD-10 Finland

Persistent ostium secundum

17.1

11.2

J01DA01

ATC

[U] cefalexin

1.3

11.2

1319

11375

N03AX16

ATC

[U] pregabalin

1.5

11.2

428

3073

B05DB

ATC

Hypertonic solutions

5.3

11.1

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

11.0

126

659

N17.8

ICD-10 Finland

Other acute renal failure

4.4

11.0

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

11.0

308

A10AC01

ATC

insulin (human); parenteral

1.8

10.9

159

900

A02BC01

ATC

omeprazole; systemic

1.4

10.9

523

3915

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

10.9

309

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.8

1078

9056

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

10.8

114

580

J01DB01

ATC

cefalexin; oral

1.4

10.7

1805

16349

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

28.1

10.7

F19.0

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication

28.1

10.7

FN1AD

NOMESCO Finland

CT of coronary arteries

3.5

10.7

104

ZX108

NOMESCO Finland

Inhalation

5.3

10.6

I20.01

ICD-10 Finland

Unstable angina

2.8

10.6

189

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

10.5

239

1529

C02EA02, ,

ATC

2.2

10.5

423

I45.3

ICD-10 Finland

Trifascicular block

110.4

10.4

I45.6

ICD-10 Finland

Pre-excitation syndrome

110.4

10.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

10.4

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

10.4

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

10.4

Initial installation of the atrial pacemaker

+∞

10.4

Initial pacemaker installation

+∞

10.4

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

10.4

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

10.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

10.4

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

10.4

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.4

10.4

111

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

10.4

284

1899

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.1

10.3

137

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

10.3

148

C09AA04

ATC

perindopril; oral

2.1

10.3

447

B01AB04

ATC

dalteparin; parenteral

2.1

10.2

468

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

10.2

245

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

10.2

198

1217

C10AA05

ATC

atorvastatin; oral

1.3

10.2

800

6479

R03BA05

ATC

fluticasone; inhalant

1.5

10.2

344

2407

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

10.1

283

B05DA

ATC

Isotonic solutions

4.6

10.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.0

855

7006

E86

ICD-10 Finland

Volume depletion

2.6

10.0

212

Catheterization and pressure measurement of the right side of the heart

40.2

10.0

SPAT1254

SPAT

Administration of medicine

1.6

9.9

273

1826

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

9.9

152

874

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

9.9

112

584

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.2

9.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

9.9

255

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.7

9.9

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

9.8

110

A02BC05

ATC

esomeprazole; systemic

1.3

9.8

773

6256

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.9

9.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

9.8

247

1621

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.7

127

696

R51.80

ICD-10 Finland

Headache

1.5

9.7

287

1952

R42

ICD-10 Finland

Dizziness and giddiness

1.4

9.7

420

3082

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

55.2

9.6

N05AH04

ATC

quetiapine; oral

1.5

9.6

371

2661

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.9

9.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

9.6

186

1144

Q23.11

ICD-10 Finland

Bicuspid aortic valve

11.4

9.6

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.8

9.5

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.1

9.5

407

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

9.5

155

909

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

100.4

9.4

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

100.4

9.4

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

100.4

9.4

V03AA01, ,

ATC

3.1

9.4

129

I40.1

ICD-10 Finland

Isolated myocarditis

+∞

9.4

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

9.4

C01BD07

ATC

dronedarone; oral

+∞

9.4

AC4

MVP

+∞

9.4

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

9.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

9.4

181

1111

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

9.4

124

K04

ICPC

Palpitations/awareness of heart

2.3

9.4

318

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

9.3

357

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.1

9.3

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.4

9.3

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

4.7

9.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.3

745

6036

I49

ICD-10 Finland

Other cardiac arrhythmias

3.8

9.2

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.1

9.2

120

JN4AD

NOMESCO Finland

Body CT examination

1.6

9.2

214

1377

AN3

Balloon angioplasty and metallic stent

2.6

9.2

198

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.1

732

5929

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.3

9.1

AA5PD

NOMESCO Finland

CT examination of brain pefusion

4.6

9.1

Q21.19

ICD-10 Finland

Atrial septal defect NOS

15.6

9.0

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

15.6

9.0

GD1UN

NOMESCO Finland

Lung circulation SPECT

10.1

9.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

9.0

171

J01FA10

ATC

azithromycin; systemic

1.3

9.0

1148

9896

XG466

NOMESCO Finland

Sleep oxymetry

2.5

9.0

230

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.3

8.9

305

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

8.9

397

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

8.9

404

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

24.1

8.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

8.9

553

4307

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.0

8.9

128

V03AE03

ATC

lanthanum carbonate; oral

10.7

8.8

J81

ICD-10 Finland

Pulmonary oedema

9.5

8.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

8.8

108

581

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.9

8.7

135

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.7

307

2164

R04.2

ICD-10 Finland

Haemoptysis

2.2

8.7

309

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

50.1

8.7

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

50.1

8.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

8.7

422

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.6

284

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.6

102

541

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

8.6

217

J01DA09

ATC

[U] cefadroxil

1.4

8.5

516

3998

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

8.5

432

3252

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

8.5

110

W19

ICD-10 Finland

Unspecified fall

1.6

8.5

200

1292

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

8.5

151

908

TK810

NOMESCO Finland

Hemofiltration

7.4

8.4

C03AA03

ATC

hydrochlorothiazide; oral

1.7

8.4

145

863

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

8.4

116

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

90.3

8.4

AP3

Catheterization of the right and left side of the heart

90.3

8.4

N05BA02

ATC

chlordiazepoxide; systemic

2.4

8.4

231

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

8.4

256

Z49.2

ICD-10 Finland

Other dialysis

4.3

8.4

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

8.4

353

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

8.4

A03

ICPC

Fever

1.4

8.3

332

2394

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.7

8.3

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

8.3

Aortic Valve Replacement (AVR)

+∞

8.3

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

8.3

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

8.3

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

8.3

Catheter ablation of arrhythmia

+∞

8.3

I51.2

ICD-10 Finland

Rupture of papillary muscle, not elsewhere classified

+∞

8.3

B04AB02, ,

ATC

2.8

8.3

144

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

3.0

8.3

117

XF620

NOMESCO Finland

Examination of circulation with color method

8.5

8.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

8.2

189

1212

C02AC05

ATC

moxonidine; oral

2.1

8.2

383

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

8.2

253

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.2

552

4349

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

8.1

A13

ICPC

Concern/fear medical treatment

2.8

8.1

135

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

8.1

200

1305

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

8.1

231

1557

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.8

8.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

8.1

249

1706

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

8.1

148

896

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

8.1

447

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.1

H02AB09

ATC

hydrocortisone; systemic

2.4

8.1

211

5CM18, ,

NOMESCO Finland

11.7

8.1

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

8.0

231

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.3

7.9

R4190

NOMESCO Finland

Nutritional therapy

2.0

7.9

382

132

Kela drug reimbursment

Sarcoidosis

4.6

7.9

K92.1

ICD-10 Finland

Melaena

1.8

7.8

106

588

J45

ICD-10 Finland

Asthma

1.6

7.8

180

1156

J01MA02

ATC

ciprofloxacin; systemic

1.3

7.8

785

6531

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.0

7.8

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.0

7.8

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.7

7.7

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

45.1

7.7

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

7.7

448

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

7.7

139

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.7

252

1750

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

7.7

273

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.5

7.6

C09AA01

ATC

captopril; oral

2.9

7.6

123

R80

ICD-10 Finland

Isolated proteinuria

4.0

7.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.6

500

ZXD00

NOMESCO Finland

Emergency procedure

2.2

7.5

263

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

7.5

349

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.9

7.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.4

791

6619

FFA10

NOMESCO Finland

Excision of lesion of atrium

80.3

7.4

E87.6

ICD-10 Finland

Hypokalaemia

2.1

7.4

297

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

7.4

512

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.7

7.4

B04AB01, ,

ATC

3.4

7.4

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

7.3

N02BE01

ATC

paracetamol; systemic, rectal

1.3

7.3

1939

18080

R03AC12

ATC

salmeterol; inhalant

1.9

7.3

449

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

7.3

174

1127

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.6

7.3

FXE00

NOMESCO Finland

Use of ECLA

+∞

7.3

4291A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Myocardial degeneration

+∞

7.3

AQ2

Electrophysiological electroanatomical examination

+∞

7.3

I30.8

ICD-10 Finland

Other forms of acute pericarditis

+∞

7.3

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

7.3

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

7.3

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

+∞

7.3

5284

FHL

Mitral defect correction with flap prosthesis or graft

+∞

7.3

4298B

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[SPORT HEART]

+∞

7.3

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

7.3

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

7.3

XFP02, ,

NOMESCO Finland

+∞

7.3

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

7.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

7.3

457

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

2.9

7.3

110

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

7.3

121

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.2

7.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

7.2

158

1004

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.3

7.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

7.1

288

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

30.1

7.1

A02BA04

ATC

nizatidine; systemic

1.6

7.1

147

919

M05BA04

ATC

alendronic acid; oral

1.6

7.1

151

951

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

7.1

700

5793

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.3

7.1

224

78200

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Precordial pain

7.9

7.1

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.8

7.1

I97.0

ICD-10 Finland

Postcardiotomy syndrome

12.0

7.1

R03DA04

ATC

theophylline; systemic, rectal

1.7

7.0

112

653

J20

ICD-10 Finland

Acute bronchitis

1.6

7.0

180

1185

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

10.0

7.0

WX900

NOMESCO Finland

Resuscitation

10.0

7.0

N06AB03

ATC

fluoxetine; oral

1.5

7.0

216

1481

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.2

7.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

6.9

239

1676

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

6.9

443

3453

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.6

6.9

153

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

6.9

153

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

6.9

246

V03AE01

ATC

polystyrene sulfonate; oral

3.0

6.9

J01FA15

ATC

telithromycin; oral

1.6

6.9

169

1102

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

6.9

253

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

6.9

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.3

6.8

N05BA12

ATC

alprazolam; oral

1.5

6.8

180

1194

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.8

136

844

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.1

6.8

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.8

6.8

120

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.0

6.8

A10BK03

ATC

empagliflozin; oral

1.6

6.8

169

1107

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.8

269

1939

I44.4

ICD-10 Finland

Left anterior fascicular block

40.1

6.8

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

40.1

6.8

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

4.3

6.7

C08CA02

ATC

felodipine; oral

1.6

6.7

158

1020

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.7

312

2310

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

6.7

100

572

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.7

223

1552

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.2

6.7

WX402

NOMESCO Finland

General anaesthesia

1.4

6.7

396

3051

SPAT1263

SPAT

Sampling

1.3

6.7

756

6358

J01FA09

ATC

clarithromycin; systemic

1.3

6.7

561

4544

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

6.7

457

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.7

805

6823

N07BB01

ATC

disulfiram; oral

1.8

6.7

486

A02BA02

ATC

ranitidine; systemic

1.4

6.6

350

2648

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

5.9

6.6

C01BA03

ATC

disopyramide; systemic

12.3

6.6

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

12.3

6.6

C08CA01

ATC

amlodipine; oral

1.3

6.5

699

5838

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.0

6.5

SPAT1255

SPAT

Intravenous administration of medicine

1.7

6.5

111

662

K24

ICPC

Fear of heart disease

2.4

6.5

183

C08CA07

ATC

nisoldipine; oral

3.1

6.5

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

6.5

173

1152

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

6.4

159

N03AE01

ATC

clonazepam; systemic

1.7

6.4

109

648

5311

FHL

Bypass surgery in one vein

70.0

6.4

WX902

NOMESCO Finland

External defibrillation of heart

70.0

6.4

R03BA08

ATC

ciclesonide; inhalant

1.6

6.4

139

881

WNF00

NOMESCO Finland

Infection source and contact determination

7.4

6.4

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

14.3

6.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

6.4

268

K65.0

ICD-10 Finland

Acute peritonitis

3.0

6.4

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.0

6.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.0

6.3

C07AB03

ATC

atenolol; systemic

1.8

6.3

553

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

8.2

6.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

6.3

137

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

6.3

387

N05CF02

ATC

zolpidem; oral

1.4

6.3

300

2233

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

6.2

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

6.2

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

6.2

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

6.2

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

6.2

FE1AT

NOMESCO Finland

Pericardial puncture with ultrasound guidance

+∞

6.2

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

6.2

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

6.2

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

6.2

AC2

MVR bio

+∞

6.2

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

+∞

6.2

Cardiac muscle biopsy

+∞

6.2

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

6.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

6.2

186

1267

R4120

NOMESCO Finland

Occupational therapy

1.7

6.2

116

708

N06AA12

ATC

doxepin; systemic

1.8

6.2

542

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.2

261

1902

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.5

6.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.9

6.2

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.3

6.1

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.4

6.1

169

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

6.1

110

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

6.1

139

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

6.1

201

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.8

6.1

R60.0

ICD-10 Finland

Localized oedema

1.5

6.1

207

1449

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

12.5

6.1

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

6.1

145

941

N05AN01

ATC

lithium; oral

2.2

6.1

227

R03BA02

ATC

budesonide; inhalant

1.4

6.0

312

2351

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.5

6.0

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Heart failure, unspecified
I50.9 [45576879]

4.8e+00

5.1e+00

—

1.0e+50

—

5.5e+00

4.4e+00

cases:5.41%

controls:0.05%

cases:4.57%

controls:0.03%

—

cases:3.73%

controls:0.00%

—

cases:6.19%

controls:0.03%

cases:7.05%

controls:0.09%

129

2257

23763

109

2277

23767

—

2297

23774

—

106

1606

23245

104

1372

19631

Cardiology
6 [38004451]

1.4e+00

2.5e+00

3.6e+00

—

5.2e+00

4.0e+00

2.6e+00

cases:15.51%

controls:4.21%

cases:13.79%

controls:1.36%

cases:6.58%

controls:0.19%

—

cases:22.30%

controls:0.16%

cases:43.63%

controls:1.36%

cases:36.38%

controls:4.25%

370

1002

2016

22772

329

323

2057

23451

157

2229

23728

—

396

1380

23701

747

317

965

22934

537

835

939

18814

Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]

1.6e+00

2.5e+00

3.8e+00

—

4.7e+00

3.9e+00

2.5e+00

cases:5.91%

controls:1.26%

cases:4.44%

controls:0.39%

cases:2.05%

controls:0.05%

—

cases:5.52%

controls:0.05%

cases:15.95%

controls:0.39%

cases:13.96%

controls:1.29%

141

300

2245

23474

106

2280

23681

2337

23763

—

1678

23728

273

1439

23161

206

253

1270

19396

Internal Medicine
11 [38004456]

1.0e+00

1.5e+00

2.7e+00

7.3e+00

3.1e+00

2.0e+00

1.2e+00

cases:35.41%

controls:16.27%

cases:23.13%

controls:6.23%

cases:14.04%

controls:1.06%

cases:38.10%

controls:0.04%

cases:19.65%

controls:1.14%

cases:32.30%

controls:5.92%

cases:37.47%

controls:15.34%

845

3869

1541

19905

552

1480

1834

22294

335

252

2051

23522

909

1477

23764

349

271

1427

23469

553

1376

1159

21875

553

3014

923

16635

Hypertension secondary to other renal disorders
I15.1 [45557535]

2.9e+00

3.5e+00

—

1.0e+50

3.9e+00

3.4e+00

3.3e+00

cases:1.17%

controls:0.07%

cases:1.30%

controls:0.04%

—

cases:0.21%

controls:0.00%

cases:1.24%

controls:0.03%

cases:1.93%

controls:0.06%

cases:1.83%

controls:0.07%

2358

23758

2355

23765

—

2381

23774

1754

23734

1679

23236

1449

19636

Hemodialysis
TK800 [2001305768]

1.9e+00

2.7e+00

2.9e+00

—

3.0e+00

3.4e+00

3.1e+00

cases:0.88%

controls:0.13%

cases:0.84%

controls:0.06%

cases:0.54%

controls:0.03%

—

cases:0.51%

controls:0.03%

cases:1.17%

controls:0.04%

cases:1.63%

controls:0.07%

2365

23742

2366

23760

2373

23767

—

1767

23734

1692

23242

1452

19635

Bacteria identified in Blood by Culture
600-7 [3023368]

9.4e-01

1.5e+00

3.3e+00

5.4e+00

3.4e+00

1.5e+00

9.2e-01

cases:7.88%

controls:3.24%

cases:5.91%

controls:1.37%

cases:3.19%

controls:0.12%

cases:5.32%

controls:0.03%

cases:5.91%

controls:0.20%

cases:6.31%

controls:1.50%

cases:10.77%

controls:4.57%

188

770

2198

23004

141

325

2245

23449

2310

23745

127

2259

23768

105

1671

23692

108

348

1604

22903

159

898

1317

18751

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

1.4e+00

2.0e+00

3.7e+00

—

5.2e+00

2.8e+00

1.8e+00

cases:7.80%

controls:2.13%

cases:7.71%

controls:1.10%

cases:5.32%

controls:0.13%

—

cases:12.78%

controls:0.08%

cases:16.53%

controls:1.19%

cases:20.87%

controls:4.16%

186

507

2200

23267

184

261

2202

23513

127

2259

23742

—

227

1549

23721

283

276

1429

22975

308

817

1168

18832

Emergency Room and Inpatient Visit
ERIP [262]

8.4e-01

1.4e+00

3.0e+00

6.6e+00

3.0e+00

1.3e+00

7.0e-01

cases:7.21%

controls:3.26%

cases:6.54%

controls:1.77%

cases:3.52%

controls:0.18%

cases:13.12%

controls:0.02%

cases:4.56%

controls:0.23%

cases:7.59%

controls:2.09%

cases:11.79%

controls:6.20%

172

774

2214

23000

156

421

2230

23353

2302

23732

313

2073

23769

1695

23686

130

485

1582

22766

174

1218

1302

18431

INR in Blood by Coagulation assay
34714-6 [3032080]

8.8e-01

1.4e+00

2.6e+00

5.8e+00

3.3e+00

1.8e+00

1.1e+00

cases:13.62%

controls:6.16%

cases:10.90%

controls:2.95%

cases:6.29%

controls:0.50%

cases:7.33%

controls:0.03%

cases:12.61%

controls:0.51%

cases:15.07%

controls:2.92%

cases:20.93%

controls:7.84%

325

1464

2061

22310

260

702

2126

23072

150

119

2236

23655

175

2211

23768

224

120

1552

23620

258

679

1454

22572

309

1540

1167

18109

digoxin; oral, parenteral
C01AA05 [21600234]

3.3e+00

3.5e+00

3.1e+00

—

3.5e+00

3.6e+00

cases:4.27%

controls:0.17%

cases:3.77%

controls:0.12%

cases:0.63%

controls:0.03%

—

cases:3.33%

controls:0.11%

cases:4.13%

controls:0.12%

102

2284

23734

2296

23745

2371

23767

—

1655

23226

1415

19625

Standard cardiac ultrasound examination
FM1AE [2001303278]

2.0e+00

2.8e+00

—

1.0e+50

4.9e+00

4.1e+00

3.0e+00

cases:6.29%

controls:0.93%

cases:4.90%

controls:0.31%

—

cases:9.68%

controls:0.00%

cases:5.52%

controls:0.04%

cases:15.13%

controls:0.30%

cases:15.38%

controls:0.91%

150

220

2236

23554

117

2269

23701

—

231

2155

23774

1678

23730

259

1453

23181

227

178

1249

19471

warfarin; oral, parenteral
B01AA03 [21600965]

2.3e+00

2.5e+00

2.4e+00

—

3.8e+00

3.0e+00

2.6e+00

cases:9.26%

controls:1.03%

cases:8.80%

controls:0.79%

cases:2.05%

controls:0.19%

—

cases:7.66%

controls:0.19%

cases:13.14%

controls:0.72%

cases:14.09%

controls:1.16%

221

246

2165

23528

210

187

2176

23587

2337

23730

—

136

1640

23695

225

167

1487

23084

208

227

1268

19422

Emergency Room Visit
ER [9203]

7.7e-01

1.2e+00

2.7e+00

7.0e+00

2.5e+00

1.3e+00

9.4e-01

cases:44.97%

controls:27.52%

cases:23.97%

controls:9.08%

cases:14.17%

controls:1.07%

cases:38.60%

controls:0.05%

cases:12.27%

controls:1.15%

cases:26.17%

controls:8.61%

cases:45.12%

controls:24.25%

1073

6543

1313

17231

572

2158

1814

21616

338

255

2048

23519

921

1465

23761

218

272

1558

23468

448

2001

1264

21250

666

4764

810

14885

Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]

1.2e+00

2.0e+00

3.9e+00

—

4.4e+00

2.9e+00

2.0e+00

cases:2.77%

controls:0.83%

cases:1.97%

controls:0.26%

cases:1.42%

controls:0.03%

—

cases:4.17%

controls:0.05%

cases:4.32%

controls:0.25%

cases:5.62%

controls:0.79%

197

2320

23577

2339

23712

2352

23767

—

1702

23727

1638

23193

155

1393

19494

Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]

1.1e+00

2.0e+00

4.1e+00

1.0e+50

4.7e+00

2.8e+00

1.6e+00

cases:2.68%

controls:0.87%

cases:1.76%

controls:0.25%

cases:1.26%

controls:0.02%

cases:3.02%

controls:0.00%

cases:5.41%

controls:0.05%

cases:3.86%

controls:0.25%

cases:4.13%

controls:0.85%

206

2322

23568

2344

23715

2356

23769

2314

23774

1680

23728

1646

23193

167

1415

19482

furosemide; oral, parenteral
C03CA01 [21601518]

1.9e+00

2.2e+00

2.5e+00

2.7e+00

3.0e+00

2.2e+00

1.7e+00

cases:13.16%

controls:2.24%

cases:14.59%

controls:1.79%

cases:5.20%

controls:0.47%

cases:0.38%

controls:0.03%

cases:8.73%

controls:0.47%

cases:15.54%

controls:2.05%

cases:17.34%

controls:3.75%

314

533

2072

23241

348

426

2038

23348

124

111

2262

23663

2377

23768

155

112

1621

23628

266

477

1446

22774

256

736

1220

18913

Thorax X-ray examination outside radiological department
GD1UA [2001303652]

1.2e+00

2.5e+00

4.4e+00

1.0e+50

4.0e+00

2.5e+00

1.7e+00

cases:3.52%

controls:1.12%

cases:3.27%

controls:0.29%

cases:1.97%

controls:0.03%

cases:4.99%

controls:0.00%

cases:1.58%

controls:0.03%

cases:3.15%

controls:0.28%

cases:5.62%

controls:1.11%

267

2302

23507

2308

23705

2339

23768

119

2267

23774

1748

23733

1658

23187

219

1393

19430

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

1.1e+00

1.9e+00

3.7e+00

1.0e+50

4.9e+00

2.6e+00

1.5e+00

cases:6.29%

controls:2.09%

cases:6.08%

controls:0.99%

cases:5.20%

controls:0.13%

cases:9.93%

controls:0.00%

cases:15.03%

controls:0.13%

cases:11.80%

controls:0.97%

cases:12.94%

controls:3.06%

150

496

2236

23278

145

235

2241

23539

124

2262

23742

237

2149

23774

267

1509

23709

202

226

1510

23025

191

601

1285

19048

apixaban; oral
B01AF02 [43534762]

1.9e+00

2.2e+00

2.4e+00

—

3.5e+00

3.1e+00

2.5e+00

cases:1.30%

controls:0.21%

cases:1.80%

controls:0.20%

cases:0.88%

controls:0.08%

—

cases:1.86%

controls:0.06%

cases:3.91%

controls:0.18%

cases:5.22%

controls:0.47%

2355

23725

2343

23726

2365

23755

—

1743

23726

1645

23209

1399

19557

Outpatient Hospital
22 [8756]

6.1e-01

9.2e-01

2.2e+00

6.4e+00

3.0e+00

1.3e+00

9.1e-01

cases:30.85%

controls:19.58%

cases:12.99%

controls:5.62%

cases:6.66%

controls:0.76%

cases:19.57%

controls:0.04%

cases:10.30%

controls:0.57%

cases:16.71%

controls:5.06%

cases:30.15%

controls:14.78%

736

4656

1650

19118

310

1335

2076

22439

159

181

2227

23593

467

1919

23764

183

135

1593

23605

286

1177

1426

22074

445

2905

1031

16744

Angiography of heart and/or coronary arteries
FN1AC [2001302996]

8.9e-01

2.0e+00

3.8e+00

—

4.4e+00

2.6e+00

1.5e+00

cases:4.36%

controls:1.84%

cases:3.48%

controls:0.50%

cases:2.10%

controls:0.05%

—

cases:2.93%

controls:0.04%

cases:5.20%

controls:0.41%

cases:6.44%

controls:1.45%

104

437

2282

23337

119

2303

23655

2336

23763

—

1724

23731

1623

23155

284

1381

19365

Polycystic kidney, autosomal dominant
Q61.2 [45558415]

1.9e+00

2.0e+00

2.8e+00

—

3.3e+00

2.5e+00

2.6e+00

cases:0.38%

controls:0.06%

cases:0.42%

controls:0.05%

cases:0.34%

controls:0.02%

—

cases:0.56%

controls:0.02%

cases:0.76%

controls:0.06%

cases:0.95%

controls:0.07%

2377

23760

2376

23761

2378

23769

—

1766

23735

1699

23236

1462

19635

Inpatient Hospital
21 [8717]

6.8e-01

1.1e+00

2.4e+00

6.3e+00

2.6e+00

1.2e+00

7.9e-01

cases:40.28%

controls:25.55%

cases:21.12%

controls:8.22%

cases:12.53%

controls:1.27%

cases:33.11%

controls:0.09%

cases:14.98%

controls:1.28%

cases:21.61%

controls:7.95%

cases:35.98%

controls:20.40%

961

6074

1425

17700

504

1954

1882

21820

299

303

2087

23471

790

1596

23752

266

303

1510

23437

370

1848

1342

21403

531

4008

945

15641

darbepoetin alfa; parenteral
B03XA02 [21601134]

2.7e+00

2.6e+00

2.7e+00

—

3.0e+00

2.2e+00

1.7e+00

cases:0.75%

controls:0.05%

cases:0.88%

controls:0.06%

cases:0.38%

controls:0.03%

—

cases:0.56%

controls:0.03%

cases:0.88%

controls:0.09%

cases:0.88%

controls:0.17%

2368

23762

2365

23759

2377

23768

—

1766

23733

1697

23229

1463

19616

ECG with 12 standard connections
XF400 [2001303368]

1.4e+00

1.7e+00

3.7e+00

1.0e+50

4.0e+00

2.2e+00

1.5e+00

cases:4.27%

controls:1.11%

cases:2.39%

controls:0.43%

cases:1.34%

controls:0.03%

cases:2.93%

controls:0.00%

cases:1.80%

controls:0.03%

cases:2.92%

controls:0.32%

cases:4.54%

controls:1.05%

102

264

2284

23510

102

2329

23672

2354

23766

2316

23774

1744

23732

1662

23177

207

1409

19442

spironolactone; oral
C03DA01 [21601534]

2.0e+00

2.3e+00

2.0e+00

—

2.9e+00

2.6e+00

2.4e+00

cases:4.40%

controls:0.59%

cases:4.86%

controls:0.52%

cases:1.51%

controls:0.20%

—

cases:3.10%

controls:0.17%

cases:7.30%

controls:0.59%

cases:9.82%

controls:1.02%

105

141

2281

23633

116

123

2270

23651

2350

23727

—

1721

23700

125

137

1587

23114

145

201

1331

19448

Thoracic and Cardiac Surgery
OMOP4822009 [45756830]

9.6e-01

1.9e+00

2.7e+00

1.0e+50

3.4e+00

2.7e+00

2.2e+00

cases:1.84%

controls:0.72%

cases:1.63%

controls:0.25%

cases:0.67%

controls:0.05%

cases:0.59%

controls:0.00%

cases:1.80%

controls:0.06%

cases:3.15%

controls:0.22%

cases:3.79%

controls:0.45%

170

2342

23604

2347

23714

2370

23763

2372

23774

1744

23726

1658

23199

1420

19561

Old myocardial infarction
I25.2 [45601025]

1.3e+00

2.1e+00

2.6e+00

1.0e+50

3.6e+00

2.3e+00

1.8e+00

cases:1.84%

controls:0.50%

cases:1.30%

controls:0.17%

cases:0.38%

controls:0.03%

cases:1.30%

controls:0.00%

cases:0.79%

controls:0.02%

cases:2.16%

controls:0.21%

cases:3.46%

controls:0.60%

120

2342

23654

2355

23734

2377

23767

2355

23774

1762

23735

1675

23202

118

1425

19531

Emergency Medicine
93 [38004510]

4.4e-01

9.1e-01

2.5e+00

5.9e+00

2.2e+00

9.8e-01

4.7e-01

cases:16.18%

controls:11.02%

cases:12.99%

controls:5.64%

cases:7.25%

controls:0.61%

cases:16.51%

controls:0.05%

cases:6.08%

controls:0.70%

cases:14.54%

controls:6.00%

cases:24.80%

controls:17.11%

386

2620

2000

21154

310

1342

2076

22432

173

145

2213

23629

394

1992

23761

108

166

1668

23574

249

1396

1463

21855

366

3361

1110

16288

12 lead EKG panel
34534-8 [3044889]

2.4e-01

6.2e-01

2.1e+00

5.0e+00

3.3e+00

1.3e+00

7.5e-01

cases:16.93%

controls:13.78%

cases:11.78%

controls:6.68%

cases:5.53%

controls:0.72%

cases:3.77%

controls:0.03%

cases:15.77%

controls:0.70%

cases:20.91%

controls:6.58%

cases:32.18%

controls:18.28%

404

3277

1982

20497

281

1587

2105

22187

132

171

2254

23603

2296

23768

280

166

1496

23574

358

1530

1354

21721

475

3591

1001

16058

EKG study
11524-6 [3013512]

3.6e-01

8.4e-01

2.4e+00

5.0e+00

3.1e+00

1.2e+00

5.2e-01

cases:6.92%

controls:4.94%

cases:5.45%

controls:2.43%

cases:2.85%

controls:0.27%

cases:3.48%

controls:0.03%

cases:5.74%

controls:0.27%

cases:8.29%

controls:2.66%

cases:11.59%

controls:7.25%

165

1175

2221

22599

130

577

2256

23197

2318

23709

2303

23768

102

1674

23675

142

618

1570

22633

171

1424

1305

18225

ciclosporin; oral, parenteral
L04AD01 [21603924]

1.3e+00

1.8e+00

2.1e+00

—

2.9e+00

2.6e+00

2.5e+00

cases:0.71%

controls:0.20%

cases:0.80%

controls:0.13%

cases:0.50%

controls:0.06%

—

cases:1.07%

controls:0.06%

cases:1.69%

controls:0.13%

cases:2.10%

controls:0.18%

2369

23726

2367

23743

2374

23760

—

1757

23726

1683

23221

1445

19613

Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]

1.1e+00

1.9e+00

3.5e+00

1.0e+50

4.1e+00

1.9e+00

7.5e-01

cases:2.14%

controls:0.71%

cases:2.22%

controls:0.35%

cases:0.92%

controls:0.03%

cases:1.97%

controls:0.00%

cases:1.91%

controls:0.03%

cases:2.04%

controls:0.31%

cases:2.57%

controls:1.23%

169

2335

23605

2333

23690

2364

23767

2339

23774

1742

23732

1677

23178

242

1438

19407

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

6.8e-01

1.3e+00

3.7e+00

—

4.1e+00

2.1e+00

1.2e+00

cases:9.35%

controls:4.95%

cases:7.33%

controls:2.22%

cases:6.16%

controls:0.16%

—

cases:13.01%

controls:0.24%

cases:15.42%

controls:2.21%

cases:21.21%

controls:7.24%

223

1177

2163

22597

175

527

2211

23247

147

2239

23737

—

231

1545

23682

264

513

1448

22738

313

1422

1163

18227

Oxygen saturation in Arterial blood
2708-6 [3016502]

1.2e+00

1.7e+00

3.3e+00

1.0e+50

4.1e+00

1.9e+00

7.6e-01

cases:2.47%

controls:0.78%

cases:2.18%

controls:0.39%

cases:1.01%

controls:0.04%

cases:1.89%

controls:0.00%

cases:1.97%

controls:0.03%

cases:2.16%

controls:0.33%

cases:2.78%

controls:1.32%

186

2327

23588

2334

23682

2362

23765

2341

23774

1741

23732

1675

23175

259

1435

19390

Chest pain, unspecified
R07.4 [45558450]

7.2e-01

1.0e+00

3.7e+00

1.0e+50

3.6e+00

2.1e+00

1.6e+00

cases:5.36%

controls:2.69%

cases:2.60%

controls:0.93%

cases:3.60%

controls:0.10%

cases:5.36%

controls:0.00%

cases:4.17%

controls:0.12%

cases:8.47%

controls:1.09%

cases:13.89%

controls:3.15%

128

640

2258

23134

220

2324

23554

2300

23751

128

2258

23774

1702

23712

145

253

1567

22998

205

618

1271

19031

Supplier / Service Provider
OMOP5117446 [33004]

-4.4e-01

-1.8e-01

1.0e-01

2.6e+00

4.2e+00

3.0e+00

3.4e+00

cases:17.77%

controls:25.21%

cases:6.71%

controls:7.93%

cases:1.05%

controls:0.95%

cases:0.29%

controls:0.02%

cases:4.62%

controls:0.08%

cases:7.94%

controls:0.41%

cases:17.55%

controls:0.73%

424

5994

1962

17780

160

1886

2226

21888

225

2361

23549

2379

23769

1694

23722

136

1576

23156

259

144

1217

19505

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

6.0e-01

1.1e+00

1.9e+00

4.6e+00

2.7e+00

1.1e+00

7.2e-01

cases:13.96%

controls:8.14%

cases:11.74%

controls:4.31%

cases:5.57%

controls:0.87%

cases:3.65%

controls:0.04%

cases:11.66%

controls:0.89%

cases:12.50%

controls:4.40%

cases:20.26%

controls:10.98%

333

1936

2053

21838

280

1024

2106

22750

133

207

2253

23567

2299

23765

207

212

1569

23528

214

1022

1498

22229

299

2158

1177

17491

Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]

1.1e+00

1.7e+00

3.2e+00

1.0e+50

3.7e+00

1.9e+00

1.0e+00

cases:2.51%

controls:0.82%

cases:2.05%

controls:0.38%

cases:0.63%

controls:0.03%

cases:0.96%

controls:0.00%

cases:1.46%

controls:0.04%

cases:2.51%

controls:0.37%

cases:3.59%

controls:1.31%

194

2326

23580

2337

23684

2371

23768

2363

23774

1750

23731

1669

23166

257

1423

19392

Thorax X-ray examination
GD1AA [2001303617]

9.9e-01

1.6e+00

3.3e+00

—

3.2e+00

2.0e+00

1.4e+00

cases:13.03%

controls:5.29%

cases:9.72%

controls:2.03%

cases:4.90%

controls:0.19%

—

cases:5.57%

controls:0.24%

cases:13.96%

controls:2.05%

cases:19.99%

controls:5.98%

311

1258

2075

22516

232

483

2154

23291

117

2269

23728

—

1677

23684

239

477

1473

22774

295

1175

1181

18474

Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]

1.2e+00

1.7e+00

3.0e+00

1.0e+50

3.0e+00

2.0e+00

1.5e+00

cases:1.76%

controls:0.55%

cases:1.42%

controls:0.26%

cases:0.59%

controls:0.03%

cases:0.46%

controls:0.00%

cases:0.84%

controls:0.04%

cases:2.16%

controls:0.29%

cases:3.46%

controls:0.78%

131

2344

23643

2352

23712

2372

23767

2375

23774

1761

23730

1675

23184

153

1425

19496

Atrial fibrillation/flutter
K78 [2002000605]

3.0e+00

2.8e+00

—

3.6e+00

3.0e+00

cases:1.72%

controls:0.08%

cases:0.75%

controls:0.05%

—

cases:1.23%

controls:0.03%

cases:2.57%

controls:0.13%

2345

23754

2368

23763

—

1691

23243

1438

19623

Nephrology
39 [38004479]

1.5e+00

1.9e+00

2.3e+00

—

2.5e+00

2.2e+00

2.0e+00

cases:2.72%

controls:0.62%

cases:2.85%

controls:0.43%

cases:1.72%

controls:0.17%

—

cases:2.08%

controls:0.18%

cases:4.21%

controls:0.49%

cases:5.49%

controls:0.80%

148

2321

23626

103

2318

23671

2345

23734

—

1739

23697

113

1640

23138

158

1395

19491

Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]

1.1e+00

1.7e+00

3.1e+00

1.0e+50

3.9e+00

1.9e+00

7.1e-01

cases:2.98%

controls:0.99%

cases:2.43%

controls:0.47%

cases:1.09%

controls:0.05%

cases:2.05%

controls:0.00%

cases:2.25%

controls:0.05%

cases:2.57%

controls:0.40%

cases:2.91%

controls:1.45%

236

2315

23538

111

2328

23663

2360

23762

2337

23774

1736

23729

1668

23157

285

1433

19364

pH of Arterial blood
2744-1 [3019977]

1.2e+00

1.7e+00

3.0e+00

1.0e+50

3.9e+00

1.8e+00

7.5e-01

cases:3.06%

controls:0.99%

cases:2.47%

controls:0.48%

cases:1.05%

controls:0.05%

cases:2.10%

controls:0.00%

cases:2.25%

controls:0.05%

cases:2.51%

controls:0.40%

cases:3.05%

controls:1.47%

235

2313

23539

114

2327

23660

2361

23762

2336

23774

1736

23729

1669

23157

289

1431

19360

Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]

1.1e+00

1.7e+00

3.1e+00

1.0e+50

3.9e+00

1.9e+00

7.1e-01

cases:2.98%

controls:0.99%

cases:2.43%

controls:0.47%

cases:1.09%

controls:0.05%

cases:2.05%

controls:0.00%

cases:2.25%

controls:0.05%

cases:2.57%

controls:0.40%

cases:2.91%

controls:1.45%

236

2315

23538

112

2328

23662

2360

23762

2337

23774

1736

23729

1668

23157

285

1433

19364

Base excess in Arterial blood by calculation
1925-7 [3003396]

1.1e+00

1.7e+00

3.0e+00

1.0e+50

3.9e+00

1.8e+00

7.4e-01

cases:3.02%

controls:1.00%

cases:2.43%

controls:0.47%

cases:1.05%

controls:0.05%

cases:2.01%

controls:0.00%

cases:2.20%

controls:0.05%

cases:2.51%

controls:0.40%

cases:3.05%

controls:1.48%

238

2314

23536

112

2328

23662

2361

23762

2338

23774

1737

23729

1669

23157

291

1431

19358

Gas panel - Venous blood
24339-4 [3000991]

1.2e+00

1.7e+00

2.9e+00

1.0e+50

3.4e+00

1.9e+00

1.2e+00

cases:2.64%

controls:0.84%

cases:2.35%

controls:0.43%

cases:0.84%

controls:0.05%

cases:0.88%

controls:0.00%

cases:1.52%

controls:0.05%

cases:2.80%

controls:0.43%

cases:4.13%

controls:1.29%

200

2323

23574

102

2330

23672

2366

23763

2365

23774

1749

23728

101

1664

23150

254

1415

19395

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

3.1e-01

7.1e-01

2.0e+00

5.0e+00

2.7e+00

9.9e-01

5.1e-01

cases:30.26%

controls:24.17%

cases:25.65%

controls:14.49%

cases:16.97%

controls:2.79%

cases:21.84%

controls:0.18%

cases:30.57%

controls:2.76%

cases:32.48%

controls:15.13%

cases:44.65%

controls:32.65%

722

5747

1664

18027

612

3444

1774

20330

405

664

1981

23110

521

1865

23731

543

655

1233

23085

556

3519

1156

19732

659

6416

817

13233

Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]

7.1e-01

1.7e+00

2.8e+00

—

3.7e+00

2.3e+00

1.8e+00

cases:0.67%

controls:0.33%

cases:0.75%

controls:0.14%

cases:0.46%

controls:0.03%

—

cases:1.86%

controls:0.05%

cases:1.34%

controls:0.14%

cases:2.10%

controls:0.34%

2370

23695

2368

23741

2375

23767

—

1743

23729

1689

23218

1445

19582

Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]

1.3e+00

1.7e+00

2.2e+00

1.0e+50

3.7e+00

2.2e+00

9.2e-01

cases:1.63%

controls:0.45%

cases:1.30%

controls:0.24%

cases:0.34%

controls:0.04%

cases:0.67%

controls:0.00%

cases:1.24%

controls:0.03%

cases:1.69%

controls:0.19%

cases:1.63%

controls:0.66%

106

2347

23668

2355

23716

2378

23765

2370

23774

1754

23733

1683

23207

129

1452

19520

General Practice
1 [38004446]

6.8e-01

1.2e+00

2.1e+00

4.8e+00

1.9e+00

9.4e-01

4.5e-01

cases:19.53%

controls:10.94%

cases:12.03%

controls:4.07%

cases:4.90%

controls:0.64%

cases:5.03%

controls:0.04%

cases:4.39%

controls:0.70%

cases:11.04%

controls:4.62%

cases:20.12%

controls:13.80%

466

2602

1920

21172

287

968

2099

22806

117

151

2269

23623

120

2266

23764

167

1698

23573

189

1075

1523

22176

297

2711

1179

16938

Bacterial infection, unspecified
A49.9 [45590816]

1.2e+00

2.2e+00

2.9e+00

—

2.9e+00

1.9e+00

8.7e-01

cases:2.35%

controls:0.72%

cases:1.97%

controls:0.23%

cases:0.71%

controls:0.04%

—

cases:1.01%

controls:0.06%

cases:1.93%

controls:0.28%

cases:2.30%

controls:0.98%

172

2330

23602

2339

23720

2369

23765

—

1758

23726

1679

23185

193

1442

19456

Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]

1.0e+00

1.7e+00

2.6e+00

—

3.6e+00

1.6e+00

1.4e+00

cases:2.01%

controls:0.73%

cases:1.84%

controls:0.33%

cases:0.59%

controls:0.04%

—

cases:1.18%

controls:0.03%

cases:1.52%

controls:0.31%

cases:2.85%

controls:0.75%

174

2338

23600

2342

23696

2372

23764

—

1755

23732

1686

23179

148

1434

19501

Ventricular premature depolarization
I49.3 [45538386]

2.7e+00

2.6e+00

—

1.0e+50

—

3.9e+00

2.7e+00

cases:1.22%

controls:0.08%

cases:0.46%

controls:0.03%

—

cases:0.63%

controls:0.00%

—

cases:1.64%

controls:0.03%

cases:2.44%

controls:0.17%

2357

23754

2375

23766

—

2371

23774

—

1684

23243

1440

19616

Medical doctor
Z2221 [2001311556]

7.7e-01

1.4e+00

2.4e+00

—

3.5e+00

2.4e+00

1.4e+00

cases:7.25%

controls:3.49%

cases:3.69%

controls:0.95%

cases:1.30%

controls:0.11%

—

cases:2.98%

controls:0.10%

cases:8.47%

controls:0.84%

cases:9.42%

controls:2.47%

173

829

2213

22945

226

2298

23548

2355

23747

—

1723

23717

145

196

1567

23055

139

486

1337

19163

Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]

1.3e+00

1.6e+00

2.9e+00

1.0e+50

3.5e+00

1.6e+00

9.6e-01

cases:2.77%

controls:0.79%

cases:2.26%

controls:0.48%

cases:0.92%

controls:0.05%

cases:2.39%

controls:0.00%

cases:3.10%

controls:0.09%

cases:2.63%

controls:0.55%

cases:4.54%

controls:1.80%

188

2320

23586

114

2332

23660

2364

23762

2329

23774

1721

23718

127

1667

23124

353

1409

19296

Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]

1.0e+00

1.8e+00

2.7e+00

—

3.4e+00

1.6e+00

1.2e+00

cases:2.10%

controls:0.75%

cases:2.10%

controls:0.36%

cases:0.63%

controls:0.04%

—

cases:1.41%

controls:0.05%

cases:1.93%

controls:0.38%

cases:3.25%

controls:0.99%

178

2336

23596

2336

23688

2371

23764

—

1751

23729

1679

23163

195

1428

19454

Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]

8.0e-01

1.4e+00

3.2e+00

1.0e+50

3.6e+00

1.8e+00

1.1e+00

cases:3.06%

controls:1.40%

cases:2.60%

controls:0.64%

cases:1.30%

controls:0.05%

cases:1.84%

controls:0.00%

cases:2.25%

controls:0.06%

cases:3.33%

controls:0.59%

cases:5.49%

controls:1.97%

333

2313

23441

152

2324

23622

2355

23761

2342

23774

1736

23725

138

1655

23113

388

1395

19261

Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]

1.3e+00

1.5e+00

3.2e+00

—

3.3e+00

1.5e+00

1.0e+00

cases:4.32%

controls:1.26%

cases:3.39%

controls:0.76%

cases:1.51%

controls:0.06%

—

cases:3.94%

controls:0.15%

cases:3.56%

controls:0.81%

cases:6.30%

controls:2.41%

103

300

2283

23474

181

2305

23593

2350

23759

—

1706

23705

189

1651

23062

473

1383

19176

Differential panel, method unspecified - Blood
69738-3 [42870588]

5.7e-01

9.5e-01

1.6e+00

3.6e+00

2.8e+00

1.3e+00

9.5e-01

cases:9.60%

controls:5.67%

cases:8.42%

controls:3.44%

cases:3.56%

controls:0.74%

cases:1.51%

controls:0.04%

cases:10.75%

controls:0.73%

cases:11.86%

controls:3.61%

cases:16.40%

controls:7.03%

229

1349

2157

22425

201

818

2185

22956

175

2301

23599

2350

23764

191

174

1585

23566

203

839

1509

22412

242

1381

1234

18268

Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]

1.3e+00

1.6e+00

3.0e+00

1.0e+50

3.4e+00

1.5e+00

9.0e-01

cases:2.68%

controls:0.77%

cases:2.31%

controls:0.48%

cases:1.01%

controls:0.05%

cases:2.43%

controls:0.00%

cases:2.98%

controls:0.10%

cases:2.69%

controls:0.59%

cases:4.54%

controls:1.90%

183

2322

23591

113

2331

23661

2362

23762

2328

23774

1723

23716

137

1666

23114

373

1409

19276

pH of Capillary blood
2745-8 [3009343]

1.0e+00

1.7e+00

2.6e+00

—

3.4e+00

1.6e+00

1.2e+00

cases:2.10%

controls:0.75%

cases:1.97%

controls:0.35%

cases:0.59%

controls:0.04%

—

cases:1.41%

controls:0.05%

cases:1.87%

controls:0.37%

cases:3.18%

controls:0.97%

178

2336

23596

2339

23691

2372

23764

—

1751

23729

1680

23166

191

1429

19458

Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]

1.2e+00

1.7e+00

2.2e+00

—

3.0e+00

1.8e+00

1.7e+00

cases:3.52%

controls:1.06%

cases:3.06%

controls:0.56%

cases:1.30%

controls:0.14%

—

cases:3.15%

controls:0.16%

cases:3.45%

controls:0.56%

cases:6.37%

controls:1.29%

252

2302

23522

132

2313

23642

2355

23741

—

1720

23702

131

1653

23120

253

1382

19396

FISTULA - Fistula
FISTULA-1 [2002330212]

2.2e+00

2.8e+00

—

2.9e+00

3.8e+00

cases:0.38%

controls:0.04%

cases:0.42%

controls:0.03%

—

cases:0.64%

controls:0.03%

cases:1.08%

controls:0.03%

2377

23764

2376

23768

—

1701

23243

1460

19644

Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]

1.1e+00

1.5e+00

2.6e+00

1.0e+50

3.3e+00

1.7e+00

1.3e+00

cases:5.49%

controls:1.82%

cases:4.07%

controls:0.93%

cases:1.68%

controls:0.12%

cases:0.67%

controls:0.00%

cases:4.95%

controls:0.19%

cases:4.50%

controls:0.82%

cases:7.79%

controls:2.18%

131

432

2255

23342

221

2289

23553

2346

23745

2370

23774

1688

23696

191

1635

23060

115

429

1361

19220

Normoblasts [#/volume] in Blood
715-3 [3021589]

3.9e-01

6.4e-01

1.6e+00

4.6e+00

2.6e+00

1.0e+00

7.1e-01

cases:10.94%

controls:7.67%

cases:10.69%

controls:5.96%

cases:5.99%

controls:1.27%

cases:4.57%

controls:0.05%

cases:15.15%

controls:1.27%

cases:15.71%

controls:6.13%

cases:20.53%

controls:11.25%

261

1824

2125

21950

255

1416

2131

22358

143

301

2243

23473

109

2277

23763

269

301

1507

23439

269

1425

1443

21826

303

2211

1173

17438

Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]

6.7e-01

1.5e+00

2.5e+00

—

4.6e+00

1.7e+00

1.3e+00

cases:1.01%

controls:0.52%

cases:0.92%

controls:0.20%

cases:0.25%

controls:0.02%

—

cases:2.36%

controls:0.03%

cases:0.82%

controls:0.15%

cases:2.17%

controls:0.58%

123

2362

23651

2364

23726

2380

23769

—

1734

23734

1698

23215

113

1444

19536

Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]

1.7e+00

1.9e+00

—

1.0e+50

4.2e+00

1.8e+00

2.0e+00

cases:0.92%

controls:0.17%

cases:0.71%

controls:0.11%

—

cases:0.71%

controls:0.00%

cases:1.91%

controls:0.03%

cases:0.88%

controls:0.14%

cases:1.56%

controls:0.21%

2364

23733

2369

23748

—

2369

23774

1742

23733

1697

23218

1453

19607

Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]

9.0e-01

1.6e+00

2.8e+00

—

3.6e+00

2.0e+00

1.5e+00

cases:0.54%

controls:0.22%

cases:0.50%

controls:0.10%

cases:0.34%

controls:0.02%

—

cases:1.58%

controls:0.04%

cases:0.82%

controls:0.11%

cases:1.08%

controls:0.24%

2373

23721

2374

23750

2378

23769

—

1748

23730

1698

23226

1460

19602

Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]

8.9e-01

1.6e+00

2.7e+00

1.0e+50

3.1e+00

2.2e+00

9.9e-01

cases:1.51%

controls:0.63%

cases:1.55%

controls:0.30%

cases:0.50%

controls:0.03%

cases:0.88%

controls:0.00%

cases:1.63%

controls:0.08%

cases:2.10%

controls:0.23%

cases:2.03%

controls:0.77%

149

2350

23625

2349

23702

2374

23766

2365

23774

1747

23722

1676

23198

151

1446

19498

Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]

7.5e-01

1.3e+00

3.5e+00

1.0e+50

3.3e+00

1.6e+00

1.0e+00

cases:1.89%

controls:0.90%

cases:1.38%

controls:0.39%

cases:0.92%

controls:0.03%

cases:0.67%

controls:0.00%

cases:1.18%

controls:0.04%

cases:2.04%

controls:0.41%

cases:4.13%

controls:1.52%

214

2341

23560

2353

23681

2364

23767

2370

23774

1755

23730

1677

23156

298

1415

19351

Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]

9.7e-01

1.6e+00

2.2e+00

—

3.3e+00

1.9e+00

1.5e+00

cases:3.98%

controls:1.54%

cases:3.56%

controls:0.77%

cases:1.05%

controls:0.12%

—

cases:3.83%

controls:0.14%

cases:5.26%

controls:0.80%

cases:9.55%

controls:2.41%

367

2291

23407

182

2301

23592

2361

23746

—

1708

23706

187

1622

23064

141

473

1335

19176

Short blood count panel - Blood
55429-5 [40758558]

5.5e-01

7.4e-01

1.5e+00

4.2e+00

2.5e+00

1.2e+00

8.1e-01

cases:7.38%

controls:4.40%

cases:4.65%

controls:2.27%

cases:2.22%

controls:0.53%

cases:1.84%

controls:0.03%

cases:6.31%

controls:0.56%

cases:7.07%

controls:2.17%

cases:11.38%

controls:5.38%

176

1045

2210

22729

111

540

2275

23234

125

2333

23649

2342

23767

112

133

1664

23607

121

505

1591

22746

168

1058

1308

18591

magnesium hydroxide; oral
A02AA04 [21600052]

1.7e+00

1.9e+00

2.2e+00

—

2.4e+00

2.0e+00

1.3e+00

cases:1.22%

controls:0.23%

cases:0.92%

controls:0.14%

cases:0.50%

controls:0.05%

—

cases:0.62%

controls:0.06%

cases:1.05%

controls:0.14%

cases:1.15%

controls:0.33%

2357

23719

2364

23740

2374

23761

—

1765

23726

1694

23219

1459

19584

magnesium hydroxide; oral
G04BX01 [21602658]

1.7e+00

1.9e+00

2.2e+00

—

2.4e+00

2.0e+00

1.3e+00

cases:1.22%

controls:0.23%

cases:0.92%

controls:0.14%

cases:0.50%

controls:0.05%

—

cases:0.62%

controls:0.06%

cases:1.05%

controls:0.14%

cases:1.15%

controls:0.33%

2357

23719

2364

23740

2374

23761

—

1765

23726

1694

23219

1459

19584

pH of Venous blood
2746-6 [3012544]

1.0e+00

1.4e+00

3.1e+00

1.0e+50

3.1e+00

1.7e+00

1.1e+00

cases:2.93%

controls:1.09%

cases:2.10%

controls:0.51%

cases:1.13%

controls:0.05%

cases:1.05%

controls:0.00%

cases:1.58%

controls:0.07%

cases:2.69%

controls:0.52%

cases:5.01%

controls:1.77%

259

2316

23515

121

2336

23653

2359

23762

2361

23774

1748

23723

121

1666

23130

347

1402

19302

Extracorporeal dialysis
Z49.1 [45537649]

1.4e+00

2.3e+00

2.6e+00

—

3.3e+00

3.2e+00

cases:0.25%

controls:0.06%

cases:0.34%

controls:0.03%

cases:0.29%

controls:0.02%

—

cases:0.58%

controls:0.02%

cases:0.95%

controls:0.04%

2380

23759

2378

23766

2379

23769

—

1702

23246

1462

19641

Base excess in Venous blood by calculation
1927-3 [3002032]

9.8e-01

1.4e+00

3.1e+00

1.0e+50

3.1e+00

1.7e+00

1.1e+00

cases:2.81%

controls:1.07%

cases:2.01%

controls:0.49%

cases:1.09%

controls:0.05%

cases:1.01%

controls:0.00%

cases:1.52%

controls:0.07%

cases:2.63%

controls:0.50%

cases:5.22%

controls:1.72%

255

2319

23519

116

2338

23658

2360

23762

2362

23774

1749

23723

117

1667

23134

337

1399

19312

Monocytes [#/volume] in Blood
26484-6 [3001604]

5.3e-01

8.8e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

8.3e-01

cases:14.12%

controls:8.86%

cases:11.90%

controls:5.32%

cases:4.74%

controls:1.11%

cases:2.18%

controls:0.06%

cases:14.92%

controls:1.06%

cases:16.59%

controls:5.53%

cases:23.10%

controls:11.56%

337

2107

2049

21667

284

1264

2102

22510

113

264

2273

23510

2334

23760

265

251

1511

23489

284

1285

1428

21966

341

2272

1135

17377

Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]

9.4e-01

1.4e+00

3.1e+00

1.0e+50

3.2e+00

1.7e+00

1.1e+00

cases:2.68%

controls:1.06%

cases:2.01%

controls:0.50%

cases:1.09%

controls:0.05%

cases:0.92%

controls:0.00%

cases:1.58%

controls:0.07%

cases:2.69%

controls:0.52%

cases:5.08%

controls:1.75%

253

2322

23521

119

2338

23655

2360

23762

2364

23774

1748

23724

122

1666

23129

343

1401

19306

Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]

9.7e-01

1.6e+00

2.1e+00

—

3.3e+00

1.9e+00

1.5e+00

cases:3.73%

controls:1.44%

cases:3.44%

controls:0.71%

cases:0.88%

controls:0.11%

—

cases:3.55%

controls:0.13%

cases:4.79%

controls:0.76%

cases:9.28%

controls:2.18%

343

2297

23431

168

2304

23606

2365

23747

—

1713

23708

176

1630

23075

137

428

1339

19221

Basophils [#/volume] in Blood
26444-0 [3006315]

5.2e-01

8.7e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

8.3e-01

cases:14.08%

controls:8.90%

cases:11.86%

controls:5.34%

cases:4.74%

controls:1.11%

cases:2.18%

controls:0.06%

cases:14.92%

controls:1.06%

cases:16.59%

controls:5.54%

cases:23.10%

controls:11.61%

336

2115

2050

21659

283

1269

2103

22505

113

264

2273

23510

2334

23760

265

252

1511

23488

284

1289

1428

21962

341

2282

1135

17367

Monocytes/Leukocytes in Blood
26485-3 [3019069]

4.8e-01

8.8e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

8.3e-01

cases:13.16%

controls:8.53%

cases:11.27%

controls:5.01%

cases:4.69%

controls:1.04%

cases:2.05%

controls:0.06%

cases:14.36%

controls:1.04%

cases:15.77%

controls:5.20%

cases:21.68%

controls:10.72%

314

2029

2072

21745

269

1192

2117

22582

112

248

2274

23526

2337

23760

255

247

1521

23493

270

1208

1442

22043

320

2107

1156

17542

Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]

1.5e+00

1.7e+00

—

1.0e+50

3.9e+00

2.3e+00

2.0e+00

cases:0.67%

controls:0.15%

cases:0.54%

controls:0.10%

—

cases:0.54%

controls:0.00%

cases:1.41%

controls:0.03%

cases:0.82%

controls:0.09%

cases:0.95%

controls:0.13%

2370

23738

2373

23750

—

2373

23774

1751

23733

1698

23231

1462

19623

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

4.9e-01

8.8e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

8.4e-01

cases:13.12%

controls:8.50%

cases:11.32%

controls:5.01%

cases:4.69%

controls:1.04%

cases:2.01%

controls:0.06%

cases:14.25%

controls:1.04%

cases:15.65%

controls:5.17%

cases:21.61%

controls:10.67%

313

2020

2073

21754

270

1191

2116

22583

112

248

2274

23526

2338

23760

253

246

1523

23494

268

1202

1444

22049

319

2097

1157

17552

mycophenolic acid; oral, parenteral
L04AA06 [21603896]

1.2e+00

1.3e+00

1.6e+00

—

2.3e+00

2.6e+00

cases:0.59%

controls:0.18%

cases:0.67%

controls:0.19%

cases:0.34%

controls:0.07%

—

cases:0.79%

controls:0.08%

cases:2.04%

controls:0.20%

cases:3.12%

controls:0.24%

2372

23731

2370

23729

2378

23758

—

1762

23721

1677

23204

1430

19602

Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]

9.4e-01

1.6e+00

2.2e+00

—

3.3e+00

1.9e+00

1.4e+00

cases:4.36%

controls:1.75%

cases:3.77%

controls:0.79%

cases:1.09%

controls:0.12%

—

cases:4.00%

controls:0.16%

cases:5.67%

controls:0.89%

cases:9.89%

controls:2.65%

104

416

2282

23358

189

2296

23585

2360

23745

—

1705

23702

207

1615

23044

146

520

1330

19129

bisoprolol; oral
C07AB07 [21601689]

9.7e-01

1.1e+00

1.3e+00

2.0e+00

2.5e+00

1.8e+00

1.6e+00

cases:20.83%

controls:9.10%

cases:20.75%

controls:7.99%

cases:7.63%

controls:2.25%

cases:0.75%

controls:0.10%

cases:22.58%

controls:2.33%

cases:35.75%

controls:8.44%

cases:38.41%

controls:11.22%

497

2163

1889

21611

495

1900

1891

21874

182

536

2204

23238

2368

23750

401

553

1375

23187

612

1963

1100

21288

567

2204

909

17445

aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]

8.8e-01

1.1e+00

2.8e+00

1.0e+50

3.7e+00

1.8e+00

9.2e-01

cases:4.07%

controls:1.72%

cases:2.35%

controls:0.77%

cases:1.01%

controls:0.06%

cases:1.38%

controls:0.00%

cases:2.82%

controls:0.07%

cases:3.45%

controls:0.61%

cases:5.22%

controls:2.14%

410

2289

23364

183

2330

23591

2362

23760

2353

23774

1726

23723

141

1653

23110

420

1399

19229

Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]

2.2e+00

2.0e+00

—

1.0e+50

2.9e+00

2.1e+00

cases:0.54%

controls:0.06%

cases:0.50%

controls:0.07%

—

cases:0.25%

controls:0.00%

cases:0.45%

controls:0.03%

cases:0.64%

controls:0.08%

cases:0.95%

controls:0.12%

2373

23760

2374

23757

—

2380

23774

1768

23734

1701

23233

1462

19625

Basophils/Leukocytes in Blood
30180-4 [3022096]

4.8e-01

8.8e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

8.3e-01

cases:13.08%

controls:8.48%

cases:11.23%

controls:5.00%

cases:4.61%

controls:1.05%

cases:2.01%

controls:0.06%

cases:14.30%

controls:1.05%

cases:15.65%

controls:5.17%

cases:21.54%

controls:10.73%

312

2016

2074

21758

268

1188

2118

22586

110

249

2276

23525

2338

23760

254

249

1522

23491

268

1202

1444

22049

318

2109

1158

17540

Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]

8.7e-01

1.5e+00

2.5e+00

—

3.7e+00

1.6e+00

1.1e+00

cases:2.01%

controls:0.85%

cases:1.38%

controls:0.32%

cases:0.42%

controls:0.03%

—

cases:1.18%

controls:0.03%

cases:1.58%

controls:0.34%

cases:2.71%

controls:0.92%

202

2338

23572

2353

23698

2376

23766

—

1755

23733

1685

23173

181

1436

19468

Chronic kidney disease, unspecified
N18.9 [45553438]

1.3e+00

1.7e+00

2.5e+00

—

2.3e+00

2.0e+00

1.5e+00

cases:1.55%

controls:0.42%

cases:1.09%

controls:0.21%

cases:0.59%

controls:0.05%

—

cases:0.62%

controls:0.06%

cases:1.64%

controls:0.23%

cases:2.44%

controls:0.55%

2349

23675

2360

23725

2372

23762

—

1765

23725

1684

23197

108

1440

19541

Other chronic renal failure
N18.8 [45534123]

1.8e+00

2.3e+00

2.6e+00

1.0e+50

—

2.6e+00

1.9e+00

cases:0.96%

controls:0.16%

cases:0.67%

controls:0.07%

cases:0.29%

controls:0.02%

cases:0.46%

controls:0.00%

—

cases:0.99%

controls:0.07%

cases:1.22%

controls:0.19%

2363

23735

2370

23758

2379

23769

2375

23774

—

1695

23234

1458

19612

Eosinophils [#/volume] in Blood
26449-9 [3013115]

5.0e-01

8.6e-01

1.5e+00

3.6e+00

2.7e+00

1.2e+00

7.9e-01

cases:14.54%

controls:9.32%

cases:12.24%

controls:5.56%

cases:5.03%

controls:1.19%

cases:2.31%

controls:0.06%

cases:15.15%

controls:1.14%

cases:17.17%

controls:5.78%

cases:23.31%

controls:12.13%

347

2216

2039

21558

292

1323

2094

22451

120

284

2266

23490

2331

23759

269

271

1507

23469

294

1343

1418

21908

344

2383

1132

17266

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

4.6e-01

8.4e-01

1.5e+00

3.7e+00

2.7e+00

1.2e+00

7.6e-01

cases:12.87%

controls:8.53%

cases:11.06%

controls:5.09%

cases:4.40%

controls:1.02%

cases:1.84%

controls:0.05%

cases:14.02%

controls:1.04%

cases:15.19%

controls:5.29%

cases:20.80%

controls:10.97%

307

2027

2079

21747

264

1211

2122

22563

105

242

2281

23532

2342

23763

249

246

1527

23494

260

1230

1452

22021

307

2155

1169

17494

Other and unspecified premature depolarization
I49.4 [45543180]

2.8e+00

2.6e+00

—

1.0e+50

—

3.1e+00

2.7e+00

cases:0.34%

controls:0.02%

cases:0.29%

controls:0.02%

—

cases:0.25%

controls:0.00%

—

cases:0.47%

controls:0.02%

cases:0.88%

controls:0.06%

2378

23769

2379

23769

—

2380

23774

—

1704

23246

1463

19637

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

2.2e-01

4.7e-01

1.8e+00

5.0e+00

2.6e+00

7.1e-01

3.7e-01

cases:30.89%

controls:26.48%

cases:28.37%

controls:19.79%

cases:17.77%

controls:3.37%

cases:21.84%

controls:0.19%

cases:32.15%

controls:3.49%

cases:34.58%

controls:20.59%

cases:47.56%

controls:38.49%

737

6295

1649

17479

677

4705

1709

19069

424

801

1962

22973

521

1865

23729

571

828

1205

22912

592

4788

1120

18463

702

7562

774

12087

Gas panel - Capillary blood
24337-8 [3022313]

9.4e-01

1.6e+00

2.6e+00

—

3.2e+00

1.6e+00

1.2e+00

cases:1.55%

controls:0.61%

cases:1.34%

controls:0.27%

cases:0.46%

controls:0.03%

—

cases:1.01%

controls:0.04%

cases:1.29%

controls:0.26%

cases:2.17%

controls:0.67%

146

2349

23628

2354

23710

2375

23766

—

1758

23730

1690

23190

131

1444

19518

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

4.8e-01

8.5e-01

1.5e+00

3.6e+00

2.7e+00

1.2e+00

8.0e-01

cases:13.37%

controls:8.75%

cases:11.40%

controls:5.21%

cases:4.65%

controls:1.08%

cases:2.05%

controls:0.06%

cases:14.47%

controls:1.09%

cases:15.89%

controls:5.37%

cases:21.95%

controls:11.22%

319

2080

2067

21694

272

1239

2114

22535

111

257

2275

23517

2337

23760

257

258

1519

23482

272

1249

1440

22002

324

2204

1152

17445

Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]

1.6e+00

1.8e+00

—

1.0e+50

4.0e+00

1.9e+00

cases:0.84%

controls:0.18%

cases:0.71%

controls:0.12%

—

cases:0.67%

controls:0.00%

cases:1.86%

controls:0.03%

cases:0.88%

controls:0.14%

cases:1.42%

controls:0.22%

2366

23732

2369

23746

—

2370

23774

1743

23732

1697

23219

1455

19605

Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]

8.7e-01

1.7e+00

2.4e+00

—

3.2e+00

1.5e+00

1.4e+00

cases:1.34%

controls:0.56%

cases:1.17%

controls:0.21%

cases:0.38%

controls:0.03%

—

cases:0.73%

controls:0.03%

cases:0.88%

controls:0.20%

cases:1.63%

controls:0.41%

134

2354

23640

2358

23723

2377

23766

—

1763

23733

1697

23205

1452

19569

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

5.1e-01

8.4e-01

1.5e+00

3.6e+00

2.8e+00

1.2e+00

7.9e-01

cases:14.50%

controls:9.27%

cases:12.07%

controls:5.59%

cases:4.74%

controls:1.15%

cases:2.18%

controls:0.06%

cases:15.03%

controls:1.12%

cases:16.71%

controls:5.75%

cases:23.31%

controls:12.12%

346

2203

2040

21571

288

1329

2098

22445

113

273

2273

23501

2334

23759

267

265

1509

23475

286

1338

1426

21913

344

2381

1132

17268

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

2.2e-01

4.7e-01

1.8e+00

5.0e+00

2.6e+00

7.1e-01

3.7e-01

cases:31.14%

controls:26.71%

cases:28.63%

controls:20.02%

cases:18.02%

controls:3.43%

cases:21.54%

controls:0.19%

cases:32.15%

controls:3.56%

cases:34.87%

controls:20.85%

cases:47.70%

controls:38.74%

743

6351

1643

17423

683

4759

1703

19015

430

815

1956

22959

514

1872

23728

571

845

1205

22895

597

4848

1115

18403

704

7612

772

12037

Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]

1.1e+00

1.5e+00

2.5e+00

—

3.3e+00

1.7e+00

1.1e+00

cases:3.56%

controls:1.22%

cases:3.10%

controls:0.73%

cases:1.30%

controls:0.11%

—

cases:4.28%

controls:0.17%

cases:3.62%

controls:0.69%

cases:4.95%

controls:1.77%

289

2301

23485

173

2312

23601

2355

23748

—

1700

23700

161

1650

23090

348

1403

19301

Urgent procedure
ZXD05 [2001311386]

7.2e-01

1.6e+00

3.1e+00

1.0e+50

3.9e+00

9.1e-01

7.5e-01

cases:6.24%

controls:3.13%

cases:3.65%

controls:0.73%

cases:1.80%

controls:0.08%

cases:3.98%

controls:0.00%

cases:2.42%

controls:0.05%

cases:1.93%

controls:0.78%

cases:5.49%

controls:2.66%

149

744

2237

23030

173

2299

23601

2343

23755

2291

23774

1733

23728

182

1679

23069

522

1395

19127

sotalol; oral, parenteral
C07AA07 [21601672]

1.8e+00

—

2.5e+00

2.3e+00

2.5e+00

cases:1.01%

controls:0.17%

cases:0.84%

controls:0.13%

—

cases:0.51%

controls:0.04%

cases:1.46%

controls:0.14%

cases:2.17%

controls:0.18%

2362

23734

2366

23742

—

1767

23730

1687

23218

1444

19613

Atrial fibrillation and flutter
I48 [45596206]

5.7e+00

—

1.0e+50

—

5.2e+00

cases:9.01%

controls:0.03%

—

cases:3.39%

controls:0.00%

cases:4.32%

controls:0.00%

cases:3.77%

controls:0.00%

—

cases:12.33%

controls:0.08%

215

2171

23766

—

2305

23774

103

2283

23774

1709

23740

—

182

1294

19634

Ambulatory ECG
XF404 [2001303370]

2.0e+00

2.1e+00

1.0e+50

—

3.7e+00

3.1e+00

cases:2.01%

controls:0.29%

cases:0.67%

controls:0.08%

cases:0.25%

controls:0.00%

cases:0.96%

controls:0.00%

—

cases:2.98%

controls:0.08%

cases:2.85%

controls:0.13%

2338

23705

2370

23755

2380

23774

2363

23774

—

1661

23233

1434

19624

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

8.5e-01

1.1e+00

2.9e+00

—

3.5e+00

1.4e+00

9.0e-01

cases:6.41%

controls:2.84%

cases:3.31%

controls:1.11%

cases:1.76%

controls:0.10%

—

cases:3.27%

controls:0.10%

cases:4.32%

controls:1.05%

cases:8.40%

controls:3.60%

153

675

2233

23099

264

2307

23510

2344

23751

—

1718

23717

244

1638

23007

124

707

1352

18942

Pulmonary Disease
29 [38004472]

7.6e-01

1.1e+00

1.5e+00

4.0e+00

1.5e+00

1.1e+00

7.8e-01

cases:13.70%

controls:6.93%

cases:10.02%

controls:3.53%

cases:3.52%

controls:0.81%

cases:1.51%

controls:0.03%

cases:3.27%

controls:0.72%

cases:10.92%

controls:3.81%

cases:16.12%

controls:8.10%

327

1648

2059

22126

239

840

2147

22934

192

2302

23582

2350

23767

170

1718

23570

187

886

1525

22365

238

1592

1238

18057

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

4.4e-01

7.4e-01

1.5e+00

5.0e+00

1.9e+00

6.9e-01

4.9e-01

cases:17.18%

controls:11.80%

cases:11.23%

controls:5.70%

cases:3.52%

controls:0.81%

cases:3.52%

controls:0.03%

cases:6.02%

controls:0.91%

cases:10.51%

controls:5.56%

cases:22.15%

controls:14.83%

410

2805

1976

20969

268

1356

2118

22418

193

2302

23581

2302

23768

107

216

1669

23524

180

1293

1532

21958

327

2914

1149

16735

Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]

1.1e+00

1.6e+00

—

4.3e+00

2.5e+00

1.2e+00

cases:1.22%

controls:0.39%

cases:0.75%

controls:0.15%

—

cases:1.52%

controls:0.02%

cases:1.23%

controls:0.10%

cases:1.29%

controls:0.39%

2357

23681

2368

23739

—

1749

23735

1691

23227

1457

19572

Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]

1.4e+00

1.7e+00

2.3e+00

1.0e+50

2.7e+00

1.7e+00

8.5e-01

cases:0.96%

controls:0.23%

cases:1.30%

controls:0.24%

cases:0.34%

controls:0.03%

cases:0.96%

controls:0.00%

cases:0.84%

controls:0.06%

cases:1.29%

controls:0.23%

cases:2.17%

controls:0.94%

2363

23719

2355

23716

2378

23766

2363

23774

1761

23726

1690

23197

184

1444

19465

Supine thorax X-ray examination
GD1QA [2001303648]

1.0e+00

1.8e+00

3.0e+00

—

2.8e+00

1.4e+00

7.0e-01

cases:3.10%

controls:1.12%

cases:2.77%

controls:0.47%

cases:1.26%

controls:0.06%

—

cases:0.79%

controls:0.05%

cases:2.16%

controls:0.57%

cases:3.86%

controls:1.96%

266

2312

23508

112

2320

23662

2356

23759

—

1762

23728

132

1675

23119

386

1419

19263

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

4.2e-01

9.2e-01

1.9e+00

3.5e+00

2.4e+00

9.5e-01

6.4e-01

cases:10.18%

controls:6.93%

cases:8.76%

controls:3.68%

cases:3.98%

controls:0.64%

cases:1.22%

controls:0.04%

cases:6.76%

controls:0.68%

cases:9.11%

controls:3.73%

cases:16.06%

controls:9.18%

243

1647

2143

22127

209

874

2177

22900

152

2291

23622

2357

23765

120

162

1656

23578

156

868

1556

22383

237

1803

1239

17846

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

4.9e-01

7.9e-01

1.4e+00

3.6e+00

2.4e+00

1.1e+00

7.8e-01

cases:16.18%

controls:10.56%

cases:13.66%

controls:6.68%

cases:6.29%

controls:1.70%

cases:3.02%

controls:0.09%

cases:15.93%

controls:1.62%

cases:18.11%

controls:6.74%

cases:25.14%

controls:13.31%

386

2511

2000

21263

326

1587

2060

22187

150

405

2236

23369

2314

23753

283

385

1493

23355

310

1567

1402

21684

371

2615

1105

17034

Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]

1.1e+00

1.2e+00

—

4.4e+00

2.4e+00

1.5e+00

cases:1.38%

controls:0.48%

cases:0.63%

controls:0.19%

—

cases:1.63%

controls:0.02%

cases:1.40%

controls:0.13%

cases:1.83%

controls:0.41%

113

2353

23661

2371

23730

—

1747

23735

1688

23220

1449

19568

Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]

1.2e+00

1.3e+00

—

4.3e+00

2.2e+00

1.5e+00

cases:1.34%

controls:0.40%

cases:0.63%

controls:0.18%

—

cases:1.52%

controls:0.02%

cases:1.11%

controls:0.12%

cases:1.42%

controls:0.33%

2354

23680

2371

23732

—

1749

23735

1693

23223

1455

19584

Check up of cardiac pacemaker
XFP20 [2001303367]

—

1.0e+50

5.4e+00

5.1e+00

—

cases:0.80%

controls:0.00%

cases:0.56%

controls:0.00%

cases:5.20%

controls:0.03%

cases:7.25%

controls:0.05%

—

2367

23774

1766

23740

1623

23245

107

1369

19640

Respiratory and circulatory monitoring
WX700 [2001310817]

9.8e-01

1.2e+00

2.8e+00

1.0e+50

3.3e+00

1.3e+00

9.2e-01

cases:3.98%

controls:1.53%

cases:1.84%

controls:0.58%

cases:0.75%

controls:0.05%

cases:2.35%

controls:0.00%

cases:1.24%

controls:0.05%

cases:1.75%

controls:0.47%

cases:4.20%

controls:1.72%

363

2291

23411

139

2342

23635

2368

23763

2330

23774

1754

23729

109

1682

23142

338

1414

19311

Dyspnoea
R06.0 [45558449]

9.8e-01

1.5e+00

2.9e+00

1.0e+50

2.3e+00

1.8e+00

1.0e+00

cases:5.41%

controls:2.09%

cases:3.69%

controls:0.83%

cases:1.68%

controls:0.09%

cases:1.76%

controls:0.00%

cases:1.13%

controls:0.11%

cases:4.73%

controls:0.85%

cases:7.66%

controls:2.92%

129

497

2257

23277

198

2298

23576

2346

23752

2344

23774

1756

23713

197

1631

23054

113

574

1363

19075

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

2.3e-01

4.6e-01

1.6e+00

4.8e+00

2.3e+00

6.3e-01

4.3e-01

cases:24.35%

controls:20.35%

cases:24.02%

controls:16.60%

cases:13.87%

controls:3.22%

cases:15.67%

controls:0.15%

cases:24.94%

controls:3.16%

cases:28.50%

controls:17.50%

cases:41.33%

controls:31.49%

581

4837

1805

18937

573

3947

1813

19827

331

765

2055

23009

374

2012

23739

443

749

1333

22991

488

4070

1224

19181

610

6187

866

13462

Thrombin time
3243-3 [3036489]

1.2e+00

—

1.0e+50

4.3e+00

2.3e+00

1.4e+00

cases:1.72%

controls:0.52%

cases:0.67%

controls:0.20%

—

cases:0.21%

controls:0.00%

cases:1.58%

controls:0.02%

cases:1.40%

controls:0.15%

cases:1.83%

controls:0.45%

124

2345

23650

2370

23727

—

2381

23774

1748

23735

1688

23217

1449

19560

Reticulocytes [#/volume] in Blood
14196-0 [3023520]

8.7e-01

1.6e+00

2.5e+00

—

3.2e+00

1.5e+00

6.4e-01

cases:1.89%

controls:0.80%

cases:1.55%

controls:0.32%

cases:0.46%

controls:0.04%

—

cases:1.58%

controls:0.06%

cases:1.93%

controls:0.42%

cases:2.57%

controls:1.38%

190

2341

23584

2349

23697

2375

23765

—

1748

23725

1679

23154

271

1438

19378

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

4.2e-01

7.4e-01

1.5e+00

4.0e+00

2.3e+00

8.2e-01

5.2e-01

cases:21.37%

controls:15.19%

cases:17.69%

controls:9.28%

cases:7.96%

controls:1.88%

cases:4.15%

controls:0.08%

cases:15.99%

controls:1.84%

cases:19.04%

controls:9.35%

cases:30.49%

controls:20.72%

510

3611

1876

20163

422

2207

1964

21567

190

448

2196

23326

2287

23755

284

437

1492

23303

326

2174

1386

21077

450

4072

1026

15577

Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]

2.0e+00

2.4e+00

—

1.0e+50

—

3.5e+00

2.4e+00

cases:1.55%

controls:0.21%

cases:0.88%

controls:0.08%

—

cases:1.55%

controls:0.00%

—

cases:1.69%

controls:0.05%

cases:2.03%

controls:0.19%

2349

23723

2365

23755

—

2349

23774

—

1683

23239

1446

19611

potassium chloride; oral
A12BA01 [21600877]

1.3e+00

1.7e+00

1.2e+00

—

2.6e+00

1.9e+00

1.5e+00

cases:3.44%

controls:1.00%

cases:2.81%

controls:0.52%

cases:0.59%

controls:0.17%

—

cases:2.20%

controls:0.16%

cases:3.91%

controls:0.60%

cases:5.35%

controls:1.22%

237

2304

23537

123

2319

23651

2372

23733

—

1737

23702

140

1645

23111

239

1397

19410

Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]

5.0e-01

1.3e+00

3.1e+00

1.0e+50

3.3e+00

1.6e+00

9.2e-01

cases:0.80%

controls:0.48%

cases:0.67%

controls:0.19%

cases:0.46%

controls:0.02%

cases:0.42%

controls:0.00%

cases:0.56%

controls:0.02%

cases:1.17%

controls:0.23%

cases:2.37%

controls:0.96%

115

2367

23659

2370

23730

2375

23769

2376

23774

1766

23735

1692

23198

188

1441

19461

Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]

6.6e-01

1.3e+00

2.8e+00

—

3.4e+00

1.5e+00

5.7e-01

cases:7.38%

controls:3.96%

cases:5.45%

controls:1.58%

cases:2.64%

controls:0.16%

—

cases:5.57%

controls:0.20%

cases:6.60%

controls:1.59%

cases:9.55%

controls:5.65%

176

941

2210

22833

130

375

2256

23399

2323

23736

—

1677

23693

113

370

1599

22881

141

1110

1335

18539

Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]

1.1e+00

2.0e+00

—

1.0e+50

3.8e+00

2.3e+00

2.2e+00

cases:0.38%

controls:0.13%

cases:0.34%

controls:0.05%

—

cases:0.21%

controls:0.00%

cases:0.90%

controls:0.02%

cases:0.47%

controls:0.05%

cases:0.61%

controls:0.07%

2377

23744

2378

23763

—

2381

23774

1760

23735

1704

23240

1467

19635

Other chest pain
R07.3 [45597166]

6.4e-01

1.2e+00

2.5e+00

1.0e+50

3.2e+00

2.3e+00

9.7e-01

cases:1.22%

controls:0.64%

cases:0.59%

controls:0.17%

cases:0.29%

controls:0.03%

cases:0.80%

controls:0.00%

cases:0.62%

controls:0.03%

cases:2.04%

controls:0.22%

cases:2.51%

controls:0.96%

153

2357

23621

2372

23733

2379

23768

2367

23774

1765

23734

1677

23201

189

1439

19460

Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]

1.1e+00

1.7e+00

—

1.0e+50

4.1e+00

2.2e+00

9.9e-01

cases:1.51%

controls:0.49%

cases:1.47%

controls:0.26%

—

cases:1.26%

controls:0.00%

cases:1.46%

controls:0.03%

cases:1.64%

controls:0.18%

cases:2.10%

controls:0.79%

117

2350

23657

2351

23712

—

2356

23774

1750

23734

1684

23208

155

1445

19494

Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]

5.7e-01

1.2e+00

3.0e+00

1.0e+50

3.3e+00

1.6e+00

1.0e+00

cases:0.84%

controls:0.48%

cases:0.59%

controls:0.17%

cases:0.42%

controls:0.02%

cases:0.29%

controls:0.00%

cases:0.56%

controls:0.02%

cases:1.11%

controls:0.23%

cases:2.51%

controls:0.92%

113

2366

23661

2372

23733

2376

23769

2379

23774

1766

23735

1693

23197

181

1439

19468

Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]

8.4e-01

1.5e+00

2.1e+00

—

3.4e+00

1.5e+00

8.7e-01

cases:3.14%

controls:1.38%

cases:2.05%

controls:0.49%

cases:0.59%

controls:0.08%

—

cases:2.25%

controls:0.08%

cases:2.69%

controls:0.60%

cases:4.34%

controls:1.86%

327

2311

23447

116

2337

23658

2372

23756

—

1736

23721

140

1666

23111

366

1412

19283

Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]

1.3e+00

1.8e+00

—

3.6e+00

2.4e+00

9.4e-01

cases:1.55%

controls:0.43%

cases:0.96%

controls:0.16%

—

cases:1.18%

controls:0.03%

cases:1.52%

controls:0.13%

cases:1.49%

controls:0.59%

102

2349

23672

2363

23737

—

1755

23732

1686

23220

115

1454

19534

Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]

1.1e+00

1.8e+00

—

1.0e+50

4.1e+00

2.2e+00

9.1e-01

cases:1.51%

controls:0.49%

cases:1.51%

controls:0.26%

—

cases:1.17%

controls:0.00%

cases:1.46%

controls:0.03%

cases:1.69%

controls:0.19%

cases:2.03%

controls:0.83%

116

2350

23658

2350

23712

—

2358

23774

1750

23734

1683

23206

163

1446

19486

Nuclear Ab [Titer] in Serum
29953-7 [3037522]

4.7e-01

1.2e+00

1.8e+00

—

4.6e+00

1.2e+00

8.1e-01

cases:3.06%

controls:1.93%

cases:2.10%

controls:0.61%

cases:0.38%

controls:0.06%

—

cases:3.60%

controls:0.04%

cases:1.99%

controls:0.63%

cases:4.54%

controls:2.07%

459

2313

23315

146

2336

23628

2377

23759

—

1712

23731

147

1678

23104

406

1409

19243

Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 [3007847]

2.3e+00

2.1e+00

1.0e+50

—

1.0e+50

4.1e+00

3.7e+00

cases:0.38%

controls:0.04%

cases:0.21%

controls:0.03%

cases:0.29%

controls:0.00%

—

cases:0.62%

controls:0.00%

cases:1.46%

controls:0.03%

cases:2.37%

controls:0.06%

2377

23765

2381

23768

2379

23774

—

1765

23740

1687

23245

1441

19637

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

6.3e-01

1.1e+00

2.5e+00

—

3.4e+00

1.5e+00

9.2e-01

cases:7.29%

controls:4.01%

cases:5.83%

controls:1.92%

cases:2.43%

controls:0.21%

—

cases:6.48%

controls:0.23%

cases:6.54%

controls:1.61%

cases:10.43%

controls:4.44%

174

953

2212

22821

139

457

2247

23317

2328

23724

—

115

1661

23685

112

375

1600

22876

154

873

1322

18776

ramipril; oral
C09AA05 [21601789]

6.3e-01

8.0e-01

1.3e+00

2.1e+00

2.5e+00

1.6e+00

1.2e+00

cases:8.01%

controls:4.42%

cases:7.54%

controls:3.55%

cases:3.06%

controls:0.88%

cases:0.29%

controls:0.04%

cases:11.60%

controls:1.11%

cases:16.18%

controls:3.65%

cases:14.57%

controls:5.04%

191

1050

2195

22724

180

843

2206

22931

209

2313

23565

2379

23765

206

264

1570

23476

277

848

1435

22403

215

991

1261

18658

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

5.1e-01

7.9e-01

1.6e+00

2.6e+00

2.5e+00

1.1e+00

8.5e-01

cases:9.26%

controls:5.77%

cases:6.87%

controls:3.25%

cases:1.97%

controls:0.40%

cases:0.34%

controls:0.03%

cases:5.35%

controls:0.45%

cases:10.51%

controls:3.68%

cases:20.33%

controls:9.87%

221

1372

2165

22402

164

773

2222

23001

2339

23679

2378

23768

106

1681

23634

180

856

1532

22395

300

1939

1176

17710

Pneumonia, unspecified
J18.9 [45601123]

1.0e+00

1.5e+00

3.2e+00

—

2.4e+00

1.3e+00

5.3e-01

cases:5.78%

controls:2.16%

cases:4.15%

controls:0.92%

cases:3.06%

controls:0.13%

—

cases:1.69%

controls:0.15%

cases:3.80%

controls:1.11%

cases:5.89%

controls:3.55%

138

514

2248

23260

219

2287

23555

2313

23744

—

1746

23704

257

1647

22994

698

1389

18951

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

1.6e-01

3.6e-01

1.6e+00

4.7e+00

2.3e+00

6.8e-01

3.7e-01

cases:22.84%

controls:20.21%

cases:21.33%

controls:15.97%

cases:14.63%

controls:3.37%

cases:16.68%

controls:0.18%

cases:25.39%

controls:3.34%

cases:28.10%

controls:16.59%

cases:38.55%

controls:30.30%

545

4804

1841

18970

509

3796

1877

19978

349

802

2037

22972

398

1988

23731

451

793

1325

22947

481

3858

1231

19393

569

5954

907

13695

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

1.4e-01

4.0e-01

1.6e+00

4.8e+00

2.3e+00

5.8e-01

3.0e-01

cases:32.56%

controls:29.67%

cases:31.39%

controls:23.50%

cases:19.28%

controls:4.59%

cases:21.92%

controls:0.24%

cases:32.83%

controls:4.58%

cases:36.92%

controls:24.63%

cases:50.81%

controls:43.41%

777

7053

1609

16721

749

5586

1637

18188

460

1092

1926

22682

523

1863

23717

583

1087

1193

22653

632

5726

1080

17525

750

8530

726

11119

Doppler ultrasound examination of heart
FM1DE [2001303299]

1.7e+00

2.1e+00

—

1.0e+50

—

3.7e+00

2.5e+00

cases:1.97%

controls:0.38%

cases:0.92%

controls:0.11%

—

cases:1.84%

controls:0.00%

—

cases:3.68%

controls:0.09%

cases:3.39%

controls:0.30%

2339

23683

2364

23748

—

2342

23774

—

1649

23229

1426

19590

Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]

4.5e-01

1.2e+00

3.4e+00

1.0e+50

3.2e+00

1.3e+00

8.6e-01

cases:1.01%

controls:0.64%

cases:0.88%

controls:0.27%

cases:0.63%

controls:0.02%

cases:0.54%

controls:0.00%

cases:0.79%

controls:0.03%

cases:1.17%

controls:0.32%

cases:2.85%

controls:1.22%

153

2362

23621

2365

23710

2371

23769

2373

23774

1762

23732

1692

23177

240

1434

19409

Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]

5.9e-01

1.6e+00

2.3e+00

—

2.8e+00

1.5e+00

1.1e+00

cases:2.10%

controls:1.17%

cases:2.51%

controls:0.54%

cases:0.84%

controls:0.08%

—

cases:1.35%

controls:0.08%

cases:2.34%

controls:0.52%

cases:4.27%

controls:1.47%

278

2336

23496

128

2326

23646

2366

23754

—

1752

23721

122

1672

23129

289

1413

19360

Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]

8.9e-01

1.4e+00

2.4e+00

—

3.2e+00

1.1e+00

9.0e-01

cases:2.10%

controls:0.87%

cases:1.38%

controls:0.36%

cases:0.67%

controls:0.06%

—

cases:1.41%

controls:0.06%

cases:1.29%

controls:0.42%

cases:2.51%

controls:1.04%

207

2336

23567

2353

23688

2370

23760

—

1751

23726

1690

23154

204

1439

19445

Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]

1.0e+00

2.2e+00

2.6e+00

—

2.3e+00

1.7e+00

cases:0.96%

controls:0.35%

cases:0.80%

controls:0.09%

cases:0.29%

controls:0.02%

—

cases:1.52%

controls:0.15%

cases:2.17%

controls:0.39%

2363

23691

2367

23752

2379

23769

—

1686

23216

1444

19573

Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]

1.1e+00

1.8e+00

—

1.0e+50

3.9e+00

2.2e+00

9.2e-01

cases:1.47%

controls:0.51%

cases:1.51%

controls:0.26%

—

cases:1.22%

controls:0.00%

cases:1.46%

controls:0.03%

cases:1.75%

controls:0.19%

cases:1.90%

controls:0.77%

121

2351

23653

2350

23711

—

2357

23774

1750

23733

1682

23206

151

1448

19498

Atherosclerotic heart disease
I25.1 [45596196]

6.6e-01

1.1e+00

2.0e+00

—

2.9e+00

2.0e+00

1.2e+00

cases:4.90%

controls:2.61%

cases:3.86%

controls:1.27%

cases:1.51%

controls:0.21%

—

cases:3.66%

controls:0.21%

cases:9.05%

controls:1.38%

cases:10.84%

controls:3.49%

117

620

2269

23154

301

2294

23473

2350

23725

—

1711

23689

155

320

1557

22931

160

686

1316

18963

Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]

5.9e-01

1.1e+00

2.4e+00

—

4.5e+00

1.2e+00

5.3e-01

cases:1.68%

controls:0.94%

cases:1.01%

controls:0.33%

cases:0.34%

controls:0.03%

—

cases:2.31%

controls:0.03%

cases:0.93%

controls:0.30%

cases:1.83%

controls:1.08%

223

2346

23551

2362

23696

2378

23767

—

1735

23734

1696

23182

213

1449

19436

dabigatran etexilate; oral
B01AE07 [21601026]

2.1e+00

2.6e+00

—

3.1e+00

1.9e+00

cases:0.59%

controls:0.08%

cases:0.59%

controls:0.04%

—

cases:0.58%

controls:0.03%

cases:0.81%

controls:0.12%

2372

23756

2372

23764

—

1702

23245

1464

19626

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

3.1e-01

6.2e-01

1.4e+00

4.3e+00

1.9e+00

6.2e-01

5.1e-01

cases:16.81%

controls:12.89%

cases:11.27%

controls:6.38%

cases:3.60%

controls:0.90%

cases:2.51%

controls:0.03%

cases:6.48%

controls:1.00%

cases:11.16%

controls:6.35%

cases:24.59%

controls:16.33%

401

3065

1985

20709

269

1517

2117

22257

213

2300

23561

2326

23766

115

238

1661

23502

191

1476

1521

21775

363

3208

1113

16441

Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]

2.1e+00

2.5e+00

1.0e+50

—

3.0e+00

2.1e+00

cases:1.42%

controls:0.18%

cases:0.92%

controls:0.08%

cases:0.42%

controls:0.00%

cases:0.25%

controls:0.00%

—

cases:1.58%

controls:0.08%

cases:2.10%

controls:0.26%

2352

23732

2364

23756

2376

23774

2380

23774

—

1685

23233

1445

19597

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

7.7e-01

1.3e+00

2.2e+00

—

2.7e+00

1.4e+00

1.3e+00

cases:3.94%

controls:1.86%

cases:3.52%

controls:1.01%

cases:1.34%

controls:0.15%

—

cases:3.55%

controls:0.24%

cases:3.97%

controls:0.99%

cases:7.25%

controls:2.14%

442

2292

23332

241

2302

23533

2354

23739

—

1713

23684

231

1644

23020

107

420

1369

19229

FVC percent change Respiratory system
69982-7 [42868471]

9.1e-01

8.7e-01

2.3e+00

—

1.8e+00

1.9e+00

1.8e+00

cases:2.89%

controls:1.19%

cases:1.01%

controls:0.42%

cases:0.29%

controls:0.03%

—

cases:0.39%

controls:0.06%

cases:2.10%

controls:0.31%

cases:4.00%

controls:0.65%

283

2317

23491

101

2362

23673

2379

23767

—

1769

23725

1676

23178

128

1417

19521

FEV1 --post bronchodilation
20155-8 [3023550]

9.1e-01

8.7e-01

2.3e+00

—

1.8e+00

1.9e+00

1.8e+00

cases:2.89%

controls:1.19%

cases:1.01%

controls:0.42%

cases:0.29%

controls:0.03%

—

cases:0.39%

controls:0.06%

cases:2.10%

controls:0.31%

cases:4.00%

controls:0.65%

283

2317

23491

101

2362

23673

2379

23767

—

1769

23725

1676

23178

128

1417

19521

FEV1 percent change
69983-5 [42868472]

9.1e-01

8.7e-01

2.3e+00

—

1.8e+00

1.9e+00

1.8e+00

cases:2.89%

controls:1.19%

cases:1.01%

controls:0.42%

cases:0.29%

controls:0.03%

—

cases:0.39%

controls:0.06%

cases:2.10%

controls:0.31%

cases:4.00%

controls:0.65%

283

2317

23491

101

2362

23673

2379

23767

—

1769

23725

1676

23178

128

1417

19521

FEV1/FVC --post bronchodilation
69970-2 [42868459]

9.1e-01

8.7e-01

2.3e+00

—

1.8e+00

1.9e+00

1.8e+00

cases:2.89%

controls:1.19%

cases:1.01%

controls:0.42%

cases:0.29%

controls:0.03%

—

cases:0.39%

controls:0.06%

cases:2.10%

controls:0.31%

cases:4.00%

controls:0.65%

283

2317

23491

101

2362

23673

2379

23767

—

1769

23725

1676

23178

128

1417

19521

Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]

9.1e-01

8.7e-01

2.3e+00

—

1.8e+00

1.9e+00

1.8e+00

cases:2.89%

controls:1.19%

cases:1.01%

controls:0.42%

cases:0.29%

controls:0.03%

—

cases:0.39%

controls:0.06%

cases:2.10%

controls:0.31%

cases:4.00%

controls:0.65%

283

2317

23491

101

2362

23673

2379

23767

—

1769

23725

1676

23178

128

1417

19521

IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]

5.6e-01

9.7e-01

2.1e+00

—

3.5e+00

1.3e+00

1.2e+00

cases:1.89%

controls:1.09%

cases:1.17%

controls:0.45%

cases:0.50%

controls:0.06%

—

cases:1.52%

controls:0.05%

cases:1.87%

controls:0.52%

cases:3.66%

controls:1.16%

259

2341

23515

107

2358

23667

2374

23760

—

1749

23729

120

1680

23131

227

1422

19422

Acute subendocardial infarction unspecified coronary artery status
I21.49 [2000502437]

5.2e-01

2.3e+00

—

1.0e+50

3.6e+00

2.4e+00

1.4e+00

cases:0.63%

controls:0.37%

cases:0.84%

controls:0.08%

—

cases:3.35%

controls:0.00%

cases:0.79%

controls:0.02%

cases:0.99%

controls:0.09%

cases:1.49%

controls:0.39%

2371

23685

2366

23754

—

2306

23774

1762

23735

1695

23229

1454

19573

Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]

1.2e+00

1.8e+00

—

1.0e+50

3.5e+00

2.3e+00

2.0e+00

cases:0.34%

controls:0.10%

cases:0.29%

controls:0.05%

—

cases:0.21%

controls:0.00%

cases:0.68%

controls:0.02%

cases:0.47%

controls:0.05%

cases:0.54%

controls:0.07%

2378

23750

2379

23763

—

2381

23774

1764

23735

1704

23240

1468

19635

More than three and less than five hours
ZXE20 [2001311408]

5.1e-01

9.3e-01

2.4e+00

1.0e+50

3.2e+00

1.6e+00

1.5e+00

cases:2.14%

controls:1.30%

cases:0.84%

controls:0.33%

cases:0.34%

controls:0.03%

cases:0.29%

controls:0.00%

cases:0.51%

controls:0.02%

cases:1.23%

controls:0.25%

cases:3.12%

controls:0.75%

308

2335

23466

2366

23695

2378

23767

2379

23774

1767

23735

1691

23194

147

1430

19502

Essential (primary) hypertension
I10 [45591453]

2.8e-01

5.2e-01

1.2e+00

5.1e+00

1.5e+00

7.4e-01

2.8e-01

cases:16.64%

controls:13.16%

cases:10.52%

controls:6.52%

cases:3.39%

controls:1.03%

cases:8.47%

controls:0.06%

cases:4.56%

controls:1.03%

cases:13.61%

controls:7.02%

cases:22.22%

controls:17.70%

397

3129

1989

20645

251

1549

2135

22225

245

2305

23529

202

2184

23760

244

1695

23496

233

1632

1479

21619

328

3478

1148

16171

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

5.7e-01

7.3e-01

1.4e+00

4.7e+00

1.5e+00

7.6e-01

1.9e-01

cases:6.83%

controls:3.98%

cases:4.19%

controls:2.07%

cases:1.47%

controls:0.37%

cases:3.02%

controls:0.03%

cases:1.69%

controls:0.39%

cases:4.67%

controls:2.23%

cases:6.57%

controls:5.50%

163

947

2223

22827

100

492

2286

23282

2351

23686

2314

23767

1746

23648

519

1632

22732

1081

1379

18568

Bacteria identified in Isolate by Culture
43409-2 [3042936]

1.0e+00

1.2e+00

2.7e+00

1.0e+50

2.8e+00

1.1e+00

7.3e-01

cases:4.53%

controls:1.72%

cases:2.01%

controls:0.61%

cases:0.71%

controls:0.05%

cases:0.21%

controls:0.00%

cases:1.58%

controls:0.10%

cases:2.10%

controls:0.71%

cases:4.27%

controls:2.10%

108

409

2278

23365

145

2338

23629

2369

23763

2381

23774

1748

23717

166

1676

23085

412

1413

19237

Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]

1.0e+00

2.4e+00

—

3.5e+00

2.6e+00

cases:0.96%

controls:0.34%

cases:1.26%

controls:0.11%

—

cases:2.75%

controls:0.08%

cases:3.86%

controls:0.31%

2363

23693

2356

23747

—

1665

23232

1419

19588

One hour or less
ZXE00 [2001311394]

6.2e-01

1.0e+00

2.4e+00

—

3.1e+00

1.5e+00

9.8e-01

cases:8.84%

controls:4.97%

cases:3.23%

controls:1.20%

cases:1.17%

controls:0.11%

—

cases:2.36%

controls:0.11%

cases:4.38%

controls:1.05%

cases:8.74%

controls:3.47%

211

1181

2175

22593

285

2309

23489

2358

23749

—

1734

23713

245

1637

23006

129

682

1347

18967

Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]

6.6e-01

1.5e+00

—

4.8e+00

2.0e+00

1.2e+00

cases:1.09%

controls:0.57%

cases:0.59%

controls:0.13%

—

cases:2.53%

controls:0.02%

cases:1.05%

controls:0.14%

cases:1.83%

controls:0.55%

135

2360

23639

2372

23743

—

1731

23735

1694

23218

109

1449

19540

Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]

1.0e+00

2.1e+00

2.3e+00

—

2.3e+00

1.8e+00

cases:0.92%

controls:0.34%

cases:0.80%

controls:0.10%

cases:0.25%

controls:0.03%

—

cases:1.52%

controls:0.15%

cases:2.17%

controls:0.37%

2364

23694

2367

23751

2380

23768

—

1686

23216

1444

19576

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

3.3e-01

5.6e-01

1.2e+00

3.5e+00

2.5e+00

8.2e-01

4.9e-01

cases:19.45%

controls:14.81%

cases:11.82%

controls:7.10%

cases:3.52%

controls:1.05%

cases:1.38%

controls:0.04%

cases:10.14%

controls:0.93%

cases:15.36%

controls:7.38%

cases:27.17%

controls:18.63%

464

3521

1922

20253

282

1688

2104

22086

249

2302

23525

2353

23764

180

220

1596

23520

263

1717

1449

21534

401

3661

1075

15988

Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]

9.5e-01

9.0e-01

1.9e+00

—

2.0e+00

1.7e+00

1.9e+00

cases:3.35%

controls:1.33%

cases:1.22%

controls:0.50%

cases:0.29%

controls:0.04%

—

cases:0.51%

controls:0.07%

cases:2.28%

controls:0.41%

cases:4.81%

controls:0.73%

316

2306

23458

118

2357

23656

2379

23764

—

1767

23723

1673

23156

144

1405

19505

FEV1/FVC
19926-5 [3011505]

9.5e-01

9.0e-01

1.9e+00

—

2.0e+00

1.7e+00

1.9e+00

cases:3.35%

controls:1.33%

cases:1.22%

controls:0.50%

cases:0.29%

controls:0.04%

—

cases:0.51%

controls:0.07%

cases:2.28%

controls:0.41%

cases:4.81%

controls:0.73%

316

2306

23458

118

2357

23656

2379

23764

—

1767

23723

1673

23156

144

1405

19505

FEV1
20150-9 [3024653]

9.5e-01

9.0e-01

1.9e+00

—

2.0e+00

1.7e+00

1.9e+00

cases:3.35%

controls:1.33%

cases:1.22%

controls:0.50%

cases:0.29%

controls:0.04%

—

cases:0.51%

controls:0.07%

cases:2.28%

controls:0.41%

cases:4.81%

controls:0.73%

316

2306

23458

118

2357

23656

2379

23764

—

1767

23723

1673

23156

144

1405

19505

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]

6.6e-01

1.2e+00

2.4e+00

1.0e+50

2.9e+00

1.1e+00

cases:2.47%

controls:1.30%

cases:1.55%

controls:0.45%

cases:0.50%

controls:0.05%

cases:0.42%

controls:0.00%

cases:1.07%

controls:0.06%

cases:1.64%

controls:0.52%

cases:4.00%

controls:1.41%

308

2327

23466

108

2349

23666

2374

23763

2376

23774

1757

23726

122

1684

23129

278

1417

19371

azathioprine; oral, parenteral
L04AX01 [21603927]

9.0e-01

9.8e-01

1.2e+00

—

2.4e+00

2.0e+00

cases:1.38%

controls:0.57%

cases:1.17%

controls:0.45%

cases:0.54%

controls:0.17%

—

cases:1.41%

controls:0.13%

cases:3.04%

controls:0.43%

cases:3.46%

controls:0.50%

135

2353

23639

106

2358

23668

2373

23734

—

1751

23710

101

1660

23150

1425

19550

Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]

7.7e-01

1.2e+00

2.2e+00

—

2.7e+00

1.5e+00

9.1e-01

cases:3.06%

controls:1.43%

cases:2.05%

controls:0.60%

cases:0.67%

controls:0.07%

—

cases:1.41%

controls:0.10%

cases:2.28%

controls:0.51%

cases:3.52%

controls:1.45%

341

2313

23433

142

2337

23632

2370

23757

—

1751

23717

118

1673

23133

285

1424

19364

Platelets [#/volume] in Blood
26515-7 [3007461]

1.1e-01

3.4e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:34.87%

controls:32.45%

cases:32.98%

controls:26.02%

cases:21.21%

controls:5.46%

cases:23.05%

controls:0.31%

cases:33.11%

controls:5.41%

cases:39.14%

controls:27.25%

cases:52.57%

controls:46.80%

832

7715

1554

16059

787

6186

1599

17588

506

1297

1880

22477

550

1836

23701

588

1284

1188

22456

670

6335

1042

16916

776

9196

700

10453

Leukocytes [#/volume] in Blood
26464-8 [3010813]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:35.00%

controls:32.56%

cases:32.98%

controls:26.11%

cases:21.29%

controls:5.48%

cases:23.05%

controls:0.31%

cases:33.22%

controls:5.43%

cases:39.25%

controls:27.38%

cases:52.64%

controls:46.96%

835

7740

1551

16034

787

6208

1599

17566

508

1304

1878

22470

550

1836

23701

590

1288

1186

22452

672

6366

1040

16885

777

9227

699

10422

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:34.95%

controls:32.53%

cases:32.98%

controls:26.06%

cases:21.21%

controls:5.47%

cases:23.05%

controls:0.31%

cases:33.11%

controls:5.41%

cases:39.14%

controls:27.31%

cases:52.57%

controls:46.90%

834

7733

1552

16041

787

6195

1599

17579

506

1300

1880

22474

550

1836

23701

588

1285

1188

22455

670

6351

1042

16900

776

9215

700

10434

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:35.00%

controls:32.53%

cases:32.90%

controls:26.07%

cases:21.17%

controls:5.48%

cases:23.13%

controls:0.31%

cases:33.16%

controls:5.42%

cases:39.14%

controls:27.33%

cases:52.57%

controls:46.91%

835

7733

1551

16041

785

6199

1601

17575

505

1302

1881

22472

552

1834

23701

589

1287

1187

22453

670

6355

1042

16896

776

9217

700

10432

MCH [Entitic mass]
28539-5 [3035941]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:34.91%

controls:32.48%

cases:32.90%

controls:26.04%

cases:21.17%

controls:5.46%

cases:23.05%

controls:0.31%

cases:33.11%

controls:5.42%

cases:39.14%

controls:27.33%

cases:52.57%

controls:46.88%

833

7721

1553

16053

785

6190

1601

17584

505

1299

1881

22475

550

1836

23701

588

1287

1188

22453

670

6354

1042

16897

776

9212

700

10437

CBC panel - Blood by Automated count
58410-2 [40761511]

1.0e-01

3.1e-01

1.6e+00

4.5e+00

2.2e+00

5.6e-01

2.6e-01

cases:29.04%

controls:26.99%

cases:22.13%

controls:17.26%

cases:12.49%

controls:2.90%

cases:13.03%

controls:0.16%

cases:20.66%

controls:2.94%

cases:26.81%

controls:17.31%

cases:42.41%

controls:36.12%

693

6417

1693

17357

528

4104

1858

19670

298

689

2088

23085

311

2075

23735

367

697

1409

23043

459

4024

1253

19227

626

7097

850

12552

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.3e-01

cases:34.95%

controls:32.53%

cases:32.94%

controls:26.08%

cases:21.17%

controls:5.47%

cases:23.05%

controls:0.31%

cases:33.11%

controls:5.43%

cases:39.14%

controls:27.35%

cases:52.57%

controls:46.92%

834

7734

1552

16040

786

6200

1600

17574

505

1301

1881

22473

550

1836

23701

588

1288

1188

22452

670

6359

1042

16892

776

9219

700

10430

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

1.1e-01

3.3e-01

1.5e+00

4.6e+00

2.2e+00

5.4e-01

2.2e-01

cases:34.95%

controls:32.56%

cases:32.98%

controls:26.10%

cases:21.21%

controls:5.47%

cases:23.05%

controls:0.31%

cases:33.11%

controls:5.44%

cases:39.19%

controls:27.38%

cases:52.57%

controls:46.99%

834

7740

1552

16034

787

6206

1599

17568

506

1301

1880

22473

550

1836

23701

588

1291

1188

22449

671

6366

1041

16885

776

9233

700

10416

Fever, unspecified
R50.9 [45582716]

9.7e-01

8.9e-01

2.7e+00

—

2.3e+00

1.5e+00

9.7e-01

cases:3.23%

controls:1.25%

cases:1.09%

controls:0.45%

cases:0.80%

controls:0.05%

—

cases:0.79%

controls:0.08%

cases:2.34%

controls:0.54%

cases:4.13%

controls:1.61%

296

2309

23478

107

2360

23667

2367

23761

—

1762

23722

125

1672

23126

317

1415

19332

Coronary angiography
AN1 [2000200163]

1.1e+00

1.4e+00

3.1e+00

1.0e+50

—

2.5e+00

1.3e+00

cases:2.22%

controls:0.75%

cases:0.80%

controls:0.20%

cases:0.54%

controls:0.03%

cases:3.73%

controls:0.00%

—

cases:1.64%

controls:0.14%

cases:1.90%

controls:0.54%

178

2333

23596

2367

23726

2373

23768

2297

23774

—

1684

23219

107

1448

19542

Acute bronchitis, unspecified
J20.9 [45562445]

5.6e-01

1.1e+00

2.5e+00

1.0e+50

3.2e+00

1.1e+00

7.5e-01

cases:3.27%

controls:1.89%

cases:1.47%

controls:0.50%

cases:0.63%

controls:0.05%

cases:0.50%

controls:0.00%

cases:0.51%

controls:0.02%

cases:1.46%

controls:0.49%

cases:4.13%

controls:1.99%

449

2308

23325

119

2351

23655

2371

23762

2374

23774

1767

23735

114

1687

23137

391

1415

19258

Cathetrisation of vein
TPH04 [2001309597]

9.9e-01

1.3e+00

2.5e+00

—

1.9e+00

1.4e+00

1.1e+00

cases:4.99%

controls:1.91%

cases:2.60%

controls:0.74%

cases:1.05%

controls:0.08%

—

cases:0.62%

controls:0.09%

cases:2.80%

controls:0.68%

cases:6.50%

controls:2.35%

119

453

2267

23321

176

2324

23598

2361

23754

—

1765

23718

159

1664

23092

462

1380

19187

Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]

8.1e-01

1.2e+00

2.5e+00

1.0e+50

2.7e+00

1.2e+00

8.1e-01

cases:3.44%

controls:1.55%

cases:1.89%

controls:0.57%

cases:0.88%

controls:0.08%

cases:0.34%

controls:0.00%

cases:1.41%

controls:0.10%

cases:1.69%

controls:0.54%

cases:4.13%

controls:1.88%

369

2304

23405

135

2341

23639

2365

23756

2378

23774

1751

23717

125

1683

23126

369

1415

19280

Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]

1.1e+00

1.2e+00

2.5e+00

—

3.2e+00

1.4e+00

1.0e+00

cases:0.75%

controls:0.26%

cases:0.50%

controls:0.16%

cases:0.25%

controls:0.02%

—

cases:0.90%

controls:0.04%

cases:0.64%

controls:0.16%

cases:1.22%

controls:0.44%

2368

23713

2374

23737

2380

23769

—

1760

23731

1701

23213

1458

19563

Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]

1.1e+00

1.2e+00

2.5e+00

—

3.2e+00

1.4e+00

1.0e+00

cases:0.75%

controls:0.26%

cases:0.50%

controls:0.16%

cases:0.25%

controls:0.02%

—

cases:0.90%

controls:0.04%

cases:0.64%

controls:0.16%

cases:1.22%

controls:0.44%

2368

23713

2374

23737

2380

23769

—

1760

23731

1701

23213

1458

19563

rivaroxaban; oral
B01AF01 [43534761]

8.5e-01

1.4e+00

1.8e+00

—

2.6e+00

1.4e+00

1.1e+00

cases:2.56%

controls:1.11%

cases:1.76%

controls:0.45%

cases:0.71%

controls:0.12%

—

cases:1.18%

controls:0.09%

cases:1.93%

controls:0.49%

cases:3.66%

controls:1.22%

263

2325

23511

108

2344

23666

2369

23746

—

1755

23719

114

1679

23137

239

1422

19410

Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]

8.0e-01

9.9e-01

1.8e+00

—

3.2e+00

1.4e+00

8.8e-01

cases:2.35%

controls:1.07%

cases:1.13%

controls:0.42%

cases:0.29%

controls:0.05%

—

cases:0.90%

controls:0.04%

cases:1.64%

controls:0.40%

cases:3.12%

controls:1.32%

255

2330

23519

101

2359

23673

2379

23763

—

1760

23731

1684

23159

259

1430

19390

Infectious Disease
44 [38004484]

6.8e-01

1.2e+00

1.9e+00

—

2.6e+00

1.7e+00

1.1e+00

cases:2.68%

controls:1.38%

cases:1.72%

controls:0.54%

cases:0.54%

controls:0.08%

—

cases:1.30%

controls:0.10%

cases:2.69%

controls:0.51%

cases:3.73%

controls:1.24%

329

2322

23445

129

2345

23645

2373

23754

—

1753

23716

118

1666

23133

243

1421

19406

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

9.1e-02

3.3e-01

1.5e+00

4.5e+00

2.1e+00

5.1e-01

2.0e-01

cases:25.86%

controls:24.15%

cases:22.97%

controls:17.70%

cases:14.04%

controls:3.52%

cases:15.76%

controls:0.21%

cases:22.64%

controls:3.52%

cases:27.16%

controls:18.30%

cases:39.57%

controls:34.94%

617

5742

1769

18032

548

4207

1838

19567

335

838

2051

22936

376

2010

23723

402

835

1374

22905

465

4255

1247

18996

584

6866

892

12783

Base excess in Blood by calculation
11555-0 [3012501]

9.2e-01

1.5e+00

—

1.0e+50

2.9e+00

2.4e+00

1.3e+00

cases:0.75%

controls:0.30%

cases:0.50%

controls:0.11%

—

cases:0.42%

controls:0.00%

cases:0.62%

controls:0.03%

cases:0.64%

controls:0.06%

cases:0.75%

controls:0.20%

2368

23702

2374

23747

—

2376

23774

1765

23732

1701

23238

1465

19609

Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]

9.2e-01

1.5e+00

—

1.0e+50

2.9e+00

2.4e+00

1.3e+00

cases:0.75%

controls:0.30%

cases:0.50%

controls:0.11%

—

cases:0.42%

controls:0.00%

cases:0.62%

controls:0.03%

cases:0.64%

controls:0.06%

cases:0.75%

controls:0.20%

2368

23702

2374

23747

—

2376

23774

1765

23732

1701

23238

1465

19609

Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]

5.7e-01

1.1e+00

2.3e+00

—

4.5e+00

1.2e+00

6.1e-01

cases:1.51%

controls:0.86%

cases:0.92%

controls:0.31%

cases:0.25%

controls:0.03%

—

cases:2.20%

controls:0.03%

cases:0.93%

controls:0.29%

cases:1.76%

controls:0.97%

204

2350

23570

2364

23701

2380

23768

—

1737

23734

1696

23184

190

1450

19459

Acute upper respiratory infection, unspecified
J06.9 [45562437]

4.0e-01

4.9e-01

1.3e+00

3.9e+00

1.7e+00

6.4e-01

6.1e-01

cases:9.14%

controls:6.33%

cases:4.27%

controls:2.65%

cases:1.17%

controls:0.33%

cases:1.26%

controls:0.03%

cases:1.58%

controls:0.28%

cases:5.72%

controls:3.10%

cases:17.28%

controls:10.15%

218

1505

2168

22269

102

631

2284

23143

2358

23695

2356

23768

1748

23673

721

1614

22530

255

1995

1221

17654

alfacalcidol; oral, parenteral
A11CC03 [21600818]

1.8e+00

2.2e+00

—

2.5e+00

cases:0.75%

controls:0.13%

cases:0.71%

controls:0.08%

—

cases:1.17%

controls:0.09%

cases:1.83%

controls:0.15%

2368

23744

2369

23756

—

1692

23229

1449

19619

Oxygen [Partial pressure] in Blood
11556-8 [3027315]

9.0e-01

1.5e+00

—

1.0e+50

2.9e+00

2.4e+00

1.3e+00

cases:0.75%

controls:0.31%

cases:0.50%

controls:0.11%

—

cases:0.42%

controls:0.00%

cases:0.62%

controls:0.03%

cases:0.64%

controls:0.06%

cases:0.75%

controls:0.20%

2368

23701

2374

23747

—

2376

23774

1765

23732

1701

23238

1465

19609

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

2.5e-01

5.9e-01

1.4e+00

4.0e+00

2.0e+00

4.5e-01

4.2e-01

cases:15.59%

controls:12.62%

cases:10.35%

controls:6.01%

cases:2.81%

controls:0.74%

cases:1.30%

controls:0.03%

cases:5.12%

controls:0.72%

cases:9.00%

controls:5.93%

cases:24.59%

controls:17.69%

372

3000

2014

20774

247

1430

2139

22344

175

2319

23599

2355

23768

172

1685

23568

154

1378

1558

21873

363

3476

1113

16173

ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]

1.8e+00

2.2e+00

—

2.3e+00

2.6e+00

cases:0.84%

controls:0.14%

cases:0.80%

controls:0.09%

—

cases:1.11%

controls:0.11%

cases:1.63%

controls:0.12%

2366

23740

2367

23753

—

1693

23226

1452

19626

Physiotherapy
R4110 [2001310233]

6.2e-01

1.1e+00

2.0e+00

—

2.6e+00

1.6e+00

1.0e+00

cases:6.58%

controls:3.63%

cases:3.86%

controls:1.30%

cases:1.17%

controls:0.16%

—

cases:2.87%

controls:0.21%

cases:5.67%

controls:1.18%

cases:8.27%

controls:3.20%

157

864

2229

22910

309

2294

23465

2358

23735

—

1725

23690

275

1615

22976

122

629

1354

19020

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

1.9e-01

4.4e-01

1.6e+00

4.6e+00

1.5e+00

4.8e-01

3.4e-01

cases:10.14%

controls:8.56%

cases:7.75%

controls:5.16%

cases:2.93%

controls:0.64%

cases:3.23%

controls:0.03%

cases:3.15%

controls:0.72%

cases:7.36%

controls:4.69%

cases:18.90%

controls:14.26%

242

2035

2144

21739

185

1226

2201

22548

151

2316

23623

2309

23766

171

1720

23569

126

1090

1586

22161

279

2801

1197

16848

Social worker
Z2446 [2001311559]

7.7e-01

1.9e+00

—

1.0e+50

2.9e+00

1.7e+00

1.6e+00

cases:1.34%

controls:0.63%

cases:1.05%

controls:0.16%

—

cases:0.42%

controls:0.00%

cases:0.39%

controls:0.02%

cases:0.88%

controls:0.16%

cases:1.42%

controls:0.29%

149

2354

23625

2361

23735

—

2376

23774

1769

23735

1697

23214

1455

19593

Nonallergic asthma
J45.1 [45557625]

9.4e-01

1.0e+00

2.2e+00

—

2.4e+00

1.2e+00

1.0e+00

cases:1.55%

controls:0.61%

cases:0.84%

controls:0.30%

cases:0.42%

controls:0.05%

—

cases:0.34%

controls:0.03%

cases:1.05%

controls:0.31%

cases:1.90%

controls:0.70%

145

2349

23629

2366

23702

2376

23763

—

1770

23733

1694

23180

137

1448

19512

Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]

1.2e+00

1.1e+00

1.8e+00

—

2.6e+00

1.3e+00

8.3e-01

cases:1.47%

controls:0.43%

cases:0.71%

controls:0.23%

cases:0.29%

controls:0.05%

—

cases:0.34%

controls:0.03%

cases:1.05%

controls:0.29%

cases:1.56%

controls:0.69%

103

2351

23671

2369

23720

2379

23762

—

1770

23734

1694

23184

135

1453

19514

Inpatient Visit
IP [9201]

5.1e-01

1.2e+00

2.2e+00

—

2.7e+00

1.4e+00

6.9e-01

cases:10.06%

controls:6.29%

cases:7.38%

controls:2.37%

cases:2.60%

controls:0.28%

—

cases:3.83%

controls:0.28%

cases:9.35%

controls:2.40%

cases:12.53%

controls:6.68%

240

1496

2146

22278

176

563

2210

23211

2324

23707

—

1708

23674

160

557

1552

22694

185

1312

1291

18337

Upper gastrointestinal surgery
106 [44777669]

3.8e-01

7.6e-01

1.4e+00

3.5e+00

1.3e+00

8.2e-01

5.3e-01

cases:10.52%

controls:7.47%

cases:5.70%

controls:2.74%

cases:1.68%

controls:0.43%

cases:0.71%

controls:0.02%

cases:1.52%

controls:0.43%

cases:6.43%

controls:2.92%

cases:13.01%

controls:8.07%

251

1776

2135

21998

136

652

2250

23122

103

2346

23671

2369

23769

101

1749

23639

110

680

1602

22571

192

1585

1284

18064

Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]

7.8e-01

1.2e+00

1.8e+00

—

3.0e+00

1.1e+00

8.3e-01

cases:2.56%

controls:1.19%

cases:1.80%

controls:0.55%

cases:0.38%

controls:0.06%

—

cases:1.52%

controls:0.08%

cases:1.34%

controls:0.47%

cases:2.78%

controls:1.23%

282

2325

23492

131

2343

23643

2377

23759

—

1749

23722

109

1689

23142

242

1435

19407

Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]

7.0e-01

9.2e-01

1.6e+00

—

3.1e+00

1.4e+00

9.7e-01

cases:3.73%

controls:1.88%

cases:1.68%

controls:0.68%

cases:0.38%

controls:0.08%

—

cases:1.69%

controls:0.08%

cases:2.57%

controls:0.65%

cases:5.08%

controls:1.98%

447

2297

23327

161

2346

23613

2377

23755

—

1746

23722

150

1668

23101

389

1401

19260

DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]

6.1e-01

1.5e+00

—

4.2e+00

1.9e+00

1.0e+00

cases:0.96%

controls:0.53%

cases:0.84%

controls:0.18%

—

cases:1.35%

controls:0.02%

cases:1.17%

controls:0.18%

cases:1.63%

controls:0.58%

125

2363

23649

2366

23731

—

1752

23735

1692

23209

114

1452

19535

Sleep apnoea
G47.3 [45562094]

5.2e-01

7.1e-01

1.2e+00

4.1e+00

1.0e+00

5.9e-01

5.0e-01

cases:5.70%

controls:3.47%

cases:4.11%

controls:2.05%

cases:1.55%

controls:0.47%

cases:1.22%

controls:0.02%

cases:1.18%

controls:0.43%

cases:4.03%

controls:2.28%

cases:7.72%

controls:4.82%

136

825

2250

22949

488

2288

23286

111

2349

23663

2357

23769

102

1755

23638

530

1643

22721

114

947

1362

18702

sulfamethoxazole and trimethoprim
J01EE01 [21602961]

9.8e-01

1.1e+00

1.6e+00

—

2.5e+00

2.4e+00

1.6e+00

cases:1.09%

controls:0.41%

cases:0.63%

controls:0.21%

cases:0.29%

controls:0.06%

—

cases:0.84%

controls:0.07%

cases:2.28%

controls:0.22%

cases:2.24%

controls:0.46%

2360

23676

2371

23725

2379

23760

—

1761

23724

1673

23201

1443

19558

Abdominal ultrasound examination
JN3AE [2001305555]

9.3e-01

1.6e+00

1.0e+50

2.8e+00

2.1e+00

1.2e+00

cases:2.77%

controls:1.11%

cases:1.97%

controls:0.41%

cases:0.54%

controls:0.00%

cases:0.92%

controls:0.00%

cases:0.62%

controls:0.04%

cases:2.10%

controls:0.26%

cases:3.79%

controls:1.21%

264

2320

23510

2339

23677

2373

23774

2364

23774

1765

23731

1676

23191

238

1420

19411

Chronic kidney disease
N18 [45582391]

1.7e+00

2.7e+00

—

2.2e+00

2.0e+00

cases:0.75%

controls:0.14%

cases:0.63%

controls:0.04%

—

cases:0.41%

controls:0.05%

cases:1.15%

controls:0.15%

2368

23741

2371

23764

—

1705

23240

1459

19619

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

5.2e-01

8.8e-01

1.9e+00

—

3.2e+00

1.3e+00

7.9e-01

cases:5.24%

controls:3.20%

cases:3.14%

controls:1.33%

cases:1.05%

controls:0.16%

—

cases:2.42%

controls:0.11%

cases:4.50%

controls:1.23%

cases:7.32%

controls:3.47%

125

760

2261

23014

317

2311

23457

2361

23737

—

1733

23715

285

1635

22966

108

681

1368

18968

Body CT examination
JN4AD [2001310897]

1.0e+00

1.6e+00

2.0e+00

—

2.8e+00

1.2e+00

5.6e-01

cases:1.47%

controls:0.55%

cases:1.59%

controls:0.32%

cases:0.50%

controls:0.07%

—

cases:0.51%

controls:0.03%

cases:1.52%

controls:0.48%

cases:1.83%

controls:1.05%

130

2351

23644

2348

23697

2374

23757

—

1767

23733

111

1686

23140

206

1449

19443

Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]

3.6e-01

8.5e-01

3.0e+00

1.0e+50

3.4e+00

1.4e+00

8.0e-01

cases:0.71%

controls:0.50%

cases:0.59%

controls:0.25%

cases:0.42%

controls:0.02%

cases:0.54%

controls:0.00%

cases:0.62%

controls:0.02%

cases:0.99%

controls:0.25%

cases:2.30%

controls:1.04%

118

2369

23656

2372

23714

2376

23769

2373

23774

1765

23735

1695

23192

205

1442

19444

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

5.5e-01

1.0e+00

2.6e+00

—

2.7e+00

1.2e+00

5.5e-01

cases:15.09%

controls:9.33%

cases:11.27%

controls:4.48%

cases:5.99%

controls:0.48%

—

cases:7.38%

controls:0.54%

cases:12.50%

controls:4.21%

cases:20.46%

controls:12.98%

360

2219

2026

21555

269

1065

2117

22709

143

113

2243

23661

—

131

128

1645

23612

214

979

1498

22272

302

2550

1174

17099

pantoprazole; oral, parenteral
A02BC02 [21600097]

5.2e-01

7.6e-01

1.2e+00

2.0e+00

2.2e+00

1.2e+00

7.3e-01

cases:20.75%

controls:13.48%

cases:15.42%

controls:7.89%

cases:5.16%

controls:1.64%

cases:0.46%

controls:0.06%

cases:12.73%

controls:1.63%

cases:21.44%

controls:7.84%

cases:29.27%

controls:16.61%

495

3205

1891

20569

368

1875

2018

21899

123

390

2263

23384

2375

23759

226

387

1550

23353

367

1824

1345

21427

432

3263

1044

16386

Intravenous
ZX120 [2001311495]

1.1e+00

1.8e+00

2.1e+00

—

1.6e+00

1.7e+00

1.8e+00

cases:2.22%

controls:0.72%

cases:1.47%

controls:0.26%

cases:0.63%

controls:0.08%

—

cases:0.34%

controls:0.07%

cases:1.34%

controls:0.25%

cases:3.59%

controls:0.64%

170

2333

23604

2351

23713

2371

23756

—

1770

23724

1689

23193

125

1423

19524

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]

7.2e-01

1.1e+00

1.5e+00

—

2.9e+00

1.3e+00

1.0e+00

cases:6.24%

controls:3.15%

cases:4.23%

controls:1.51%

cases:0.96%

controls:0.21%

—

cases:3.15%

controls:0.19%

cases:5.43%

controls:1.60%

cases:12.06%

controls:4.63%

149

748

2237

23026

101

358

2285

23416

2363

23724

—

1720

23696

373

1619

22878

178

909

1298

18740

enoxaparin; parenteral
B01AB05 [21600976]

5.3e-01

9.2e-01

1.4e+00

—

3.3e+00

1.4e+00

8.8e-01

cases:6.20%

controls:3.75%

cases:2.72%

controls:1.10%

cases:0.71%

controls:0.17%

—

cases:3.60%

controls:0.14%

cases:4.32%

controls:1.08%

cases:7.79%

controls:3.37%

148

891

2238

22883

262

2321

23512

2369

23733

—

1712

23706

250

1638

23001

115

663

1361

18986

Sampling
SPAT1263 [2001700364]

3.1e-01

8.0e-01

1.4e+00

3.1e+00

1.6e+00

8.2e-01

4.9e-01

cases:9.60%

controls:7.23%

cases:5.28%

controls:2.44%

cases:1.47%

controls:0.37%

cases:0.63%

controls:0.03%

cases:1.80%

controls:0.38%

cases:5.32%

controls:2.40%

cases:11.45%

controls:7.37%

229

1718

2157

22056

126

579

2260

23195

2351

23685

2371

23767

1744

23650

559

1621

22692

169

1448

1307

18201

Neurology
13 [38004458]

4.2e-01

5.1e-01

1.3e+00

3.8e+00

1.1e+00

7.1e-01

5.4e-01

cases:12.45%

controls:8.56%

cases:6.08%

controls:3.74%

cases:2.26%

controls:0.63%

cases:1.68%

controls:0.04%

cases:1.97%

controls:0.66%

cases:7.36%

controls:3.74%

cases:14.36%

controls:8.88%

297

2034

2089

21740

145

888

2241

22886

150

2332

23624

2346

23765

156

1741

23584

126

870

1586

22381

212

1745

1264

17904

IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]

5.5e-01

1.3e+00

—

4.2e+00

1.5e+00

1.3e+00

cases:1.26%

controls:0.73%

cases:0.92%

controls:0.25%

—

cases:1.35%

controls:0.02%

cases:1.40%

controls:0.30%

cases:2.91%

controls:0.80%

173

2356

23601

2364

23715

—

1752

23735

1688

23181

157

1433

19492

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]

6.9e-01

1.6e+00

—

4.1e+00

1.9e+00

5.5e-01

cases:2.77%

controls:1.41%

cases:1.47%

controls:0.29%

—

cases:2.31%

controls:0.04%

cases:1.69%

controls:0.25%

cases:1.83%

controls:1.06%

335

2320

23439

2351

23704

—

1735

23731

1683

23192

209

1449

19440

Angiography of the heart and coronary arteries
81 [2002100125]

1.3e+00

3.1e+00

—

1.0e+50

—

2.6e+00

1.3e+00

cases:0.92%

controls:0.24%

cases:0.63%

controls:0.03%

—

cases:0.71%

controls:0.00%

—

cases:0.47%

controls:0.03%

cases:0.75%

controls:0.20%

2364

23716

2371

23767

—

2369

23774

—

1704

23243

1465

19610

More than one and less than three hours
ZXE10 [2001311401]

4.8e-01

9.5e-01

2.7e+00

1.0e+50

2.2e+00

1.1e+00

9.0e-01

cases:7.33%

controls:4.67%

cases:2.93%

controls:1.15%

cases:0.71%

controls:0.05%

cases:0.59%

controls:0.00%

cases:0.96%

controls:0.11%

cases:2.98%

controls:0.98%

cases:6.91%

controls:2.94%

175

1111

2211

22663

274

2316

23500

2369

23762

2372

23774

1759

23715

228

1661

23023

102

577

1374

19072

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

5.7e-01

1.1e+00

1.9e+00

—

2.9e+00

1.1e+00

7.2e-01

cases:11.53%

controls:6.86%

cases:9.56%

controls:3.39%

cases:3.65%

controls:0.54%

—

cases:9.52%

controls:0.60%

cases:10.28%

controls:3.57%

cases:16.73%

controls:8.88%

275

1630

2111

22144

228

806

2158

22968

129

2299

23645

—

169

143

1607

23597

176

831

1536

22420

247

1745

1229

17904

Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]

2.1e+00

2.5e+00

—

3.7e+00

1.4e+00

cases:0.63%

controls:0.08%

cases:0.42%

controls:0.03%

—

cases:0.88%

controls:0.02%

cases:0.54%

controls:0.13%

2371

23755

2376

23766

—

1697

23246

1468

19623

Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]

1.0e+00

1.3e+00

2.4e+00

—

2.1e+00

1.5e+00

6.6e-01

cases:0.96%

controls:0.35%

cases:0.80%

controls:0.21%

cases:0.59%

controls:0.05%

—

cases:0.39%

controls:0.05%

cases:0.93%

controls:0.21%

cases:0.95%

controls:0.49%

2363

23691

2367

23724

2372

23761

—

1769

23728

1696

23202

1462

19552

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]

8.4e-01

2.2e+00

—

1.0e+50

2.9e+00

2.3e+00

cases:1.30%

controls:0.57%

cases:1.59%

controls:0.18%

—

cases:3.94%

controls:0.00%

cases:3.04%

controls:0.17%

cases:4.47%

controls:0.46%

135

2355

23639

2348

23732

—

1706

23740

1660

23212

1410

19558

calcium carbonate; oral
A12AA04 [21600863]

1.7e+00

2.2e+00

1.4e+00

—

1.6e+00

2.3e+00

2.1e+00

cases:0.96%

controls:0.18%

cases:1.09%

controls:0.12%

cases:0.21%

controls:0.05%

—

cases:0.34%

controls:0.07%

cases:1.23%

controls:0.13%

cases:1.76%

controls:0.22%

2363

23731

2360

23746

2381

23762

—

1770

23723

1691

23221

1450

19606

calcium carbonate
A02AC01 [21600065]

1.7e+00

2.2e+00

1.4e+00

—

1.6e+00

2.3e+00

2.1e+00

cases:0.96%

controls:0.18%

cases:1.09%

controls:0.12%

cases:0.21%

controls:0.05%

—

cases:0.34%

controls:0.07%

cases:1.23%

controls:0.13%

cases:1.76%

controls:0.22%

2363

23731

2360

23746

2381

23762

—

1770

23723

1691

23221

1450

19606

levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]

8.4e-01

8.6e-01

2.1e+00

—

3.2e+00

1.2e+00

3.9e-01

cases:3.65%

controls:1.61%

cases:1.51%

controls:0.64%

cases:0.67%

controls:0.08%

—

cases:1.63%

controls:0.07%

cases:1.81%

controls:0.54%

cases:2.98%

controls:2.04%

383

2299

23391

153

2350

23621

2370

23755

—

1747

23724

125

1681

23126

401

1432

19248

Hyperlipidaemia, unspecified
E78.5 [45537986]

6.2e-01

1.2e+00

2.5e+00

1.0e+50

2.0e+00

1.3e+00

6.7e-01

cases:1.63%

controls:0.88%

cases:1.13%

controls:0.35%

cases:0.29%

controls:0.03%

cases:0.80%

controls:0.00%

cases:0.45%

controls:0.06%

cases:1.46%

controls:0.40%

cases:2.37%

controls:1.23%

210

2347

23564

2359

23690

2379

23768

2367

23774

1768

23726

1687

23158

242

1441

19407

Abnormal findings on diagnostic imaging of lung
R91 [45548995]

9.1e-01

1.4e+00

2.5e+00

—

2.1e+00

1.4e+00

4.9e-01

cases:1.63%

controls:0.66%

cases:1.13%

controls:0.29%

cases:0.42%

controls:0.03%

—

cases:0.39%

controls:0.05%

cases:1.29%

controls:0.33%

cases:1.63%

controls:1.00%

158

2347

23616

2359

23706

2376

23766

—

1769

23728

1690

23175

197

1452

19452

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

6.8e-01

1.5e+00

1.7e+00

—

2.4e+00

1.1e+00

8.7e-01

cases:3.10%

controls:1.59%

cases:2.18%

controls:0.51%

cases:0.34%

controls:0.06%

—

cases:0.79%

controls:0.07%

cases:1.69%

controls:0.58%

cases:4.40%

controls:1.89%

379

2312

23395

122

2334

23652

2378

23760

—

1762

23723

134

1683

23117

372

1411

19277

Office Visit
OMOP4822458 [581477]

5.7e-01

8.7e-01

2.1e+00

—

2.7e+00

1.2e+00

8.3e-01

cases:11.99%

controls:7.16%

cases:4.86%

controls:2.10%

cases:2.18%

controls:0.27%

—

cases:4.00%

controls:0.29%

cases:6.02%

controls:1.91%

cases:11.31%

controls:5.26%

286

1702

2100

22072

116

499

2270

23275

2334

23709

—

1705

23672

103

443

1609

22808

167

1033

1309

18616

Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]

5.7e-01

8.5e-01

1.6e+00

—

3.0e+00

1.4e+00

8.6e-01

cases:3.98%

controls:2.29%

cases:1.84%

controls:0.79%

cases:0.42%

controls:0.09%

—

cases:1.69%

controls:0.08%

cases:2.75%

controls:0.71%

cases:5.96%

controls:2.62%

544

2291

23230

189

2342

23585

2376

23753

—

1746

23720

165

1665

23086

514

1388

19135

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

6.4e-01

1.0e+00

2.4e+00

—

2.6e+00

9.0e-01

5.7e-01

cases:8.13%

controls:4.48%

cases:5.20%

controls:1.94%

cases:2.43%

controls:0.22%

—

cases:2.93%

controls:0.22%

cases:4.44%

controls:1.85%

cases:10.43%

controls:6.19%

194

1065

2192

22709

124

461

2262

23313

2328

23722

—

1724

23688

431

1636

22820

154

1217

1322

18432

Outpatient Visit
OP [9202]

3.8e-01

4.7e-01

6.9e-01

3.6e+00

1.3e+00

9.8e-01

6.8e-01

cases:72.67%

controls:64.46%

cases:55.78%

controls:44.15%

cases:16.68%

controls:9.14%

cases:11.78%

controls:0.37%

cases:27.31%

controls:9.01%

cases:67.17%

controls:43.52%

cases:82.79%

controls:70.86%

1734

15325

652

8449

1331

10496

1055

13278

398

2174

1988

21600

281

2105

23685

485

2140

1291

21600

1150

10118

562

13133

1222

13923

254

5726

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

1.4e-01

3.6e-01

1.2e+00

3.9e+00

2.0e+00

4.0e-01

2.6e-01

cases:30.85%

controls:27.88%

cases:27.28%

controls:20.80%

cases:11.61%

controls:3.74%

cases:6.58%

controls:0.14%

cases:21.51%

controls:3.71%

cases:29.44%

controls:21.77%

cases:47.49%

controls:41.12%

736

6628

1650

17146

651

4944

1735

18830

277

889

2109

22885

157

2229

23740

382

881

1394

22859

504

5062

1208

18189

701

8079

775

11570

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

5.6e-01

1.0e+00

2.0e+00

—

2.8e+00

1.1e+00

6.4e-01

cases:12.62%

controls:7.64%

cases:10.39%

controls:3.92%

cases:4.23%

controls:0.59%

—

cases:9.91%

controls:0.68%

cases:11.21%

controls:4.19%

cases:18.70%

controls:10.79%

301

1816

2085

21958

248

932

2138

22842

101

141

2285

23633

—

176

162

1600

23578

192

974

1520

22277

276

2121

1200

17528

Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]

1.2e+00

1.5e+00

—

2.9e+00

1.3e+00

1.2e+00

cases:1.34%

controls:0.40%

cases:0.96%

controls:0.23%

—

cases:0.73%

controls:0.04%

cases:0.82%

controls:0.22%

cases:1.42%

controls:0.43%

2354

23678

2363

23720

—

1763

23730

1698

23201

1455

19565

Aortic aneurysm of unspecified site, without mention of rupture
I71.9 [45581813]

2.5e+00

—

2.8e+00

cases:0.46%

controls:0.04%

—

cases:0.35%

controls:0.02%

cases:0.95%

controls:0.06%

2375

23765

—

1706

23246

1462

19637

pH of Blood
11558-4 [3010421]

8.5e-01

1.4e+00

—

1.0e+50

3.2e+00

2.4e+00

9.9e-01

cases:0.75%

controls:0.32%

cases:0.59%

controls:0.14%

—

cases:0.46%

controls:0.00%

cases:0.84%

controls:0.03%

cases:1.05%

controls:0.10%

cases:1.15%

controls:0.43%

2368

23697

2372

23741

—

2375

23774

1761

23732

1694

23228

1459

19564

Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]

1.9e+00

2.3e+00

—

1.0e+50

—

1.9e+00

cases:0.46%

controls:0.07%

cases:0.38%

controls:0.04%

—

cases:0.34%

controls:0.00%

—

cases:0.41%

controls:0.06%

cases:0.81%

controls:0.12%

2375

23757

2377

23765

—

2378

23774

—

1705

23237

1464

19626

Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]

1.9e+00

2.3e+00

—

1.0e+50

—

1.9e+00

cases:0.46%

controls:0.07%

cases:0.38%

controls:0.04%

—

cases:0.34%

controls:0.00%

—

cases:0.41%

controls:0.06%

cases:0.81%

controls:0.12%

2375

23757

2377

23765

—

2378

23774

—

1705

23237

1464

19626

Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]

1.9e+00

2.3e+00

—

1.0e+50

—

1.9e+00

cases:0.46%

controls:0.07%

cases:0.38%

controls:0.04%

—

cases:0.34%

controls:0.00%

—

cases:0.41%

controls:0.06%

cases:0.81%

controls:0.12%

2375

23757

2377

23765

—

2378

23774

—

1705

23237

1464

19626

Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]

1.9e+00

2.3e+00

—

1.0e+50

—

1.9e+00

cases:0.46%

controls:0.07%

cases:0.38%

controls:0.04%

—

cases:0.34%

controls:0.00%

—

cases:0.41%

controls:0.06%

cases:0.81%

controls:0.12%

2375

23757

2377

23765

—

2378

23774

—

1705

23237

1464

19626

Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]

1.4e+00

2.1e+00

—

1.0e+50

—

2.5e+00

2.0e+00

cases:1.42%

controls:0.34%

cases:0.88%

controls:0.11%

—

cases:0.50%

controls:0.00%

—

cases:1.11%

controls:0.09%

cases:2.03%

controls:0.29%

2352

23693

2365

23749

—

2374

23774

—

1693

23229

1446

19593

Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]

1.4e+00

1.8e+00

—

3.0e+00

1.8e+00

cases:1.13%

controls:0.27%

cases:0.50%

controls:0.08%

—

cases:1.23%

controls:0.06%

cases:1.49%

controls:0.25%

2359

23709

2374

23754

—

1691

23237

1454

19599

Electrocardiogram with exercise test
46136006 [4261794]

8.6e-01

1.6e+00

—

1.0e+50

—

3.8e+00

1.8e+00

cases:1.76%

controls:0.75%

cases:0.71%

controls:0.15%

—

cases:0.71%

controls:0.00%

—

cases:5.20%

controls:0.12%

cases:2.64%

controls:0.44%

179

2344

23595

2369

23738

—

2369

23774

—

1623

23222

1437

19563

Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]

1.4e+00

1.9e+00

—

2.9e+00

1.8e+00

cases:1.17%

controls:0.29%

cases:0.63%

controls:0.09%

—

cases:1.17%

controls:0.06%

cases:1.56%

controls:0.27%

2358

23704

2371

23752

—

1692

23236

1453

19596

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

4.1e-01

7.8e-01

2.0e+00

—

2.9e+00

1.2e+00

7.6e-01

cases:6.92%

controls:4.69%

cases:4.11%

controls:1.93%

cases:1.47%

controls:0.21%

—

cases:3.21%

controls:0.19%

cases:5.26%

controls:1.64%

cases:9.55%

controls:4.73%

165

1116

2221

22658

458

2288

23316

2351

23724

—

1719

23696

381

1622

22870

141

929

1335

18720

Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]

1.5e+00

2.3e+00

—

1.0e+50

—

2.8e+00

1.4e+00

cases:0.63%

controls:0.15%

cases:0.34%

controls:0.03%

—

cases:0.38%

controls:0.00%

—

cases:0.99%

controls:0.06%

cases:0.95%

controls:0.23%

2371

23739

2378

23766

—

2377

23774

—

1695

23237

1462

19603

pH of Serum or Plasma
2753-2 [3018418]

6.0e-01

9.7e-01

1.6e+00

—

2.9e+00

1.1e+00

7.6e-01

cases:7.46%

controls:4.26%

cases:5.66%

controls:2.23%

cases:1.89%

controls:0.37%

—

cases:6.36%

controls:0.39%

cases:7.01%

controls:2.40%

cases:12.47%

controls:6.26%

178

1012

2208

22762

135

529

2251

23245

2341

23686

—

113

1663

23648

120

558

1592

22693

184

1230

1292

18419

Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]

1.3e+00

1.4e+00

—

2.8e+00

1.3e+00

1.1e+00

cases:1.17%

controls:0.33%

cases:0.88%

controls:0.21%

—

cases:0.51%

controls:0.03%

cases:0.76%

controls:0.21%

cases:1.22%

controls:0.43%

2358

23696

2365

23723

—

1767

23733

1699

23203

1458

19565

Osmolality of Urine
2695-5 [3026782]

5.3e-01

8.7e-01

2.2e+00

—

2.5e+00

1.1e+00

7.1e-01

cases:5.57%

controls:3.34%

cases:3.23%

controls:1.38%

cases:1.17%

controls:0.13%

—

cases:2.25%

controls:0.18%

cases:3.45%

controls:1.21%

cases:6.50%

controls:3.31%

133

795

2253

22979

328

2309

23446

2358

23742

—

1736

23697

281

1653

22970

651

1380

18998

Cardiac arrhythmia, unspecified
I49.9 [45581778]

1.8e+00

1.7e+00

—

1.0e+50

—

2.7e+00

1.7e+00

cases:1.89%

controls:0.32%

cases:0.75%

controls:0.14%

—

cases:0.29%

controls:0.00%

—

cases:1.69%

controls:0.12%

cases:3.05%

controls:0.55%

2341

23698

2368

23741

—

2379

23774

—

1683

23223

108

1431

19541

Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]

4.8e-01

6.6e-01

1.5e+00

2.8e+00

1.2e+00

6.5e-01

5.6e-01

cases:7.46%

controls:4.77%

cases:4.40%

controls:2.33%

cases:1.72%

controls:0.37%

cases:0.34%

controls:0.02%

cases:1.52%

controls:0.45%

cases:4.44%

controls:2.36%

cases:10.77%

controls:6.43%

178

1134

2208

22640

105

554

2281

23220

2345

23685

2378

23769

107

1749

23633

549

1636

22702

159

1264

1317

18385

Laboratory Visit
OMOP4822461 [32036]

7.9e-02

2.2e-01

1.3e+00

4.2e+00

1.8e+00

4.0e-01

1.7e-01

cases:38.31%

controls:36.46%

cases:38.18%

controls:33.16%

cases:26.70%

controls:9.28%

cases:25.48%

controls:0.52%

cases:38.34%

controls:9.28%

cases:44.57%

controls:34.93%

cases:56.44%

controls:52.32%

914

8667

1472

15107

911

7883

1475

15891

637

2206

1749

21568

608

123

1778

23651

681

2204

1095

21536

763

8122

949

15129

833

10280

643

9369

X-ray examination of the lungs in one projection
GD1PA [2001303645]

1.1e+00

2.6e+00

1.0e+50

—

2.0e+00

1.1e+00

cases:1.68%

controls:0.57%

cases:0.71%

controls:0.23%

cases:0.38%

controls:0.03%

cases:0.29%

controls:0.00%

—

cases:1.52%

controls:0.21%

cases:2.30%

controls:0.79%

135

2346

23639

2369

23719

2377

23767

2379

23774

—

1686

23203

155

1442

19494

Acute subendocardial infarction stenosed coronary artery
I21.41 [2000502433]

-1.4e-01

1.8e+00

—

1.0e+50

3.6e+00

2.4e+00

8.6e-01

cases:0.25%

controls:0.29%

cases:0.42%

controls:0.07%

—

cases:0.71%

controls:0.00%

cases:0.79%

controls:0.02%

cases:0.99%

controls:0.09%

cases:0.75%

controls:0.32%

2380

23705

2376

23758

—

2369

23774

1762

23735

1695

23230

1465

19587

HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]

5.5e-01

8.5e-01

1.3e+00

—

3.3e+00

1.1e+00

8.3e-01

cases:5.28%

controls:3.11%

cases:2.72%

controls:1.18%

cases:0.54%

controls:0.16%

—

cases:3.66%

controls:0.14%

cases:3.56%

controls:1.21%

cases:8.06%

controls:3.69%

126

740

2260

23034

280

2321

23494

2373

23737

—

1711

23706

282

1651

22969

119

726

1357

18923

Gastroenterology
10 [38004455]

4.7e-01

5.5e-01

7.9e-01

3.1e+00

1.5e+00

1.2e+00

1.0e+00

cases:6.37%

controls:4.06%

cases:3.52%

controls:2.07%

cases:0.88%

controls:0.40%

cases:0.46%

controls:0.02%

cases:1.63%

controls:0.38%

cases:6.07%

controls:1.97%

cases:11.92%

controls:4.61%

152

966

2234

22808

491

2302

23283

2365

23679

2375

23769

1747

23649

104

458

1608

22793

176

906

1300

18743

prednisolone
A07EA01 [21600653]

6.4e-01

1.0e+00

1.5e+00

—

2.3e+00

1.4e+00

9.2e-01

cases:14.38%

controls:8.14%

cases:9.22%

controls:3.49%

cases:2.81%

controls:0.66%

—

cases:5.74%

controls:0.60%

cases:12.68%

controls:3.52%

cases:19.24%

controls:8.66%

343

1935

2043

21839

220

829

2166

22945

156

2319

23618

—

102

142

1674

23598

217

818

1495

22433

284

1701

1192

17948

Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]

1.7e+00

2.0e+00

—

1.0e+50

—

2.2e+00

2.0e+00

cases:0.50%

controls:0.09%

cases:0.50%

controls:0.07%

—

cases:0.54%

controls:0.00%

—

cases:0.41%

controls:0.05%

cases:0.68%

controls:0.10%

2374

23752

2374

23757

—

2373

23774

—

1705

23240

1466

19630

prednisolone; oral, parenteral
H02AB06 [21602734]

6.3e-01

1.0e+00

1.5e+00

—

2.3e+00

1.4e+00

9.2e-01

cases:14.21%

controls:8.10%

cases:9.18%

controls:3.47%

cases:2.81%

controls:0.65%

—

cases:5.74%

controls:0.60%

cases:12.56%

controls:3.50%

cases:19.17%

controls:8.62%

339

1925

2047

21849

219

824

2167

22950

155

2319

23619

—

102

142

1674

23598

215

814

1497

22437

283

1693

1193

17956

Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]

1.6e-01

3.5e-01

1.1e+00

3.4e+00

2.1e+00

4.6e-01

2.9e-01

cases:23.26%

controls:20.45%

cases:16.22%

controls:12.00%

cases:4.48%

controls:1.53%

cases:1.55%

controls:0.05%

cases:10.81%

controls:1.44%

cases:18.69%

controls:12.68%

cases:35.64%

controls:29.37%

555

4862

1831

18912

387

2854

1999

20920

107

364

2279

23410

2349

23762

192

343

1584

23397

320

2949

1392

20302

526

5770

950

13879

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

1.6e-01

3.8e-01

1.1e+00

3.0e+00

2.3e+00

5.5e-01

3.7e-01

cases:17.60%

controls:15.35%

cases:11.69%

controls:8.27%

cases:3.35%

controls:1.10%

cases:0.84%

controls:0.04%

cases:8.90%

controls:1.01%

cases:14.08%

controls:8.61%

cases:28.05%

controls:21.22%

420

3650

1966

20124

279

1966

2107

21808

262

2306

23512

2366

23764

158

240

1618

23500

241

2003

1471

21248

414

4170

1062

15479

Monitoring vital functions without anesthesia
WX000 [2001310756]

1.2e+00

2.5e+00

—

2.3e+00

1.7e+00

cases:0.59%

controls:0.19%

cases:0.42%

controls:0.03%

—

cases:0.29%

controls:0.03%

cases:0.95%

controls:0.17%

2372

23730

2376

23766

—

1707

23244

1462

19616

Recording of ECG
SPAT1097 [2001700198]

6.4e-01

1.1e+00

1.4e+00

1.0e+50

3.3e+00

1.7e+00

9.6e-01

cases:2.39%

controls:1.27%

cases:1.17%

controls:0.40%

cases:0.21%

controls:0.05%

cases:0.71%

controls:0.00%

cases:0.68%

controls:0.03%

cases:1.87%

controls:0.35%

cases:3.52%

controls:1.38%

303

2329

23471

2358

23680

2381

23762

2369

23774

1764

23734

1680

23170

272

1424

19377

Heart failure
I50 [45581779]

3.5e+00

—

1.0e+50

—

4.2e+00

cases:1.68%

controls:0.05%

—

cases:1.13%

controls:0.00%

—

cases:2.85%

controls:0.05%

2346

23762

—

1756

23740

—

1434

19640

Intensive care
WX872 [2001310844]

1.2e+00

2.4e+00

—

1.0e+50

—

2.5e+00

1.5e+00

cases:0.88%

controls:0.26%

cases:0.75%

controls:0.07%

—

cases:0.96%

controls:0.00%

—

cases:0.76%

controls:0.06%

cases:1.02%

controls:0.22%

2365

23712

2368

23757

—

2363

23774

—

1699

23237

1461

19606

Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]

1.3e+00

1.9e+00

—

2.8e+00

1.7e+00

cases:1.13%

controls:0.32%

cases:0.59%

controls:0.09%

—

cases:1.17%

controls:0.07%

cases:1.49%

controls:0.27%

2359

23698

2372

23752

—

1692

23235

1454

19595

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
I21.90 [2000502438]

1.5e+00

3.4e+00

—

1.0e+50

—

2.7e+00

cases:0.38%

controls:0.08%

cases:0.63%

controls:0.02%

—

cases:0.96%

controls:0.00%

—

cases:0.61%

controls:0.04%

2377

23754

2371

23769

—

2363

23774

—

1467

19641

isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 [21600321]

5.7e-01

1.1e+00

1.4e+00

—

2.5e+00

1.1e+00

9.5e-01

cases:5.95%

controls:3.46%

cases:5.53%

controls:1.89%

cases:1.26%

controls:0.31%

—

cases:3.43%

controls:0.30%

cases:5.55%

controls:1.93%

cases:10.37%

controls:4.26%

142

823

2244

22951

132

450

2254

23324

2356

23701

—

1715

23668

449

1617

22802

153

838

1323

18811

Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]

8.0e-01

1.2e+00

2.4e+00

—

3.2e+00

7.8e-01

6.0e-01

cases:1.68%

controls:0.76%

cases:0.96%

controls:0.30%

cases:0.46%

controls:0.04%

—

cases:1.13%

controls:0.05%

cases:0.70%

controls:0.32%

cases:1.63%

controls:0.90%

181

2346

23593

2363

23703

2375

23764

—

1756

23729

1700

23176

177

1452

19472

General anesthesia, balanced
WX408 [2001310808]

3.8e-01

7.4e-01

2.1e+00

1.0e+50

1.9e+00

1.4e+00

1.0e+00

cases:4.90%

controls:3.39%

cases:1.55%

controls:0.75%

cases:0.42%

controls:0.05%

cases:0.38%

controls:0.00%

cases:0.51%

controls:0.08%

cases:2.34%

controls:0.59%

cases:5.35%

controls:1.97%

117

806

2269

22968

178

2349

23596

2376

23762

2377

23774

1767

23722

138

1672

23113

387

1397

19262

Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]

4.8e-01

8.5e-01

2.2e+00

—

2.4e+00

1.5e+00

1.4e+00

cases:0.63%

controls:0.39%

cases:0.59%

controls:0.25%

cases:0.34%

controls:0.04%

—

cases:0.34%

controls:0.03%

cases:1.11%

controls:0.25%

cases:2.17%

controls:0.53%

2371

23681

2372

23714

2378

23765

—

1770

23733

1693

23193

104

1444

19545

Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]

1.8e+00

1.7e+00

—

1.0e+50

—

2.2e+00

1.9e+00

cases:0.46%

controls:0.08%

cases:0.42%

controls:0.08%

—

cases:0.46%

controls:0.00%

—

cases:0.58%

controls:0.06%

cases:0.75%

controls:0.12%

2375

23755

2376

23756

—

2375

23774

—

1702

23236

1465

19626

tacrolimus; oral, parenteral
L04AD02 [21603925]

7.3e-01

9.9e-01

1.7e+00

—

2.5e+00

2.3e+00

2.6e+00

cases:0.21%

controls:0.10%

cases:0.29%

controls:0.11%

cases:0.21%

controls:0.04%

—

cases:0.56%

controls:0.05%

cases:1.23%

controls:0.12%

cases:1.69%

controls:0.13%

2381

23750

2379

23748

2381

23765

—

1766

23729

1691

23223

1451

19624

Cerebral infarction, unspecified
I63.9 [45596216]

7.2e-01

1.1e+00

2.0e+00

—

2.2e+00

1.4e+00

3.5e-01

cases:1.76%

controls:0.87%

cases:1.01%

controls:0.34%

cases:0.42%

controls:0.05%

—

cases:0.51%

controls:0.06%

cases:1.17%

controls:0.28%

cases:1.76%

controls:1.25%

206

2344

23568

2362

23694

2376

23761

—

1767

23726

1692

23185

246

1450

19403

Gas panel - Arterial blood
24336-0 [3019060]

1.1e+00

1.4e+00

3.4e+00

1.0e+50

—

1.5e+00

5.9e-01

cases:1.76%

controls:0.62%

cases:1.05%

controls:0.25%

cases:0.63%

controls:0.02%

cases:1.13%

controls:0.00%

—

cases:0.88%

controls:0.20%

cases:1.22%

controls:0.68%

147

2344

23627

2361

23715

2371

23769

2359

23774

—

1697

23204

133

1458

19516

Acute renal failure, unspecified
N17.9 [45567829]

1.4e+00

2.4e+00

—

1.0e+50

—

2.2e+00

1.4e+00

cases:0.67%

controls:0.16%

cases:0.88%

controls:0.08%

—

cases:0.25%

controls:0.00%

—

cases:0.70%

controls:0.08%

cases:1.15%

controls:0.30%

2370

23735

2365

23755

—

2380

23774

—

1700

23232

1459

19591

Bacterial pneumonia, unspecified
J15.9 [45557621]

1.3e+00

1.4e+00

—

1.0e+50

3.0e+00

1.6e+00

6.3e-01

cases:1.68%

controls:0.47%

cases:0.96%

controls:0.24%

—

cases:0.88%

controls:0.00%

cases:0.51%

controls:0.03%

cases:1.05%

controls:0.21%

cases:1.49%

controls:0.80%

111

2346

23663

2363

23717

—

2365

23774

1767

23734

1694

23203

157

1454

19492

IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]

2.5e-01

4.8e-01

2.1e+00

—

3.3e+00

1.2e+00

6.8e-01

cases:3.52%

controls:2.77%

cases:1.47%

controls:0.91%

cases:0.63%

controls:0.08%

—

cases:1.41%

controls:0.05%

cases:3.10%

controls:0.92%

cases:6.71%

controls:3.52%

659

2302

23115

216

2351

23558

2371

23755

—

1751

23728

213

1659

23038

691

1377

18958

Physiotherapist
Z3226 [2001311560]

5.7e-01

1.2e+00

—

2.7e+00

1.6e+00

1.2e+00

cases:3.06%

controls:1.76%

cases:1.59%

controls:0.48%

—

cases:0.96%

controls:0.06%

cases:2.22%

controls:0.47%

cases:4.20%

controls:1.26%

418

2313

23356

114

2348

23660

—

1759

23725

110

1674

23141

247

1414

19402

Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]

7.2e-02

2.1e-01

1.1e+00

3.4e+00

2.3e+00

2.6e-01

1.7e-01

cases:23.93%

controls:22.65%

cases:14.71%

controls:12.22%

cases:3.77%

controls:1.32%

cases:1.51%

controls:0.05%

cases:10.92%

controls:1.24%

cases:15.42%

controls:12.31%

cases:33.74%

controls:30.13%

571

5385

1815

18389

351

2904

2035

20870

314

2296

23460

2350

23762

194

295

1582

23445

264

2862

1448

20389

498

5921

978

13728

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1147

3955

4.47

295.23

6.7

1.8

2054.99

535.13

ng/l

12.40

1028

3143

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

432

1096

4.54

157.19

3.0

1.8

10.41

6.01

ug/l

2.00

374

939

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

395

948

4.75

153.97

5.0

1.8

298.34

85.85

ng/l

9.18

367

829

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

788

3115

3.22

147.95

9.0

2.8

584.67

515.84

ng/l

0.25

707

2279

(3027456) Digoxin [Moles/volume] in Serum or Plasma

41.83

140.91

3.0

1.9

0.85

1.06

nmol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

236

399

6.42

135.25

4.3

1.8

11.36

11.05

mg/l

0.24

224

371

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1188

6433

2.59

117.43

7.1

2.7

417.92

54.13

ng/l

0.90

936

4291

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

203

355

6.13

112.08

6.7

2.8

0.34

0.32

iu/ml

0.43

135

169

(3032080) INR in Blood by Coagulation assay

1321

7659

2.51

111.00

26.9

5.8

1.41

1.09

inr

59.38

1136

6214

(3004789) Transferrin [Mass/volume] in Serum or Plasma

602

2506

2.84

98.14

4.1

2.2

2.25

2.32

g/l

2.35

564

2292

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

568

2299

2.89

97.54

4.1

2.3

22.61

24.30

2.03

534

2128

(3022948) Iron [Moles/volume] in Serum or Plasma

627

2688

2.77

96.44

4.1

2.3

12.47

13.94

umol/l

5.40

592

2480

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

626

2751

2.69

91.14

2.2

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

621

2742

2.67

89.36

6.3

3.4

0.82

mmol/l

0.15

587

2580

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

271

737

4.00

87.87

3.9

1.7

36.56

40.96

u/l

2.58

243

669

(3020779) Urea [Moles/volume] in Serum or Plasma

406

1469

3.10

84.33

16.4

6.3

10.58

8.53

mmol/l

5.89

383

1412

(3023368) Bacteria identified in Blood by Culture

914

4965

2.31

82.66

5.8

3.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

730

3781

2.31

72.18

3.0

1.6

1.21

1.23

mg/l

0.09

558

2871

(3018677) aPTT in Platelet poor plasma by Coagulation assay

538

2437

2.53

71.80

4.7

2.0

31.03

28.88

8.52

518

2376

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

382

4.73

71.39

1.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

444

1895

2.63

66.64

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

462

2017

2.58

66.15

2.1

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

166

388

4.51

65.45

1.6

1.7

—

(3019977) pH of Arterial blood

431

1852

2.60

63.59

12.6

7.2

7.42

0.16

233

1003

(3003396) Base excess in Arterial blood by calculation

425

1837

2.58

61.83

12.7

7.1

1.21

0.69

mmol/l

1.76

353

1493

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

434

1896

2.55

61.74

5.8

4.4

249.67

236.37

u/l

0.88

410

1795

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

427

1854

2.57

61.52

12.6

7.1

5.10

5.11

kpa

0.07

405

1784

(3027801) Oxygen [Partial pressure] in Arterial blood

427

1854

2.57

61.52

12.6

7.1

11.97

12.89

kpa

2.60

405

1787

(3003458) Phosphate [Moles/volume] in Serum or Plasma

482

2219

2.45

61.24

12.4

5.5

1.10

1.01

mmol/l

7.46

449

2059

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

155

377

4.31

58.00

1.8

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

169

440

4.04

57.73

2.1

1.6

0.23

0.24

g/l

0.71

159

421

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

173

460

3.96

57.40

2.0

1.6

1.16

1.21

g/l

1.06

164

438

(3000991) Gas panel - Venous blood

355

1458

2.67

57.03

15.3

7.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

123

253

5.06

56.53

1.6

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

146

350

4.36

55.65

1.8

1.5

145.67

155.70

au/ml

0.46

(3016502) Oxygen saturation in Arterial blood

378

1641

2.53

54.03

13.2

7.6

95.86

96.09

0.41

363

1587

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

884

5426

1.97

52.89

3.3

2.1

515.90

242.80

u/l

0.83

852

5148

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

189

581

3.43

50.53

4.5

2.0

1612.43

353.91

ug/l

0.85

183

553

(3012544) pH of Venous blood

370

1650

2.45

49.68

6.7

3.5

7.37

7.38

2.40

231

947

(3002173) Hemoglobin [Mass/volume] in Arterial blood

354

1558

2.48

48.86

14.0

7.9

122.56

124.09

g/l

0.65

346

1522

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1353

9711

1.84

48.49

8.5

6.5

12.88

11.90

umol/l

1.32

1295

9256

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

5.38

48.23

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

190

5.27

47.10

1.4

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

380

3.90

46.60

7.1

5.7

559.36

657.74

iu/ml

0.11

(3002032) Base excess in Venous blood by calculation

356

1605

2.42

46.49

6.8

3.6

1.78

1.76

mmol/l

0.04

323

1363

(3013826) Glucose [Moles/volume] in Serum or Plasma

1458

10790

1.83

46.44

9.0

4.3

6.80

6.71

mmol/l

0.67

1418

10179

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

146

401

3.80

46.17

1.5

1.3

248.67

248.36

u/ml

0.00

106

245

(3014576) Chloride [Moles/volume] in Serum or Plasma

457

2317

2.19

45.12

13.1

6.5

104.33

104.32

mmol/l

0.02

457

2317

(44790048) Parainfluenza type 2 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

1352

9837

1.80

45.00

9.9

6.3

1.89

1.96

e9/l

0.34

1194

8573

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1168

8139

1.81

44.95

12.8

5.7

1.20

1.21

mmol/l

7.11

1115

7487

(3006315) Basophils [#/volume] in Blood

1326

9595

1.80

44.93

10.0

6.2

0.04

e9/l

0.20

1150

8156

(3013115) Eosinophils [#/volume] in Blood

1359

9916

1.80

44.67

10.4

6.5

0.20

e9/l

0.01

1197

8557

(3001604) Monocytes [#/volume] in Blood

1322

9576

1.79

44.46

10.0

6.2

0.62

0.59

e9/l

4.39

1149

8128

(3021447) Carbon dioxide [Partial pressure] in Venous blood

358

1652

2.36

44.24

6.8

3.6

5.97

5.77

kpa

2.95

350

1605

(3010375) cycloSPORINE [Mass/volume] in Blood

8.43

43.73

26.6

28.9

101.45

127.07

ug/l

1.70

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

194

662

3.09

43.60

2.1

1.8

4.51

1.94

ug/l

0.43

185

594

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1279

9214

1.78

43.46

13.6

6.3

1.21

1.22

mmol/l

5.63

1136

7950

(3009445) Proteinase 3 Ab [Units/volume] in Serum

198

685

3.05

43.45

1.8

1.7

7.25

11.72

iu/ml

—

(3006504) Eosinophils/Leukocytes in Blood

1233

8803

1.78

43.08

10.2

6.5

2.80

2.90

0.79

1192

8218

(3019069) Monocytes/Leukocytes in Blood

1235

8823

1.78

43.04

10.3

6.6

9.06

8.90

1.21

1194

8245

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

285

4.22

42.76

3.2

3.4

20936.20

2250.70

u/ml

—

(3002030) Lymphocytes/Leukocytes in Blood

1261

9086

1.77

42.47

10.2

6.4

25.93

28.31

11.48

1223

8585

(3022096) Basophils/Leukocytes in Blood

1229

8799

1.77

42.24

10.3

6.6

0.65

0.68

1.29

1187

8207

(3033658) Prothrombin time (PT) actual/Normal

762

4767

1.85

40.90

6.1

3.8

84.37

93.22

16.41

744

4670

(3018010) Neutrophils/Leukocytes in Blood

1229

8903

1.74

39.64

10.0

6.3

59.15

56.78

10.35

1203

8489

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

339

3.79

39.45

1.5

—

(3036489) Thrombin time

179

622

3.02

38.91

4.2

2.0

21.21

20.64

0.53

165

564

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

722

4521

1.83

38.17

3.0

2.2

2.90

2.69

mg/l

1.32

633

3846

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

236

967

2.59

37.50

16.6

8.5

24.32

24.13

mmol/l

0.40

226

948

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

148

475

3.25

36.80

4.9

2.5

3.73

3.52

g/l

0.72

140

458

(3027945) Reticulocytes/Erythrocytes in Blood

379

1942

2.12

35.81

3.1

2.6

1.77

1.69

0.76

344

1711

(3018418) pH of Serum or Plasma

827

5489

1.75

35.38

7.4

3.8

7.40

0.41

610

3829

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

143

462

3.22

35.16

1.5

1.3

11.62

9.38

iu/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

296

1390

2.28

34.72

5.6

3.2

4.74

4.51

kpa

1.16

284

1349

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

135

5.30

34.58

1.4

1.3

88.33

82.40

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

333

1646

2.18

34.44

2.7

2.2

390.87

379.99

nmol/l

0.37

302

1528

(3013650) Neutrophils [#/volume] in Blood by Automated count

1405

10823

1.67

33.93

13.7

9.8

4.42

4.12

e9/l

4.09

1223

9329

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

680

2.77

33.53

1.5

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

225

954

2.49

33.19

5.1

3.3

1.80

1.38

mmol/l

0.73

175

675

(3037522) Nuclear Ab [Titer] in Serum

433

2394

1.97

33.00

1.5

1.3

440.42

517.86

titre

0.64

486

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

184

709

2.72

32.98

2.0

1.6

1.54

1.50

g/l

0.21

157

611

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

163

599

2.84

31.97

1.3

—

(3009343) pH of Capillary blood

244

1094

2.36

31.78

5.4

3.4

7.41

7.42

0.16

216

891

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

279

3.73

31.65

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

226

4.04

31.39

1.5

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

247

1126

2.32

30.95

5.5

3.4

5.20

5.10

kpa

0.84

236

1075

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

285

3.65

30.68

1.5

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

257

1217

2.24

29.38

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

226

1015

2.35

29.27

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

213

944

2.37

28.42

18.8

9.2

16.23

16.33

0.20

205

908

(3042733) HLA Ab [Presence] in Serum

6.98

27.58

5.4

4.6

—

(3052851) Hemolysis interference index of Serum or Plasma

125

438

2.95

26.72

4.4

3.0

2.00

2.43

index

0.42

226

(3008152) Bicarbonate [Moles/volume] in Arterial blood

210

950

2.32

26.70

9.7

6.7

24.70

24.36

mmol/l

0.57

201

908

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1103

8317

1.58

26.60

4.7

2.8

151.01

138.81

ug/l

0.77

1046

7743

(3042936) Bacteria identified in Isolate by Culture

424

2493

1.84

26.32

2.4

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

166

684

2.53

25.93

2.1

1.7

8.27

6.58

iu/ml

0.29

162

(3024561) Albumin [Mass/volume] in Serum or Plasma

1105

8379

1.56

25.72

7.4

4.8

34.63

36.09

g/l

11.82

1026

7818

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

164

4.23

25.71

1.5

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

471

2.83

25.59

1.3

1.1

4.78

3.65

0.73

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

122

433

2.91

25.49

1.8

1.7

—

(3024471) HLA-A [Type]

6.81

25.06

1.0

—

(3024932) HLA-DR beta [Type]

6.81

25.06

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

847

6080

1.59

24.79

4.6

3.2

40.17

96.85

e6/l

1.61

687

4600

(3030467) Casts [#/volume] in Urine by Automated count

749

5237

1.61

24.41

4.4

3.1

0.45

0.42

e6/l

0.18

585

3786

(3023520) Reticulocytes [#/volume] in Blood

278

1455

2.02

24.35

3.0

2.7

71.09

66.86

e9/l

1.02

195

1057

(3017143) Hepatitis C virus Ab [Presence] in Serum

392

2305

1.83

24.18

2.0

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

147

4.30

23.98

1.5

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

266

1384

2.03

23.67

3.2

2.6

64.68

67.13

g/l

4.39

240

1264

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

132

513

2.66

23.23

2.7

3.1

67.98

67.33

mg/l

0.01

102

438

(3034860) Kappa light chains.free [Mass/volume] in Serum

132

514

2.65

23.14

2.7

3.1

85.07

146.46

mg/l

0.24

105

439

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

198

3.71

22.75

8.0

5.9

11.33

11.21

mg/l

0.07

185

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

134

531

2.61

22.68

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

207

3.60

22.06

2.3

2.4

34.76

34.11

iu/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

193

915

2.20

21.87

3.7

4.31

4.65

pmol/l

4.59

169

820

(3007853) Bacteria identified in Skin by Aerobe culture

350

2048

1.82

21.80

2.2

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

268

1440

1.96

21.71

2.3

2.7

10.61

10.67

g/l

0.07

248

1324

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

249

3.33

21.63

1.1

4.04

3.67

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

317

3.04

21.52

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

317

3.04

21.52

1.4

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

864

6399

1.53

21.25

3.7

3.3

43.65

37.73

u/l

0.66

814

6037

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

809

5915

1.54

21.07

3.6

2.6

58.87

61.11

u/l

0.35

762

5472

(40760888) Immunoglobulin light chains.free panel - Serum

343

2.93

21.02

2.5

3.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

280

1549

1.91

20.77

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

533

3556

1.63

20.51

2.2

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

149

651

2.37

20.48

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

202

1002

2.10

20.38

5.5

3.1

127.81

130.98

g/l

1.05

197

970

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

114

4.45

20.35

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

116

452

2.64

20.32

2.7

3.1

6.48

2.74

ratio

0.43

263

(3026782) Osmolality of Urine

541

3633

1.62

20.24

3.7

2.8

519.28

553.16

mosm/kgh2o

3.33

487

3159

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

238

1257

1.99

20.22

7.3

3.7

118.95

78.72

ng/l

4.03

214

1101

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

468

3036

1.66

20.07

3.7

3.0

2.60

2.09

e6/l

0.66

240

1448

(3023183) Ammonium ion [Moles/volume] in Plasma

100

364

2.82

19.98

2.8

2.9

31.78

36.78

umol/l

0.98

333

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

356

2147

1.76

19.93

2.9

8.62

8.77

umol/l

0.04

320

1909

(3000850) Epithelial cells [#/volume] in Urine

600

4145

1.59

19.90

3.7

2.5

4.76

4.83

e6/l

0.07

565

3752

(3023199) Leukocytes [#/volume] in Pleural fluid

121

4.28

19.74

1.6

1.2

1594.15

10213.95

e6/l

0.62

(36304419) Bacteria [Presence] in Urine

702

5037

1.54

19.66

4.3

3.0

—

0.00

estimate

—

(3028026) IgM [Mass/volume] in Serum or Plasma

217

1122

2.02

19.56

1.6

1.9

1.38

1.41

g/l

0.06

199

1034

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

3.11

19.43

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

439

2823

1.67

19.42

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

4.74

19.39

1.6

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

637

4490

1.56

19.27

3.0

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

492

3266

1.63

19.18

3.7

2.9

1.45

1.10

e6/l

0.67

267

1676

(3018095) Leukocytes [#/volume] in Urine

912

6950

1.49

19.04

5.5

3.8

81.48

89.54

e6/l

0.15

698

4842

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

4.56

18.92

1.4

1.5

—

(1616796) Gas panel - Central venous blood

337

2.83

18.75

5.0

3.0

—

(3022313) Gas panel - Capillary blood

165

794

2.15

18.00

5.8

3.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

415

2.60

17.90

1.3

1.2

—

9.22

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

678

2.24

17.81

2.2

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

794

5948

1.49

17.77

3.1

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

4.24

17.65

1.6

1.2

73490.00

71374.76

e6/l

0.01

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.06

17.61

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

122

3.99

17.00

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

123

537

2.36

16.95

2.4

2.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

170

850

2.07

16.78

6.0

3.0

1.31

1.32

0.04

170

845

(3018333) Ribosomal P Ab [Presence] in Serum

119

4.00

16.73

1.3

1.1

—

(40758558) Short blood count panel - Blood

749

5600

1.48

16.73

9.7

6.2

—

(4268621) Lupus anticoagulant assay

190

3.32

16.69

2.4

2.3

—

(3004451) EKG impression Narrative

5.05

16.67

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

137

632

2.23

16.60

5.8

3.7

24.89

24.63

mmol/l

0.41

126

587

(3024928) Oxygen saturation in Venous blood

383

2.59

16.59

5.1

3.6

68.59

59.68

3.46

366

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

271

2.90

16.41

1.3

1.2

4.80

3.01

u/ml

0.28

118

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

294

1773

1.74

16.32

2.4

2.3

0.20

0.22

g/l

2.59

272

1670

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

129

3.77

15.75

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

129

3.77

15.75

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

272

2.85

15.72

1.4

1.2

1.57

3.51

u/ml

1.12

(3031040) Bacteria [#/volume] in Urine by Automated count

1424

12060

1.41

15.71

5.4

4.2

1471.54

1937.55

e6/l

0.14

180

(3012441) Differential panel - Pleural fluid

107

4.07

15.68

1.7

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

650

4776

1.48

15.66

3.9

2.5

366.25

343.36

umol/l

5.22

584

4258

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

3.81

15.65

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

149

3.54

15.55

4.6

2.9

15.09

11.55

index

1.28

(3021589) Normoblasts [#/volume] in Blood

1051

8467

1.41

15.35

17.8

10.1

0.00

e9/l

0.20

833

6865

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

3.69

15.25

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

134

636

2.17

15.15

2.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

129

3.69

14.98

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

387

2.48

14.77

2.9

2.0

128.75

131.92

g/l

0.55

292

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.22

14.59

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

111

496

2.29

14.53

1.2

40.73

34.69

u/ml

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1677

14710

1.41

14.50

11.8

7.7

80.37

80.06

u/l

0.09

1614

13905

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.23

14.37

1.1

—

(3026008) Bacteria identified in Urine by Culture

678

5097

1.45

14.31

3.5

3.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

346

2.54

14.19

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

150

3.38

13.96

1.3

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

221

1283

1.79

13.94

2.5

17.42

21.22

au/ml

0.31

133

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

473

2.29

13.93

1.2

4.73

2.13

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.16

13.93

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

290

1818

1.67

13.89

3.1

2.5

39.82

67.94

u/l

0.53

254

1567

(3013512) EKG study

767

5947

1.41

13.52

4.9

2.9

—

0.72

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

206

1185

1.80

13.39

1.4

1.3

40.10

57.19

au/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

105

475

2.26

13.37

1.2

26.33

13.13

u/ml

0.50

(3028271) Lactate [Moles/volume] in Capillary blood

223

2.87

13.34

2.0

1.6

1.73

1.75

mmol/l

0.04

216

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

232

1392

1.73

13.05

3.5

2.6

54.49

70.87

ml/min/173m2

5.89

588

(3024980) IgG subclass 4 [Mass/volume] in Serum

309

2.54

12.80

1.7

0.83

0.82

g/l

0.03

245

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1038

8532

1.37

12.66

3.2

2.7

—

estimate

—

(40760892) CBC W Ordered Manual Differential panel - Blood

572

4257

1.44

12.50

6.1

4.7

—

(3003181) Sodium [Moles/volume] in Urine

289

2.57

12.49

1.3

52.52

65.48

mmol/l

1.88

230

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

476

2.21

12.48

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

151

3.22

12.46

1.2

1.3

98.00

201.88

titre

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

315

2.49

12.31

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

117

574

2.09

12.19

7.4

3.9

1.80

1.35

mg/l

4.30

108

533

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

170

3.04

12.03

3.7

4.5

—

(40768446) Kidney Pathology biopsy report

4.23

11.98

2.1

1.6

—

(40768806) Pleura Pathology biopsy report

115

3.52

11.96

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

280

2.54

11.74

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

107

516

2.12

11.67

1.4

1.2

—

(3012501) Base excess in Blood by calculation

318

2.43

11.59

5.1

3.2

2.53

2.29

mmol/l

0.34

203

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

665

1.97

11.41

2.2

3.73

3.76

g/l

0.09

112

602

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

124

638

1.99

11.36

1.5

1.6

4.49

0.19

iu/ml

0.47

104

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

666

1.97

11.36

2.2

4.18

4.22

g/l

0.20

113

603

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

666

1.97

11.36

2.2

7.39

7.35

g/l

0.10

113

602

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

585

2.03

11.24

2.2

2.3

10.08

10.26

g/l

0.15

517

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

361

2.31

11.18

1.2

1.1

10.76

39.68

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

357

2.31

11.02

1.5

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

299

2.41

10.71

1.1

16.39

16.87

au/ml

0.01

(37208534) Antinuclear antibody arbitrary concentration in serum

4.74

10.70

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

501

3734

1.43

10.67

1.5

2.51

2.45

g/l

0.35

334

2352

(3016650) Hepatitis A virus Ab [Presence] in Serum

309

2.37

10.42

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.71

10.41

1.3

1.2

36.59

23.82

u/l

0.39

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1573

14008

1.32

10.18

5.6

4.0

13.90

10.75

mm/h

11.02

1474

13054

(3020876) Protein [Mass/time] in 24 hour Urine

171

2.84

10.12

2.6

2.5

1.41

1.63

g/24h

0.18

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

314

2.33

10.06

1.7

—

(3034426) Prothrombin time (PT)

4.81

10.00

1.1

1.2

27.73

28.91

0.34

(3014148) Varicella zoster virus Ab [Titer] in Serum

243

2.50

9.86

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

185

2.74

9.84

1.5

1.2

7.55

6.61

g/l

0.96

131

(3035880) pH of Pleural fluid

4.39

9.79

1.3

1.1

7.43

7.38

0.84

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.80

9.76

1.2

1.1

—

(4035726) Immunohistochemistry procedure

242

1591

1.58

9.49

1.7

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

123

3.12

9.48

1.4

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.97

9.31

1.2

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.97

9.31

1.2

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

185

2.68

9.29

1.5

1.2

0.41

0.36

g/l

0.38

130

(3028192) IgG subclass 2 [Mass/volume] in Serum

185

2.68

9.29

1.5

1.2

2.96

3.13

g/l

0.29

130

(4062490) Immunoglobulin typing, IgG

180

2.70

9.22

1.5

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

198

2.61

9.16

1.8

1.3

0.55

0.18

nmol/l

0.49

159

(3007930) Methemoglobin/Hemoglobin.total in Blood

119

656

1.85

8.93

8.1

5.3

0.91

0.89

0.21

112

620

(3019309) Folate [Moles/volume] in Red Blood Cells

414

3073

1.41

8.89

1.9

1.7

1147.38

1126.40

nmol/l

0.18

323

2351

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

622

1.87

8.84

2.3

3.18

2.89

g/l

1.78

559

(3037756) Immunofixation for Serum or Plasma

328

2.20

8.71

1.4

1.6

—

(3047181) Lactate [Moles/volume] in Blood

470

1.99

8.67

7.7

6.4

1.40

1.32

mmol/l

0.29

410

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

192

2.58

8.66

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

130

2.95

8.65

2.7

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.33

8.61

1.2

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

104

556

1.91

8.59

1.2

1.3

68.75

106.83

titre

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

125

709

1.80

8.57

9.6

1.4

3.05

5.49

mg/l

1.45

116

511

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

265

1819

1.51

8.54

4.3

2.9

—

(4195642) Thrombophilia screening test

256

2.34

8.40

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

626

1.84

8.37

1.3

1.2

0.17

1.12

u/ml

1.33

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

126

726

1.77

8.21

7.5

5.1

1.90

1.59

0.47

119

689

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.22

8.21

1.2

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.32

8.06

1.7

3.3

150.08

117.98

umol/l

0.23

(3010813) Leukocytes [#/volume] in Blood

2025

21357

0.74

7.92

40.5

20.1

7.21

6.69

e9/l

11.01

1982

20744

(3000963) Hemoglobin [Mass/volume] in Blood

2026

21355

0.74

7.77

40.8

20.2

134.44

138.04

g/l

19.38

2006

21071

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2026

21351

0.74

7.71

42.1

20.4

40.32

41.41

3.18

2003

21045

(3026361) Erythrocytes [#/volume] in Blood

2026

21349

0.74

7.68

40.4

20.0

4.48

4.57

e12/l

12.76

1980

20744

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2026

21348

0.75

7.67

40.3

20.0

91.15

90.84

2.22

2004

21051

(3035941) MCH [Entitic mass]

2026

21347

0.75

7.65

40.3

20.0

30.32

30.37

0.57

2004

21051

(3024891) Influenza virus A+B Ag [Presence] in Specimen

514

1.88

7.61

1.3

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

388

2.01

7.58

2.2

3.3

59.50

57.41

0.86

388

(3007461) Platelets [#/volume] in Blood

2026

21339

0.75

7.54

40.4

20.1

249.61

249.18

e9/l

0.10

1989

20800

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.50

7.54

1.2

1.1

168.94

220.51

iu/ml

0.48

(3030981) Hyaline casts [#/volume] in Urine by Automated count

224

1524

1.51

7.53

3.3

2.4

0.26

0.43

e6/l

0.72

216

1453

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

270

2.21

7.45

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.31

7.18

7.5

6.2

6.54

5.35

kpa

0.64

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

20.06

7.13

1.3

1.0

—

(3022145) Colonoscopy Study observation

297

2164

1.42

7.03

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

309

2270

1.41

6.98

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

332

2473

1.39

6.92

2.7

206.50

143.39

ug/g

1.71

269

2012

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.79

6.80

2.4

2.8

0.61

0.62

mmol/l

0.36

(3005322) IgE [Units/volume] in Serum or Plasma

180

1195

1.54

6.79

1.4

1.3

293.43

247.78

u/ml

0.26

167

1108

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

103

593

1.77

6.78

2.2

2.3

0.47

1.32

g/l

2.32

506

(1761868) Lipid panel - Serum or Plasma

664

7918

0.78

6.77

3.3

3.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

520

1.82

6.75

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

186

2.39

6.70

8.3

5.5

6.31

7.56

mmol/l

2.63

157

(3035715) Granulocytes [#/volume] in Blood

324

2.03

6.64

2.1

3.5

4.51

3.96

e9/l

1.21

324

(3025941) Bacteria identified in Stool by Culture

152

979

1.59

6.55

1.4

1.2

—

(3015736) pH of Urine

935

8076

1.25

6.53

4.2

3.2

6.25

6.20

0.70

520

4583

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.02

6.49

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

189

2.35

6.48

1.8

1.3

—

nmol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

260

2.14

6.46

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

442

1.86

6.37

2.1

2.5

0.00

g/l

-0.00

417

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1824

19379

0.79

6.36

6.0

5.4

2.59

2.77

mmol/l

15.12

1718

18050

(40768797) Stomach Pathology biopsy report

333

2516

1.37

6.35

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

495

1.81

6.29

2.1

2.4

0.01

0.04

g/l

0.53

444

(3000093) Morphology [Interpretation] in Blood Narrative

167

2.42

6.28

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

237

1694

1.44

6.23

5.3

4.5

1.08

0.89

0.60

106

505

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.03

6.17

1.2

5.98

7.74

pmol/l

—

(3011412) CD3 cells [#/volume] in Blood

163

2.41

6.12

2.3

2.7

1082.00

1309.94

e6/l

0.72

140

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

2.69

6.08

2.1

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

176

2.35

6.07

1.1

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

2.35

6.07

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.60

6.03

1.2

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

484

1.78

5.86

2.1

2.4

0.01

0.00

g/l

0.49

419

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

410

3238

1.32

5.81

1.4

1.3

48.69

31.37

iu/ml

0.71

119

956

(3028433) Virus identified in Specimen by Culture

3.62

5.75

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

473

1.78

5.71

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

228

2.13

5.61

1.4

—

(3037121) Protein [Mass/volume] in Urine

101

612

1.68

5.60

3.8

3.7

434.47

421.39

mg/l

0.03

295

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.20

5.59

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.20

5.59

1.6

2.0

257.40

808.14

u/ml

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.41

5.58

2.0

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.41

5.58

2.1

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.41

5.58

2.0

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

963

8450

1.22

5.57

3.0

2.4

74.93

76.50

nmol/l

0.95

879

7647

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

522

4278

1.28

5.56

1.3

2.70

1.70

u/ml

0.53

120

1144

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1790

18969

0.81

5.46

5.4

4.7

1.35

1.42

mmol/l

9.94

1679

17626

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

16.04

5.41

7.3

4.2

100.38

100.00

g/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1803

19085

0.81

5.39

5.4

4.8

4.41

4.66

mmol/l

21.84

1699

17851

(3017704) Immunofixation for Urine

2.87

5.35

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.88

5.34

5.6

7.9

5.26

6.24

mmol/l

0.41

(3044927) Protein electrophoresis panel - Urine

168

2.28

5.30

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.29

5.30

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

325

1.90

5.22

9.6

7.9

104.00

105.47

mmol/l

1.04

290

(3039000) Anion gap in Blood by calculation

325

1.90

5.22

9.6

7.9

11.60

11.34

mmol/l

0.16

290

(3035350) Ketones [Presence] in Urine by Test strip

1126

10094

1.21

5.10

4.7

3.6

13.83

5.47

estimate

0.39

221

2110

(3004616) Nuclear Ab [Presence] in Serum

211

2.10

5.05

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

219

1605

1.40

5.03

5.1

4.4

0.69

0.66

0.09

463

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

226

2.05

4.97

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1130

10155

1.20

4.93

4.7

3.6

0.00

0.01

estimate

2.20

200

1968

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1530

14142

1.21

4.93

4.6

3.9

14.94

14.72

pmol/l

2.87

1423

12882

(3024522) Salmonella sp identified in Specimen by Organism specific culture

227

2.04

4.91

1.4

—

(3008295) Osmolality of Serum or Plasma

195

2.12

4.82

1.2

1.4

283.00

281.78

mosm/kgh2o

0.07

147

(3014051) Protein [Presence] in Urine by Test strip

636

5414

1.23

4.79

3.5

2.8

0.00

0.04

—

133

(3036525) Urea [Moles/time] in 24 hour Urine

11.46

4.78

1.9

3.7

—

(3000012) Reticulocyte production index

224

2.03

4.71

1.9

2.0

0.94

0.83

0.35

155

(3025468) Yersinia sp identified in Specimen by Organism specific culture

224

2.03

4.71

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

224

2.03

4.71

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

949

8419

1.20

4.69

2.2

2.0

93.70

95.15

pmol/l

0.44

530

4503

(3015377) Calcium [Moles/volume] in Serum or Plasma

744

6449

1.22

4.68

4.8

3.5

2.34

2.36

mmol/l

4.14

680

5865

(3005988) Vibrio sp identified in Specimen by Organism specific culture

226

2.01

4.60

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.53

4.55

1.2

92.78

85.86

—

(3021601) Nitrite [Presence] in Urine by Test strip

1104

9975

1.19

4.36

4.7

3.6

0.00

estimate

0.50

216

2079

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.02

4.31

1.2

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.60

4.30

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

11.69

4.27

6.4

7.2

570.86

559.33

umol/l

—

(3042631) Mycobacterium sp identified in Specimen

226

1.96

4.25

2.1

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

610

5227

1.22

4.25

1.9

1.6

18.39

20.10

nmol/l

2.37

530

4409

(3044242) Glucose [Moles/volume] in Arterial blood

2.63

4.22

1.8

2.2

7.49

7.37

mmol/l

0.06

(3004809) Band form neutrophils/Leukocytes in Blood

298

1.83

4.22

2.9

3.8

1.86

1.22

0.82

262

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

146

2.21

4.21

1.0

1.1

12.57

18.94

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.82

4.18

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

228

1.95

4.16

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

2.81

4.12

1.1

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

174

2.08

4.11

1.7

1.5

1.19

1.26

promille

0.09

144

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

2388

0.73

4.11

1.8

2.0

3.79

3.65

ratio

0.58

132

1852

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.63

4.05

1.1

92.50

96.85

0.20

(3021440) Promyelocytes/Leukocytes in Blood

214

1623

1.35

4.02

5.6

4.5

0.08

0.12

0.63

436

(40758047) Lysozyme [Mass/volume] in Pleural fluid

10.02

4.01

1.0

11.00

14.54

mg/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.21

4.01

1.2

1.1

88.38

84.86

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

718

8140

0.84

4.00

1.9

1.47

1.40

mmol/l

1.10

618

6966

(3050794) Legionella sp Ab [Presence] in Serum

6.44

3.98

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

561

6497

0.82

3.92

3.8

4.4

21.83

21.73

0.05

231

3096

(3028679) Herpes simplex virus Ab [Presence] in Serum

106

2.37

3.90

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.80

3.89

1.3

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.97

3.84

5.9

2.6

9.98

10.35

kpa

0.26

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.97

3.84

5.9

2.6

4.86

4.82

kpa

0.06

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.54

3.79

1.4

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.54

3.79

1.4

1.9

—

(3026480) Teichoate Ab [Titer] in Serum

8.77

3.77

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

188

1414

1.36

3.74

6.9

3.6

1.22

1.23

mmol/l

1.46

168

1209

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

455

1.62

3.74

2.1

2.0

2.73

4.04

iu/l

1.59

201

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

325

1.74

3.74

1.2

1.3

13.90

34.57

u/l

1.66

269

(4198724) Urine methamphetamine measurement

2.41

3.72

1.6

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.58

3.71

2.6

1.6

205.05

148.00

1.60

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

414

4911

0.81

3.66

2.9

3.1

0.77

0.80

ug/l

0.21

257

3055

(3010838) Calcium [Moles/time] in 24 hour Urine

290

1.77

3.66

1.6

2.0

4.30

5.19

mmol/24h

1.24

254

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.79

3.56

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.79

3.56

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.51

3.54

1.7

2.8

1.70

1.15

0.52

(3019225) pH of Specimen

225

1755

1.31

3.50

6.6

3.8

7.37

7.34

1.03

187

1258

(3003327) Ova and parasites identified in Stool by Light microscopy

664

1.49

3.50

1.8

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.38

3.48

1.3

1.2

1.08

1.06

ratio

0.43

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.53

3.40

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

507

1.56

3.38

1.3

1.1

—

(3014891) Appearance of Pleural fluid

7.01

3.36

1.4

—

(3045142) Bone marrow Pathology biopsy report

189

1.92

3.33

1.1

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.72

3.32

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

2.16

3.32

2.7

2.9

458.10

642.27

e6/l

0.93

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

141

2.07

3.32

3.3

2.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.43

3.31

1.2

1.7

—

(3017569) Oxygen content in Arterial blood

2.42

3.30

2.0

2.5

15.27

16.90

1.49

(42529406) Shigella sp [Presence] in Stool by Culture

512

1.54

3.25

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.79

3.25

2.3

2.4

0.29

0.14

e9/l

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.54

3.19

2.0

1.18

1.19

mmol/l

0.20

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.18

3.19

1.3

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.38

3.18

1.0

17.57

6.00

u/l

—

(4015189) Microbial culture of sputum

3.80

3.18

1.7

2.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

507

1.53

3.18

1.3

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

132

1777

0.73

3.15

1.4

1.7

3.50

3.53

mmol/l

0.08

1228

(3044290) Cell count panel - Cerebral spinal fluid

436

1.57

3.15

1.9

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

201

1.85

3.11

1.7

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

719

8016

0.86

3.11

4.3

5.3

1.84

3.24

ug/l

2.08

645

7329

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.44

3.10

1.5

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

195

1.86

3.06

1.7

1.5

56.29

56.12

0.01

124

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.51

3.05

4.2

2.1

—

(21494434) Karyotype in Bone marrow

133

2.04

3.01

1.1

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

211

1.81

3.00

2.1

1.9

27.83

23.41

mg/l

0.21

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.30

2.99

1.2

1.0

103.11

88.38

titre

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.01

2.98

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.01

2.98

1.0

1.2

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

10.01

2.98

4.2

6.2

1.19

0.90

g/l

—

(3025159) Blasts/Leukocytes in Blood

206

1627

1.29

2.96

5.6

4.8

0.00

0.09

3.89

395

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

134

2.03

2.95

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1721

17991

0.86

2.94

4.8

4.0

1.37

1.32

mmol/l

1.86

1606

16548

(3019832) Treponema pallidum Ab [Presence] in Serum

218

1736

1.28

2.94

2.3

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1983

20506

0.85

2.93

17.0

10.9

31.08

27.88

u/l

2.05

1933

19867

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

485

1.52

2.92

1.8

1.2

3.78

3.75

mmol/l

0.09

464

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

356

3002

1.22

2.88

1.3

7.87

11.84

u/ml

0.63

125

1175

(3020961) Endomysium IgA Ab [Titer] in Serum

119

874

1.38

2.82

1.1

600.00

168.81

titre

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

2.04

2.81

2.8

3.0

230.89

223.70

e6/l

0.05

102

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

1.98

2.70

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

257

2111

1.24

2.68

11.0

5.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.22

2.67

3.6

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.18

2.67

1.8

1.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

172

1348

1.30

2.65

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.15

2.64

1.3

1.2

1.16

1.17

mmol/l

0.14

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

464

1.50

2.64

2.1

1.4

36.04

21.50

e6/l

0.21

346

(3000475) Leukocytes [#/volume] in Synovial fluid

440

1.51

2.63

2.1

1.7

16022.80

13139.76

e6/l

0.36

298

(3000330) Specific gravity of Urine by Test strip

117

868

1.36

2.62

4.4

3.4

1.02

ratio

2.61

103

789

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.16

2.60

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

148

1.90

2.60

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

149

1148

1.32

2.60

1.2

106.79

124.76

u/ml

0.24

419

(3023410) Appearance of Cerebral spinal fluid

214

1.74

2.59

2.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

107

2.06

2.57

1.6

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.01

2.56

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

3.06

2.56

1.4

1.9

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.43

2.53

1.5

1.7

28.47

29.81

0.10

(3017732) Neutrophils [#/volume] in Blood

278

2318

1.22

2.53

3.6

3.4

5.04

4.71

e9/l

0.17

247

2002

(3000570) Elastase.pancreatic [Mass/mass] in Stool

561

1.44

2.49

1.5

1.4

246.75

276.45

ug/g

0.74

330

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

545

1.44

2.48

1.8

1.3

506.42

560.59

mg/l

0.49

524

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.38

2.47

2.0

4.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

398

1.52

2.46

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.56

2.44

1.2

1.1

87.00

91.96

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.13

2.43

2.1

2.4

1.19

mmol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

473

1.47

2.43

2.2

1.5

2715.16

940.49

e6/l

0.65

370

(3003740) Influenza virus B Ag [Presence] in Specimen

400

1.51

2.41

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

227

1.68

2.40

2.2

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

634

1.40

2.38

1.4

1.5

8.78

7.81

u/l

0.28

525

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

322

2741

1.20

2.38

1.9

1.8

1.57

1.48

1.21

278

2455

(3049717) Cytology report of Urine Cyto stain

729

1.37

2.36

2.0

2.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.51

2.35

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

161

1.81

2.35

1.7

1.5

25.45

29.93

0.24

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1767

18342

0.88

2.34

5.4

4.8

6.03

5.93

mmol/l

1.76

1630

16836

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

1.80

2.31

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.12

2.28

2.2

1.8

169.78

99.17

ng/l

0.46

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

293

1.58

2.28

8.9

2.9

12.05

7.81

pmol/l

1.63

293

(3002079) Sodium [Moles/time] in 24 hour Urine

2.23

2.27

1.0

1.3

132.44

186.41

mmol/24h

1.82

(3028707) Methadone [Presence] in Urine by Screen method

424

1.47

2.23

3.0

2.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.56

2.21

1.4

1.9

—

(3014271) Vancomycin [Susceptibility]

2.20

2.21

3.2

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.41

2.19

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

168

2074

0.80

2.17

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.01

2.14

1.1

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.37

2.12

1.6

2.3

654.88

475.28

e6/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

228

1.63

2.11

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.21

2.09

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.08

2.06

1.3

1.7

—

2789.33

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.11

2.02

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

2.01

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.51

2.01

1.7

2.0

—

(3024263) Appearance of Synovial fluid

2.01

2.00

1.4

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1417

13482

1.11

2.00

4.0

3.2

60.87

48.49

u/l

4.07

1339

12690

(3016018) Differential panel - Cerebral spinal fluid

240

1.59

1.98

2.2

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2019

20714

0.87

1.98

35.0

16.7

88.26

77.86

umol/l

11.91

1999

20421

(3036071) Salmonella sp Ab [Titer] in Serum

2.15

1.98

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

119

1.86

1.97

1.0

1.1

9.14

5.36

iu/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.36

1.94

1.2

83.57

97.15

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.19

1.94

1.1

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.97

1.93

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.75

1.93

9.0

6.9

10.93

10.82

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

172

1.69

1.93

1.1

1.3

2.18

2.10

mmol/l

0.12

166

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.84

1.92

1.5

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

825

7633

1.12

1.92

4.5

3.5

0.00

0.03

estimate

5.17

193

1708

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

861

0.71

1.90

1.0

1.1

1.44

1.48

g/l

0.59

861

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.01

1.90

2.8

4.1

—

(40768800) Prostate Pathology biopsy report

541

0.64

1.87

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.94

1.84

1.2

1.1

1104.33

1516.45

miu/ml

1.43

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.21

1.84

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

1.83

1.82

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

1.83

1.82

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

138

1.75

1.79

1.7

6.63

6.49

mmol/l

0.12

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.76

1.79

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

116

916

1.28

1.77

1.6

1.7

0.36

0.32

mg/l

0.36

456

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

147

1.71

1.73

1.4

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.2

4.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.14

1.71

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

656

1.32

1.71

1.7

297.94

286.09

mu/l

0.08

604

(3011985) Renin [Units/volume] in Plasma

250

1.53

1.70

2.0

1.5

85.12

48.22

mu/l

0.47

223

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

433

1.39

1.69

3.1

1.9

0.95

0.82

nmol/l

0.60

377

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

111

1.81

1.68

2.1

2.8

44.18

40.73

0.38

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.19

1.67

1.3

1.1

—

(40765096) Chromosome analysis panel by Banding

2.19

1.67

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.03

1.64

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.93

1.64

3.0

2.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

462

1.37

1.62

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.58

1.61

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.58

1.61

1.6

138.60

259.79

umol/24h

—

(3045414) Leukocytes [Presence] in Urine

200

1695

1.19

1.61

2.6

2.1

0.00

0.01

estimate

0.78

395

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

198

1.57

1.59

5.0

3.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.00

1.58

1.2

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

447

0.64

1.57

1.1

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

600

5510

1.12

1.57

5.0

3.7

0.01

0.00

estimate

0.31

193

1906

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

330

1.43

1.56

2.2

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1962

19112

1.12

1.54

29.1

13.0

26.05

25.62

mg/l

0.24

1758

15329

(40761536) Microorganisms panel - Urine sediment

175

1473

1.20

1.53

5.0

3.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

459

1.36

1.53

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

104

829

1.26

1.51

3.0

2.1

—

(36660697) Celiac disease serology panel - Serum

173

1457

1.20

1.51

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

1.87

1.50

1.4

1.3

5.63

4.84

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1259

12017

1.09

1.49

3.4

2.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

101

1.79

1.48

1.3

1.1

105.98

78.85

u/l

0.75

(3051387) C reactive protein [Mass/volume] in Capillary blood

427

0.65

1.46

5.4

3.1

24.49

28.07

mg/l

0.27

278

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

413

3726

1.13

1.46

3.9

3.0

2.45

mmol/l

0.35

355

3346

(3002619) Bacteria identified in Specimen by Culture

2.37

1.45

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

592

5456

1.11

1.45

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

102

1.77

1.44

1.3

1.1

36.30

21.57

u/l

0.81

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

1.69

1.43

1.2

111.05

113.20

pmol/l

0.07

125

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

109

881

1.25

1.43

1.1

—

0.85

—

(3027944) Amphetamines [Presence] in Urine

128

1054

1.23

1.41

2.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

129

1064

1.22

1.40

2.8

2.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.76

1.34

7.0

2.7

28.77

20.57

mu/l

0.37

(3027008) Opiates [Presence] in Urine

129

1070

1.22

1.34

2.8

2.0

—

(3004775) Volume in Urine collected for unspecified duration

136

1.62

1.32

2.7

2.1

716.18

641.30

0.25

(3016879) Cocaine [Presence] in Urine

120

991

1.22

1.31

2.8

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

509

0.70

1.31

1.9

1.6

—

(3028300) Cannabinoids [Presence] in Urine

129

1074

1.21

1.30

2.8

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

784

1.25

1.29

1.3

1.5

29.61

24.60

iu/l

0.65

667

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1779

17301

1.09

1.29

5.6

4.7

1.97

1.89

mu/l

0.44

1665

15885

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

482

1.31

1.29

1.1

1.87

4.29

eliau/ml

—

(3033099) Centromere Ab [Titer] in Serum

2.36

1.29

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.97

1.22

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

711

1.25

1.19

5.3

2.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.18

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

128

1078

1.20

1.17

2.8

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

413

1.31

1.13

2.9

2.3

339.32

96.81

ug/min

1.26

245

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.65

1.12

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

1.12

1.0

11.52

43.66

iu/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1764

18064

0.92

1.12

6.9

5.9

39.44

38.96

mmol/mol

1.35

1673

16908

(3019150) Specific gravity of Urine by Refractometry

484

4476

1.10

1.11

4.8

3.6

1.02

kg/l

0.70

346

2907

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

238

2116

1.14

1.10

2.3

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.38

1.09

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

144

1.53

1.08

2.2

2.5

36.29

34.56

mg/l

0.05

103

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

183

2084

0.87

1.07

1.3

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.71

1.05

2.5

2.0

40.20

103.72

ug/min

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

332

1.33

1.03

1.8

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1623

16652

0.93

1.03

34.8

16.8

331.93

333.68

g/l

11.02

1613

16528

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.27

1.03

1.6

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.06

1.02

1.1

1.4

1973.69

24.77

g/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.84

1.02

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

108

910

1.19

1.01

2.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

139

1.51

1.00

1.7

1.4

78.71

84.35

umol/l

0.28

139

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.18

0.98

1.8

2.7

0.80

0.30

u/field

—

(3017509) Phencyclidine [Presence] in Urine

2.18

0.98

1.2

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

1.31

0.97

1.1

1.99

1.98

u/ml

0.00

183

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1.38

0.97

1.2

1.4

295.96

300.16

pmol/l

0.02

192

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

217

1943

1.13

0.93

4.0

4.6

11.28

23.69

ug/l

1.17

179

1604

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

589

1.23

0.93

1.3

225.12

217.34

miu/ml

0.04

269

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

269

1.34

0.92

1.1

1.0

2.26

eliau/ml

0.00

125

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.82

0.92

1.8

1.5

1631.80

693.18

nmol/24h

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

1.44

0.92

2.1

1.3

9141.18

95461.50

e6/l

1.29

108

(3019550) Sodium [Moles/volume] in Serum or Plasma

1990

19548

1.08

0.91

34.1

14.7

139.32

139.70

mmol/l

9.46

1955

19094

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

151

1.46

0.90

3.9

6.1

82.83

37.64

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.91

0.88

1.1

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

1.56

0.87

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

981

1.17

0.87

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

307

1.31

0.87

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

369

1.28

0.87

1.2

1.1

8.78

5.51

u/ml

0.68

206

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.59

0.84

1.4

1.3

284.14

484.86

u/l

0.69

(3009508) Creatinine [Moles/volume] in Urine

708

6743

1.07

0.80

4.3

3.4

7.17

8.23

mmol/l

8.14

618

5747

(3004716) Salmonella sp identified in Stool by Organism specific culture

104

897

1.17

0.79

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

123

1.47

0.77

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

583

5534

1.07

0.73

3.9

3.0

0.01

0.02

estimate

0.72

177

1648

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

2.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.00

0.72

1.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.72

1.2

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.80

0.72

1.4

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.61

0.72

1.3

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.75

0.71

1.1

1.0

7.15

8.93

mg/g

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1991

19613

1.07

0.71

34.6

14.8

3.99

3.98

mmol/l

2.01

1958

19120

(1761482) Bacteria [#/volume] in Urine by Culture

444

1.22

0.71

5.0

4.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.71

0.70

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

248

2282

1.10

0.69

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

226

2460

0.91

0.68

2.5

2.3

14.29

14.00

nmol/l

0.24

207

2271

(3022621) pH of Urine by Test strip

160

1441

1.12

0.67

3.2

2.6

6.01

6.07

0.34

113

949

(3006653) Thiamine [Moles/volume] in Blood

102

1.47

0.67

1.3

139.84

138.02

nmol/l

0.06

102

(3008401) Mugwort IgE Ab [Units/volume] in Serum

358

1.23

0.65

1.2

1.1

1.41

1.30

u/ml

0.05

163

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.61

0.65

1.7

1.5

38.21

41.42

g/l

—

(1002224) Polysomnography panel

115

1019

1.13

0.64

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

163

1.35

0.64

1.1

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

415

3915

1.07

0.63

1.8

1.7

59050874.51

33816843.20

pmol/l

0.23

337

3312

(3026389) Candida sp identified in Specimen by Organism specific culture

207

1.31

0.63

1.6

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

1.27

0.62

1.1

1.0

0.07

0.39

u/ml

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

105

0.57

0.61

1.7

23.50

27.40

umol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.67

0.61

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.61

1.0

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.50

0.59

1.5

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.58

0.56

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

364

3438

1.07

0.55

1.9

1.5

—

(3045424) Erythrocytes [Presence] in Urine

104

927

1.13

0.55

2.5

2.1

0.04

0.01

estimate

0.29

308

(3009466) Valproate [Moles/volume] in Serum or Plasma

330

1.22

0.54

6.3

5.8

350.80

354.30

umol/l

0.05

293

(40768804) Tissue Pathology biopsy report

776

7500

1.05

0.53

2.3

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

649

6248

1.05

0.52

5.4

4.1

19.16

6.16

mg/mmol

5.06

429

3959

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.61

0.52

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

161

1.31

0.51

1.3

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

677

1.14

0.51

1.6

21.48

15.52

u/ml

0.16

169

(3012516) Albumin [Mass/volume] in Urine

635

6122

1.05

0.48

4.5

3.4

94.22

37.76

mg/l

4.93

427

3939

(3014133) Dog dander IgE Ab [Units/volume] in Serum

308

1.20

0.48

1.1

4.22

3.49

u/ml

0.13

157

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

177

0.73

0.47

1.4

1.5

44.74

53.41

ug/l

0.61

177

(3041806) Other cells [#/volume] in Blood by Manual count

1.47

0.47

1.2

1.7

0.71

0.48

e9/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

292

1.20

0.45

1.1

1.73

6.19

u/ml

2.39

131

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

895

1.11

0.44

3.0

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

1.32

0.44

1.1

0.56

6.03

nmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

1.33

0.42

3.6

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.38

0.41

1.3

1.5

8.37

8.57

ug/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

518

0.87

0.40

1.6

989.68

999.08

mu/l

0.02

438

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

79.78

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

429

1.14

0.38

1.2

1.1

1.75

2.03

u/ml

0.11

240

(44806420) Estimation of glomerular filtration rate

179

1.23

0.37

2.5

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

116

1.29

0.37

1.1

—

(3008898) HLA-B27 [Presence]

687

1.11

0.36

1.1

—

(40768793) Breast Pathology biopsy report

365

1.15

0.36

1.4

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

146

0.75

0.36

1.5

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

352

0.85

0.35

1.6

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.33

0.33

1.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

100

1.30

0.33

3.5

2.3

191.15

151.64

nmol/l

0.51

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.30

0.33

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

219

1.19

0.33

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.35

0.31

1.3

1.4

—

(4024509) Urine culture

787

0.91

0.30

2.8

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

399

0.88

0.30

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

217

0.83

0.29

1.4

153.88

176.34

pmol/l

0.58

217

(3001019) Free T4 and TSH panel - Serum or Plasma

907

1.07

0.25

1.5

1.6

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1630

16147

1.03

0.24

33.6

16.4

13.88

13.50

18.72

1611

15915

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

211

0.85

0.23

1.8

—

(3025577) Chromium [Mass/volume] in Blood

0.75

0.22

2.1

1.89

2.08

ug/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.18

0.22

1.4

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

200

1.15

0.22

1.4

1.3

—

(40768443) Skin Pathology biopsy report

787

1.07

0.22

1.1

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

13.34

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

26.47

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

1.9

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

219

2268

0.96

0.20

4.6

31.07

31.73

0.43

166

1460

(1617658) Protocol used for examination of sentinel lymph nodes

115

0.78

0.20

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

249

0.88

0.19

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

226

2187

1.04

0.19

1.6

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.15

0.17

1.6

1.3

4.83

10.07

mmol/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

120

1.17

0.16

1.4

1.2

0.63

0.57

ratio

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

216

1.11

0.15

1.3

23.11

22.89

u/l

0.01

175

(44813793) Dust mix specific IgE antibody measurement

119

0.84

0.15

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

159

0.88

0.13

1.0

670.89

703.20

ng/l

—

101

(4146454) Self-monitoring of blood glucose

190

0.89

0.13

2.9

2.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

312

0.93

0.11

1.6

1.5

52.85

60.17

ug/l

0.33

265

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

172

1.11

0.11

16.9

21.0

1175.16

1398.22

nmol/l

0.83

167

(3025130) Human papilloma virus identified in Specimen

209

0.91

0.11

1.9

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

197

1926

1.02

0.10

1.6

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.15

0.10

7.3

6.3

9.00

7.92

0.19

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.15

0.10

3.6

3.2

50.73

45.91

0.42

(3005033) Fetal Nuchal fold Thickness US

238

0.92

0.09

1.4

1.5

1.27

0.01

176

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

164

1.10

0.09

11.6

17.1

808.17

805.39

nmol/l

0.01

159

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.09

0.09

3.0

2.0

2.80

79.89

ug/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

488

1.05

0.09

2.7

2.3

3489.79

4612.75

u/l

0.15

178

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.81

0.08

1.4

2.7

0.99

1.03

ug/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.14

0.08

2.0

1.9

1.08

0.84

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.83

0.07

2.5

2.7

—

693.03

—

(4211845) Urine protein measurement

0.86

0.07

2.6

3.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

244

0.94

0.06

1.4

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.11

0.06

1.9

1.5

34.03

24.09

umol/l

0.38

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

223

0.94

0.06

1.5

1.6

—

(4034850) Laboratory test

597

0.97

0.05

18.2

8.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1845

18481

0.99

0.05

26.4

12.8

81.53

83.52

ml/min/173m2

2.86

1726

16923

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

120

1.08

0.04

1.2

1.3

—

77.50

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

129

1271

1.02

0.04

1.2

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

290

0.96

0.03

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

738

1.02

0.03

5.0

3.7

108.54

3371.67

u/ml

1.33

645

(4281824) Cell count and differential, peritoneal fluid

162

1.05

0.02

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

1.04

0.01

1.2

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

237

0.97

0.01

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

327

0.98

0.01

1.3

1.1

1.20

1800.48

iu/ml

—

(40768441) Liver Pathology biopsy report

144

1.04

0.00

1.2

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

316

0.98

0.00

1.8

2.8

43.09

1029.71

u/ml

0.64

311

(3002256) Pathology report gross observation

258

2586

1.00

0.00

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

0.99

0.00

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

0.97

0.00

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

177

1.02

0.00

1.2

2.5

5.31

7.64

umol/l

—

128

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

295

0.98

0.00

1.5

1.00

1.17

ratio

0.53

186

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

295

0.98

0.00

1.5

1.23

1.20

ratio

0.09

186

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

295

0.98

0.00

1.5

0.86

0.95

ratio

0.96

186

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

155

1.03

0.00

1.6

2.2

9.18

1.76

u/field

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

105

1.05

0.00

1.4

1.2

10.55

7.70

mm/h

0.34

105

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

0.97

0.00

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

0.03

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.2

—

1.31

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.00

0.00

1.0

—

(3020650) Glucose [Presence] in Urine

0.93

-0.00

1.4

2.0

0.00

0.08

estimate

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.35

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

8.21

—

(3006462) Nitrate [Presence] in Urine

0.97

-0.00

2.6

3.7

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

172.43

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.94

-0.00

2.8

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.97

-0.00

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

0.04

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

1.86

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(3026470) Cobalt [Mass/volume] in Blood

0.94

-0.00

1.9

2.1

5.69

3.63

ug/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.93

-0.00

1.2

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

412.40

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

2.60

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.98

-0.00

1.0

33.40

59.49

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_OTHILLHEART and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.38 [2.04, 2.77]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.038

During the follow-up period (1.1.1998 — 31.12.2019), 1023 out of 3349 females with I9_OTHILLHEART died.

Males

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.371 [2.05, 2.75]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.039

During the follow-up period (1.1.1998 — 31.12.2019), 1115 out of 6178 males with I9_OTHILLHEART died.

Mortality risk

Mortality risk for people of age

years, who have I9_OTHILLHEART.

N-year risk	Females	Males
1	0.213%	0.452%
5	1.362%	2.737%
10	3.343%	6.988%
15	5.763%	13.198%
20	10.061%	21.709%

Relationships between endpoints

↥

Index endpoint: I9_OTHILLHEART – Other or ill-defined heart diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or ill-defined heart diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints